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ABSTRACT 
Background. Muscle atrophy is determined by specific molecular pathways controlling protein 
synthesis and degradation. Physical inactivity and muscle unloading are normally related to 
decreased muscle mass, but pathways controlling muscle atrophy during inactivity in humans 
are not presently clarified. Previous publications showed in animals a link between muscle 
atrophy and oxidative stress or inflammation. Inactivity was shown to be associated to 
inflammation and oxidative stress upregulation. Inflammation is controlled by several factors 
and polyunsaturated fatty acids (PUFA) of n-3 and n-6 series are known to play an anti-
inflammatory and proinflammatory role, respectively: their relative content in cell membranes 
reflects the inflammatory condition at whole body level. Oxidative stress derives from reactive 
oxygen species (ROS) production in excess to the scavenging activity of antioxidant systems. 
Homocysteine is a non-proteinogenic amino acid: increased homocysteine concentration in 
plasma is directly linked to oxidative tissue damage. Glutathione (GSH) is an antioxidant 
tripeptide: upregulated GSH availability is considered a response to occurred ROS production. 
Glutamine, is synthesized by muscles and it is utilized by immune cells: its depletion occurs in 
critically ill patients. Nutrition can play a pivotal role during inactivity: dietary protein 
supplementation can ameliorate protein turnover while energy intake restriction was linked to 
enhanced muscle atrophy. Aims and experimental design. The aim of the present thesis is to 
investigate in human healthy volunteers: i) the impact of physical inactivity on inflammation 
and oxidative stress as potential mechanisms underlying muscle atrophy; ii) the impact of 
energy balance, and of protein supplementation during inactivity on muscle atrophy, oxidative 
stress and glutamine availability. Different metabolic tests were performed in five separate 
experimental bed rest campaigns: STBR-IP, WISE, Valdoltra Bed Rest 2006 – 2007 – 2008. 
Results. Eucaloric experimental bed rest at normal protein intake: decreased n-3 and increased 
n-6 PUFA in red blood cell membranes; increased arachidonic to eicosapentaenoic acid ratio 
(Valdoltra Bed Rest 2006 – 2007 – 2008); increased homocysteine plasma concentration 
lowering clearance by remethylation (WISE); reduced plasma glutamine concentrations 
lowering its de novo synthesis (STBR-IP); decreased muscle thickness and myofibres 
pennation angle; increased muscle protein carbonylation and GSH availability in direct 
correlation with atrophy progression (Valdoltra Bed Rest 2006 – 2007). High protein intake 
during bed rest significantly lowered homocysteine concentrations by increased clearance by 
transsulfuration. Calorie restriction (20% reduction) during muscle unloading failed to affect 
changes of glutamine kinetics and availability mediated by inactivity (STBR-IP). During bed 
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rest, excessive fat mass gain, when matched to stable fat mass maintenance, significantly: 
reduced vastus lateralis muscle thickness; increased plasma leptin, myeloperoxidase and C-
reactive protein levels; enhanced, in red blood cells, activity and availability of GSH 
(Valdoltra Bed Rest 2006 – 2007). Discussion. The experimental bed rest mediated increase in 
n-6 relatively to n-3 polyunsaturated fatty acids of erythrocytes membranes confirm bed rest 
can play a pro-inflammatory role at whole body level. Upregulated levels of homocysteine 
plasma concentrations after bed rest underline that immobility can induce whole body 
oxidative stress and cardiovascular risk. Significant correlation between changes in protein 
carbonylation, as marker of oxidative damage, or antioxidant GSH availability, with muscle 
atrophy induced by bed rest, strongly suggest that physical inactivity can induce muscle 
atrophy by pathways involving oxidative stress. Carbonylated proteins are, in fact, directly 
and rapidly degraded by the proteasome system. Moreover, dietary protein supplementation 
during physical inactivity potentially reduces oxidative damage lowering plasma 
homocysteine concentration. This evidence is confirmed by publications showing, in animals, 
that high protein diet can increase homocysteine transsulfuration rate. Interestingly, during 
inactivity, positive energy balance, when matched to fat mass maintenance, was here shown to 
induce greater muscle atrophy together with greater upregulation of whole body inflammation 
and oxidative stress. Thus, such observations further suggest that inactivity mediated atrophy 
can be triggered and regulated by oxidative stress and inflammation. Calorie restriction 
probably failed to affect glutamine kinetics due to the low extent of energy intake reduction, 
but glutamine metabolism can be hypothesized to be independent from energy balance during 
inactivity. 
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INTRODUCTION 
Why study physical inactivity? 
The impact of physical exercise on human physiology has been studied during the last fifty 
years, yielding almost 185200 published works. Consequences deriving from low activity or 
from immobility were studied in humans over the last five decades and results were published 
in nearly 4000 articles. This emphasizes the scientific relevance of investigating the 
relationship between physical activity level and human health. Moderate exercise was 
demonstrated to play a positive role on health, such that the World Health Organization 
(WHO) is developing recommendations regarding required amount of physical activity in 
relation to age and gender ("Global recommendations on Physical Activity for Health" – 
WHO). On the contrary inactivity is considered to play a strongly negative role on human 
health, contributing to billions of deaths from chronic diseases, and increasing prevalence of 
physical disabilities, especially in elderly people (Fontana, 2009a). Immobility, or low 
activity, are frequent conditions, differentially associated to physiologic and pathologic states. 
Notably, social changes occurring in the last years has led to the onset of the so called 
“sedentary lifestyle”, a severe reduction of average physical activity level, with undesired 
consequences in health (Chaput and Tremblay, 2009). Moreover, variably prolonged periods 
of inactivity can be due to several illness conditions: serious trauma and neurological diseases 
can preclude the possibility to walk or move, possibly leading to long term immobility. 
Equally, diseases belonging to internal medicine and cardiology, as well as all surgical 
interventions, often require prolonged recovery periods in the horizontal position. Finally, 
muscle inactivity also characterizes the spaceflight microgravity environment where physical 
effort for initiating movements in the environment is drastically reduced. All these conditions 
underline the importance of fully characterizing net effects of inactivity on human physiology. 
The impact of physical inactivity on metabolism is difficult to assessed in hospitalized 
patients due to the significant contribution of the underlying pathology. Studies associating 
activity level and parameters characterizing selected diseases can contribute to the elucidation 
of the consequences of a sedentary lifestyle on human health (Davy et al., 1998). To clearly 
elucidate the net effect of inactivity, different experimental models can be applied. Beside 
lowerlimb casting, experimental bed rest is the most accepted model of physical inactivity. 
During bed rest studies human healthy volunteers lay in bed for different periods, performing 
all activities in the horizontal position. Bed rest studies, thus, allow to investigate causes of 
metabolic and morphologic modifications occurring as a net consequence of physical 
inactivity. 
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Besides muscle atrophy, which is the most evident effect of immobility (Alkner and Tesch, 
2004; Berry et al., 1993), unloading was shown to significantly modify the endocrine milieu 
(Biolo et al., 2005a). 
Data reported and discussed in the present thesis were collected during five different bed rest 
campaigns: 1) Short term bed rest-integrated physiology (STBR-IP) at the Clinical Research 
Center of the DLR-German Aerospace Institute (Cologne, Germany); 2) Women International 
Space Simulation for Exploration (WISE) at MEDES Clinical Research Facility of the 
Rangueil University Hospital (Toulouse, France); 3) Valdoltra Bed Rest 2006; 4) Valdoltra 
Bed Rest 2007; 5) Valdoltra Bed Rest 2008, Valdoltra Orthopaedic Hospital (Ankaran, 
Capodistria, Slovenia). Within these study campaigns, the following bed rest mediated 
changes were evaluated: a) on factors reflecting oxidative stress and inflammation levels, b) 
on antioxidant system activation and c) on muscle atrophy. Obtained results elucidated a 
possible cause of muscle atrophy related to physical inactivity. Additionally, the impact of 
experimental changes of energy or protein intake during bed rest, on muscle atrophy, 
inflammation and oxidative stress were also evaluated. 
 
Muscle atrophy 
Muscle atrophy is defined as a decrease of muscle mass. The maintenance of skeletal muscle 
mass is determined by the balance between protein synthesis and protein degradation. Skeletal 
mass is increased when there is a net gain in protein synthesis which can occur following 
exercise training (Biolo et al., 1997). In contrast, skeletal muscle mass is reduced when 
degradation overcomes protein synthesis rate. Atrophy is linked to muscle weakness, as force 
development potential is almost directly related to muscle mass or volume (Seynnes et al., 
2008). Muscle wasting (cachexia) is a co-morbidity feature frequently occurring in several 
common diseases, including e.g. cancer (Fearon and Moses, 2002), Acquired Immune 
Deficiency Syndrome (AIDS) (Dalakas and Pezeshkpour, 1988), congestive heart disease 
(Lunde et al., 2001), chronic obstructive pulmonary disease (COPD) (Couillard and Prefaut, 
2005), renal failure (Mitch, 2006) and severe burns (Pereira et al., 2005).  Clinical importance 
of muscle atrophy is underlined by poor prognosis characterizing cachectic patients in these 
setting of diseases (Dimitriu et al., 2005). 
Molecular pathways regulating protein synthesis and degradation. 
Protein synthesis 
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Studies performed in murine and cell models revealed the importance of Akt (also called 
protein kinase B) family factors (Akt-1, Akt-2, Akt-3) in the regulation of general protein 
synthesis in skeletal muscle. Akt factors are, in fact, serine/threonine-specific protein kinases, 
playing a pivotal role in muscle hyperthrophy (Bodine et al., 2001b). Activation of signaling 
cascades involving insulin-like growth factor 1 (IGF-1) and phosphatidylinositol 3-kinase 
(PI3K) induces Akt phosphorylation and activation (Bodine et al., 2001b). Akt, in turn, was 
shown to activate eukaryotic translation initiation factor 2B (eIF2B) by stimulation of 
glycogen synthase kinase-3β (GSK-3β) (Rhoads, 1999). In parallel, Akt can activate initiation 
of protein translation stimulating p70S6 kinase (p70S6K) by mammalian target of rapamycin 
(mTOR) (Terada et al., 1994). Interestingly, a period of resistance training exercise induces 
muscle hypertrophy associated with increases in phosphorylated Akt, GSK-3b and mTOR 
(Leger et al., 2009). 
 
Proteolytic pathways 
Several proteolytic systems, can contribute to the degradation of muscle proteins. In vitro and 
animal studies, showed Ca2+-activated proteases (Calpain) and the proteasome system play 
important roles in muscle protein breakdown during muscle atrophy (Furuno and Goldberg, 
1986; Ikemoto et al., 2001; Purintrapiban et al., 2003). Moreover, caspase-3 may also 
contribute to selected forms of muscle atrophy (Du et al., 2004). Actomyosin complexes 
represent 50–70% of muscle proteins (Tidball and Spencer, 2002) and, as the proteasome 
system can degrade only monomeric contractile proteins (i.e. actin and myosin) (Goll et al., 
2003), monomeric myofilaments must be released from actomyosin complexes to be degraded 
by the proteasome (Goll et al., 2003). Both calpain and caspase-3 can play a key role in 
producing actomyosin disassociation (Du et al., 2004; Goll et al., 2003; Tidball and Spencer, 
2002). Calpain activity is increased by elelvations of cytosolic calcium concentrations (Goll et 
al., 2003) and caspases are cascade activated proteases triggered by several signaling 
pathways (Primeau et al., 2002): their activation can result in protein breakdown as well as in 
apoptosis. In the proteasome system, degradation can occur by the 26S subunit (Grune et al., 
2003; Grune and Davies, 2003) which is composed by the 20S and by the regulatory 19S 
complex, the latter playing an important role in adenosine triphosphate (ATP)-dependent 
degradation (DeMartino and Ordway, 1998). Protein substrates are marked for degradation in 
the 26S proteasome pathway by covalent addition of ubiquitin. This requires the ubiquitin-
activating enzyme (E1), specific ubiquitin-conjugating enzymes (E2), and ubiquitin protein 
ligase enzymes (E3). Interestingly, two unique ubiquitin E3 ligases, atrogin1 and muscle ring 
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finger-1 (MuRF-1), were shown to be involved in skeletal muscle atrophy (Bodine et al., 
2001a; Gomes et al., 2001). MuRF-1 was shown to be directly and indirectly upregulated by 
Forkhead family of transcription factors (FoXO) (Stitt et al., 2004) and by the NF-kB 
transcription factor (Sandri et al., 2004). Ubiquitinated proteins are recognized and bound by 
the 19S regulators of the 26S proteasome, that removes the polyubiquitin chain and unfolds 
the substrate protein for final degradation into the 20S core proteasome (Grune et al., 2003).
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Figure 1 
 
 
Figure 1 summarizes molecular pathways controlling muscle mass maintenance 
by modulation of protein synthesis and degradation. 
IGF, Insulin-like growth factor; PI3K, phosphatidylinositol 3-kinase; AKT, 
protein kinase B; mTOR, mammalian target of rapamycin; p70S6K, p70S6 
kinase; GSK-3β, synthase kinase-3β; eIF2B, eukaryotic translation initiation 
factor; NF-kB, nuclear factor kappa B, FoXO, Forkhead family of transcription 
factors; MuRF-1, muscle ring finger-1. 
PROTEIN  SYNTHESIS PROTEIN DEGRADATION 
IGF 
PI3K 
Akt 
mTor 
P70S6k 
GSK-3 
eIF2B 
↑ Ca++ 
Calpain 
Caspases 
Actomyosin Actin Myosin 
Atrogin 
MuRF-1 
Actin Myosin 
Ub Ub 
Proteasome 
NF-kB 
FOXO 
 11 
Physical inactivity and muscle atrophy 
Several previous works showed that physical inactivity can significantly induce muscle 
atrophy. A bed rest period of 20 days significantly induced 9 or 10 % thickness reduction in 
postural muscles (Kawakami et al., 2000) (Akima et al., 2005) . Equally, during one month of 
bed rest (Berry et al., 1993)  quadriceps muscles uniformly reduced their cross sectional area. 
Specific morphology changes occurring as a consequence of one month of bed rest were 
demonstrated also on selected muscles. Vastus intermedius was, in fact, shown to be reduced 
by 12-16 % and a 9 % atrophy was assessed in knee extensors after seven weeks of 
experimental bed rest (Ellis et al., 1993). Vastus lateralis showed a 17 % decrease in cross 
sectional area as a consequence of an equal period of inactivity (Ferretti et al., 1997), in this 
way demonstrating this muscle is particularly affected by unloading. More prolonged periods 
of bed rest induced similar changes in human muscle atrophy: eight weeks of bed rest reduced 
the cross sectional area of thigh extensors by 14-17 % (Ferretti et al., 2001) and knee extensor 
muscles showed a similar cross sectional area reduction after the same experimental period 
(Berg et al., 1997). After 54 days of muscle unloading (Mulder et al., 2006) a linear decrease 
of 14 % in quadriceps femoris cross sectional area over the experimental period was 
demonstrated and a similar reduction was shown after a 120 day bed rest period (Leblanc et 
al., 1992) in thigh muscle mass. Thickness of postural calf muscles (soleus, flexor hallucis 
longus, and tibialis posterior) decreased by 9-12 % after 30 days of bed rest (Ellis et al., 1993). 
A previously published study demonstrated a 13 % and a 9 % cross sectional area decrease in 
soleus and in gastrocnemius after 1 month bed rest, respectively (Berry et al., 1993). An equal 
experimental period induced a 10 % calf volume and a 5 % cross sectional area reduction 
(Convertino et al., 1989). 
In another study (Leblanc et al., 1988) 35 days of bed rest induced a 12 % decrease in muscle 
cross sectional area of postural plantar flexors muscles (gastrocnemius and soleus), whereas 
postural dorsiflexor muscles were not significantly affected. In a recently published study, 5 
weeks bed rest were demonstrated to induce a 12 % reduction in cross sectional area of the 
ankle plantar flexors (Berg et al., 2007). Greater atrophy of calf muscles was demonstrated 
during a 5 week bed rest study in which soleus and gastrocnemius muscles were shown to lose 
25 % cross sectional area (Gogia et al., 1988). After extremely long term experimental periods 
(120 days) a 30 % decrease in calf muscle mass was measured (Leblanc et al., 1992). 
Thus, leg muscles are principally affected by bed rest, with thigh and calf muscles being 
almost equally sensitive to unloading. 
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These and other published data demonstrate that the loss of lean body mass (LBM) during 
prolonged periods of experimental inactivity in healthy volunteers, occurs at an average rate 
of 3-4% per week. This value is linearly maintained for the initial stages of the bed rest period, 
reaching a plateau after five or six weeks. 
Nitrogen balance and whole body protein synthesis rate, as parameters affecting muscle mass 
maintenance, were measured in the crew of two Spacelab Life Sciences (SLS) shuttle 
missions before, during, and after spaceflight (Stein et al., 1996). In this condition of muscle 
unloading, a rapid weight decline during the first 5 days was observed, follwoed by 
stabilization. In addition the daily mean nitrogen balance decreased by almost 70% during 
flight, corresponding to a loss of approximately 1 kg of LBM over 14 days.  
Methods for quantification of muscle mass changes. 
Both muscle thickness and cross-sectional-area changes are reliable and direct markers of 
variations in muscle volume (Mathur et al., 2008) and force development (Akagi et al., 2008). 
Magnetic Resonance Imaging (MRI), is considered to be the gold standard for reliable 
detection of muscle volume and size changes: by this technique even little variations of 
muscle size can be accurately detected. It does not apply ionizing radiation, but uses a 
powerful magnetic field to align the nuclear magnetization of hydrogen atoms in body water. 
Radio frequency fields are used to systematically alter the alignment of this magnetization, 
causing the hydrogen nuclei to produce a rotating magnetic field detectable by the scanner. 
This signal can be modified by other magnetic fields in order to construct an image of the 
body providing contrast between the different soft tissues (Burghart and Finn Carol, 2010). 
Ultrasonography is another reliable imaging method that can be applied to the analysis of the 
musculoskeletal system, based on computerized analysis of ultrasonic acoustic echoes. 
Ultrasound imaging can allow proper estimation of muscle thickness changes as direct 
evidence of muscle bulk alterations. Reliability of ultrasound imaging was validated versus 
MRI as a gold standard (Arbeille et al., 2009) and moreover, this technique allows a proper 
determination of muscle fibre orientation with respect to aponeurosis, i.e. pennation angle 
(Narici and Cerretelli, 1998). Pennation angle, is a reliable marker of muscle maintenance. 
Reduction of pennation angle was previously published to be associated to increased muscle 
atrophy. Aging (Morse et al., 2005) and immobilization (Narici and Cerretelli, 1998; Reeves 
et al., 2002), in fact, were shown to negatively affect muscle architecture leading to a 
sarcomere orientation remodelling and to a concomitantly enhanced muscle atrophy (de Boer 
et al., 2007). Interestingly, reductions in pennation angle were shown to be directly related to 
muscle thickness decreases (Ichinose et al., 1998).  
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 shows an ultrasound image of the human vastus lateralis muscle 
obtained in the sagittal plane. Muscle fibres fascicles are clearly visible as the 
structures stretching from the superficial and deep aponeuroses. t, muscle 
thickness; α, pennation angle. 
 
Whole body bioimpedance analysis is also considered a reliable method to assess changes of 
total muscle mass (Lim et al., 2009). Bioimpedance analysis determines the opposition of 
body tissues to an external and low intensity electric current flow: this values can be used to 
calculate total body water which in turn allows estimation of fat-free body. This parameter is 
directly associated to muscle mass changes and allows determination, by difference, of body 
fat (Lim et al., 2009). Thus, bioimpedance analysis is a suitable method also for the 
assessment of body fat, and of body composition changes. 
Measurements of body composition can be reliably performed by dual energy X-ray 
absorptiometry (DXA). This technique can measure can body fat and lean masses, by 
emission of X-rays at two energies: the separate absorption of the two X-ray emission allows 
estimation of tissue distribution (fat and LBM). The approach is based on the assumption that 
fat mass hydration is kept constant at 73 %. Measurement can be performed if specific body 
regions, such as the arms, legs, and trunk (Laskey, 1996). 
 
Inflammation 
Inflammation is a multifactorial response occurring when the immune system is acutely 
activated against potentially harmful antigens, as pathogens or dead cells. In this phase, 
macrophages, dendritic cells and mastocytes resident in the infected or damaged tissue are 
activated to release inflammatory mediators, cytokines, which are the main actors accounting 
for clinical signs of inflammation (Walter and Talbot, 1996). 
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Cytokines and markers of inflammation. 
Cytokines are known to play a pro- and anti-inflammatory role. Among several known 
proinflammatory cytokines, interleukin 1 (IL-1) is one of the mostly studied: it is composed of 
two subunits, and it plays a pleiotropic role in activating processes linked to inflammation as 
fever, lymphocytes and bone marrow cell proliferation (Dinarello, 1994). Intreleukin-6 (IL-6) 
is a cytokine that acts as both a pro-inflammatory and anti-inflammatory agent. It is also 
known as “myokyne”, as it is released by contracting muscle and is upregulated after high 
intensity physical exercise (Ostrowski et al., 1998). IL-6 upregulation after muscle 
contractions previously suggested that physical exercise can have anti-inflammatory 
properties (Petersen and Pedersen, 2006). Finally, interleukin 10 (IL-10) is an example of anti-
inflammatory cytokine, produced by monocytes and lymphocytes. It is an immunomodulator 
decreasing expression of pro-inflammatory cytokines and downregulating the activation of 
factors involved in intracellular inflammatory response as NF-kB and related tissue injury 
(Yoshidome et al., 1999). Physical exercise was shown to increase circulating IL-10 
concentrations, thus suggesting muscle activity can exert a beneficial anti-inflammatory action 
(Nunes et al., 2008). Tumor necrosis factor alpha is an additional important cytokine involved 
in systemic inflammation, especially during the acute phase. It is mainly synthesized by 
macrophages, but it is also produced by other cells as adipocytes (Winkler et al., 2003). 
Tumor necrosis factor alpha was shown to play crucial roles in the onset and maintenance of 
inflammation process, stimulating acute phase reaction factors, in liver, macrophage 
phagocytosis and chemoattraction of neutrophils (Tracey and Cerami, 1990; Tracey and 
Cerami, 1994). Through the action on two specific cell membrane receptors, tumor necrosis 
factor alpha can activate several biological responses as activation of NF-kB (Bouwmeester et 
al., 2004) and of intracellular pathways leading to cell differentiation or to apoptosis (Gaur 
and Aggarwal, 2003). Prolonged elevation of circulating tumor necrosis factor alpha can lead 
to muscle mass reduction: a wasting condition linked to poor prognosis of patients (Kandarian 
and Jackman, 2006). Synthesis of interleukins and tumor necrosis factor alpha can trigger the 
production of a known marker of inflammation called C-reactive protein (CRP). CRP is a 
factor mediating activation of a crucial immune response process as the complement system 
(Lee et al., 2002). In clinical practice it is used as marker of inflammation onset, both in 
chronic and acute conditions (Ho and Lipman, 2009). Mild elevation of CRP concentrations 
characterize metabolic and cardiovascular pathologies. Diabetes was associated to increased 
circulating CRP concentrations, and evidence indicates that inflammation can play a causative 
role in the pathology (Mugabo et al., 2009). Moreover, CRP levels over a threshold of 2 mg/l 
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were shown to be associated with an increased cardiovascular risk and mortality (Yang et al., 
2009). 
Myopathies and inflammation 
Prolonged or chronic inflammation is associated not only to cardiovascular risk, but also to 
other pathologies linked to muscle atrophy. Experiments performed in a mouse model of 
myositis, a severe pathology leading to muscle weakening and wasting, showed that artificial 
induction of inflammation upregulated, especially at long term, specific molecular markers of 
such pathology (tau, Abeta) (Kitazawa et al., 2008). Duchenne muscular dystrophy, a genetic 
disease characterized by marked muscle wasting due to the lack of the dystrophin gene, is 
strictly associated to chronic muscle inflammation: NF-kB pathway was shown to be strongly 
involved in muscle wasting progression of subjects affected by such pathology (Acharyya et 
al., 2007). Finally, idiopathic myopathies are known to be associated with enhanced release of 
proinflammatory cytokines such as CCL3, CCL4, CCL5, and of their specific receptors 
(Civatte et al., 2005). Previously published studies underlined that inflammation can be a 
possible cause of cancer cachexia, a condition of muscle wasting associated to poor prognosis 
in patients: as abovementioned tumor necrosis factor alpha, known also as cachectin, was 
shown to be one of the factors triggering hypercatabolic processes in tumor bearing subjects 
(Tracey and Cerami, 1994). 
Inflammation was shown to play a crucial role also in muscle mass wasting normally 
occurring in healthy aging subjects (sarcopenia) (Jensen, 2008). In particular IL-1, IL-6 and 
tumor necrosis factor-alpha were previously shown to potentially trigger muscle sarcopenia in 
elderly subjects (Yende et al., 2006). In addition, an interesting study based on DNA 
microarray analysis showed that a subgroup of genes involved in promotion of inflammation 
is upregulated in sarcopenic elderly subjects (Giresi et al., 2005). Interestingly, physical 
exercise training programs tailored to elderly subjects were shown to reduce muscle mass 
wasting and to reduce synthesis of proinflammatory cytokines such as interleukin-1 and tumor 
necrosis factor (Nicklas and Brinkley, 2009). Moreover, strength training programs in older 
volunteers ameliorated muscle strength and performance and, in parallel, increased levels of 
anti-inflammatory interleukin-6 and 10 (Bautmans et al., 2005). 
Inactivity and inflammation 
It is well established that inactivity is linked to enhanced risk of cardiovascular events. In an 
epidemiologic study performed in female adolescents, sedentary lifestyle was associated , with 
increased concentrations of plasma markers of inflammation such as tumor necrosis factor 
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alpha (Ischander et al., 2007). Similarly, an observational study performed in a large sample 
of male and female subjects showed that persons adopting an unhealthy sedentary lifestyle 
were characterized by mildly increased levels of CRP, a marker of low grade inflammation. 
Interestingly, appropriate moderate training programs and the so called “mediterranean diet” 
reduced the observed CRP increase (Pitsavos et al., 2007). Another epidemiologic study 
confirmed that, regardless of the degree of obesity, sedentary lifestyle is associated with 
increased levels of interleukin-6 and of CRP (Fischer et al., 2007). A previously published 
work showed in humans that experimental bed rest upregulated plasma CRP (+143%), the 
ratio between plasma IL-6 and IL-10 (4 times) and, in white blood cell, the ratio between IL-6 
and IL-10 mRNAs (5 times) (Bosutti et al., 2008). 
Inflammation and polyunsaturated fatty acids. 
The proinflammatory role of n-6 polyunsaturated fatty acids 
Cytokines are direct modulators of inflammatory pathways, but other factors are also deeply 
involved in the control of inflammation. Eicosanoids, including prostaglandines tromboxanes 
and leukotrienes are key mediators and regulators of inflammation (Lewis et al., 1990). Cell 
availability of polyunsaturated fatty acids (PUFA) of the n-6 series affects production of 
eicosanoids.  Eicosanoids are, in fact, synthesized from the n-6 PUFA arachidonic acid by the 
enzymic action of cyclooxygenase. Arachidonic acid is, in turn, synthesized in separate 
biochemical steps from the n-6 PUFA linoleic acid principally by the action of ∆6-desaturase, 
elongase and ∆5-desaturase (Figure 3). Linoleic acid is an essential FA and many vegetable 
oils (corn, sunflower, soybean and margarines) contain elevated fractions of linoleic acid 
(Bozan and Temelli, 2008): availability of n-6 PUFA is determined by linoleic acid intake and 
by endogenous synthesis (Wertz, 2009). Elevated availability of n-6 PUFA in cell membranes 
was previously linked to inflammatory diseases (Ueda et al., 2008). Increased n-6 PUFA 
concentrations, moreover, can enhance gene expression of proinflammatory cytokines and 
transcriptional activity of NF-kB (Weaver et al., 2009). These and other published evidence 
demonstrate the key role of circulating and membrane n-6 PUFA in the stimulation of pro-
inflammatory processes. 
 
Anti-inflammatory effects of n-3 PUFA. 
Apart from n-6 PUFA series, another family of fatty acids is deeply involved in the control of 
inflammation: the n-3 PUFA. They are synthesized from the n-3 PUFA alpha-linolenic acid in 
a metabolic pathway sharing the same enzymes promoting n-6 series synthesis. In n-3 PUFA 
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synthesis, ∆5-desaturase leads to eicosapentaenoic acid, that in turn is converted to 
docosahexaenoic acid in the peroxisome by the action of ∆6-desaturase. n-3 PUFA are well 
known to play an anti-inflammatory action (Figure 3). In analogy with n-6 PUFA, alpha-
linolenic acid and n-3 PUFA availability is strongly conditioned by dietary intake of alpha-
linolenic acid from vegetable oils (Wertz, 2009), but, in addition, fish oil is known to contain 
high amount of eicosapentaenoic and docosahexaenoic acids (Pickova, 2009): thus, dietary 
fish intake strongly affects availability of these two compounds. Fatty acids of the n-3 series 
are known to have an anti-inflammatory action. Increased intake of eicosapentaenoic and 
docosahexaenoic acids can affect the cell membrane content of these fatty acids (Lee et al., 
1985), thus reducing the fraction of the pro-inflammatory arachidonic acid. Decreased 
production of selected prostaglandins as well as of interleukin-1 was demonstrated as a 
consequence of n-3 PUFA supplementation (Lee et al., 1985; Endres et al., 1989). 
Additionally, eicosapentaenoic acid can lead, as substrate for cyclooxygenase, to slightly 
different isoforms of prostaglandins, characterized by lower proinflammatory potential (Bagga 
et al., 2003). Synthesis of subclasses of anti-inflammatory molecules called resolvins was 
shown to be based on eicosapentaenoic and docosahexaenoic acids as precursors (Hong et al., 
2003). In vitro cell studies showed eicosapentaenoic and docosahexaenoic acids can minimize 
the expression of interleukin-1 and of tumor necrosis factor alpha (Babcock et al., 2002) and 
such evidences were confirmed by studies demonstrating, in animals, anti-inflammatory 
effects of fish oil supplementation (Billiar et al., 1988). 
Finally, n-3 PUFA can interfere with genetic regulation of proinflammatory factors principally 
downregulating the transactivation activity of NF-kB (Ross et al., 1999) that, in turn, can 
reveal the anti catabolic potential of such class of anti-inflammatory fatty acids. Increased 
dietary n-6 to n-3 PUFA ratio was shown to increase the expression of CRP and of other 
proinflammatory agents as tumor necrosis factor (Zhang et al., 2009) 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 shows synthesis pathways of n-3 and n-6 fatty acids from essential 
precursors. 
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Membrane fatty acid composition  
Phospholipid content in red blood cell membranes can be considered a reliable marker of fatty 
acid availability in plasma, and of cell membrane composition of the whole body (Harris and 
Von Schacky, 2004). Interestingly, fatty acid membrane composition affects the activity of 
surface membrane receptors, influencing the activation of downstream intracellular pathways. 
For example, increased levels of n-3 PUFA can enhance the expression and the signaling 
activity of glucose receptor (GLUT-4) on muscle cell membrane, thus potentially ameliorating 
insulin sensitivity (Taouis et al., 2002). Moreover, the fraction of n-3 PUFA in cell 
membranes was directly associated to reduced incidence of cardiovascular diseases: this effect 
was associated to the anti-inflammatory role of n-3 PUFA and to other changes induced on 
cardiovascular system physiology by this class of fatty acids (Harris and Von Schacky, 2004). 
Published evidence proved that in human neutrophil membranes, increases in n-6 to n-3 
PUFA ratios are directly associated with the ability of synthesizing pro-inflammatory 
mediators (Zhang et al., 2009). Such evidence confirms that cell membrane relative content of 
total n-6 and n-3 fatty acids can be considered as a marker of whole body inflammatory 
condition. 
Physical exercise and membrane fatty acid composition. 
The impact of physical exercise on membrane fatty acid composition was investigated in 
several studies. Constant moderate training and acute exercise were shown to decrease both 
phosphatidylserine and polyunsaturated fatty acids in erythrocyte membranes: this effect was 
hypothesized to be caused by increased lipid peroxidation due to muscle contraction 
(Sumikawa et al., 1993). Another study emphasised n-6 PUFA content changes mediated by 
physical exercise: authors showed that linoleic acid and the sum of n-6 fatty acids were 
decreased in trained skeletal muscle phospholipids. This reveals that physical exercise can 
directly exert an anti-inflammatory role at muscle level, in this way potentially ameliorating 
insulin sensitivity (Andersson et al., 1998). Regular exercise was shown, in rats, to decrease 
∆-5 desaturase activity and arachidonic acid content; in addition, docosahesaenoic acid 
proportion in cell membrane was decreased while linoleic acid was increased (Helge et al., 
1999). Observed effects on membrane composition mediated by regular exercise where 
hypothesized to be dependent on energy substrate utilization during training (Helge et al., 
1999). Still, a previously published study showed in humans that fractions of oleic acid and 
docosahexaenoic acid were significantly higher in trained muscles when matched to untrained 
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(Helge et al., 2001). Similarly, physical exercise significantly lowered the ratio between n-6 
and n-3 PUFA in the trained muscle when compared to the untrained (Helge et al., 2001): also 
in this study regular physical exercise was confirmed to reduce whole body and muscle 
inflammation. 
 
Oxidative stress 
Oxidative stress stems from an unbalanced production of free radicals which is not sufficiently 
scavenged by the activity of antioxidant defenses of the organism. Interestingly, increased 
activity of antioxidant and cell damage repair systems can be evidenced after free radical 
production and oxidative stress onset (Tchou et al., 1991; Hardmeier et al., 1997).  
Reactive oxygen species 
Free radicals are, in general, chemical compounds characterized by an unpaired free electron 
in the external orbit. Reactive oxygen species (ROS) are the most frequent free radicals in the 
organism. They are principally derived from the following reaction of molecular oxygen 
reduction, leading to highly reactive species such as superoxide anion and hydrogen peroxide: 
 
O2 + e -→  O2 · - 
 
or 
 
O2 + 2e + 2H+ →  H2O2 
 
H2O2 is in turn converted, by metal catalysis, into other highly reactive species (as oxydril 
radical) by the following reaction: 
 
Fe2+ + H2O2 →  .OH + HO- + Fe3+ 
 
Other reactive radical species are derived from nitric oxide (NO.): this chemical compound 
can rapidly react with ROS leading to the formation of peroxynitrite (ONOO-), which is a 
potent pro-oxidant species (Ischiropoulos et al., 1992). 
Free radical sources 
Different biochemical reactions can cause the production of highly reactive species. 
Mitochondrial electron transport chain is deeply involved in this process: four complexes are 
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involved in the transport of electrons. Electrons derived from intermediates of trycarboxylic 
acid cycle and from reduced nicotinamide adenine dinucleotide (NADH) are transported to 
NADH dehydrogenase (Complex I) and to succinate dehydrogenase (Complex II). 
Intermediate carriers transport electrons to ubichinon-cytochrome C reductase (complex III) 
and to cytochrome C oxidase (Complex IV) (Halliwell and Gutteridge, 1986). Afterwards 
electrons are transferred to O2, leading to the production of hydrogen peroxide and of 
superoxyde anion (Beckman and Ames, 1998). 
NADPH oxidase activity can also lead to the production of free radicals and this process can 
be stimulated by increased availability of calcium through protein kinase C-ERK1/2 pathway 
(Javesghani et al., 2002). 
Xanthine oxidase is an enzyme involved in purine catabolism. Xanthine oxidase can also 
cause the production of free radicals oxidizing hypoxanthine to xanthine, which in turn can be 
converted to uric acid (Whidden et al., 2009). 
Microsomial complexes of cytochrome P450 are also involved in direct production of 
superoxide anions, while performing their detoxifying activity against xenobiotics (Goeptar et 
al., 1995). 
Lipids β-oxidation can also determine the production of hydrogen peroxide in the 
peroxisomes, but the actual contribution of this process to free radical production is difficult to 
be assessed due to the presence of catalase enzyme (Beckman and Ames, 1998). 
Highly reactive species are also significantly released by activated phagocytes during 
inflammation. After phagocytosis, in fact, this class of cells produces superoxide anions, 
hydrogen peroxide and nitric oxide in order to neutralyze pathogenic agents (Moslen, 1994). 
Finally, nitric oxide is rapidly produced by specific isoenzymes (nitric oxide synthetase)  in 
order to control vasodilation and immune responses (Liu and Hotchkiss, 1995). 
Molecular targets of free radicals action. 
Several classes of macromolecules can be modified by the action of free radicals. 
Peroxidation of cell membrane lipids can alter membrane fluidity, in turn affecting action of 
protein receptors exposed on the cell surface (Ghosh et al., 1993). Unsaturated aldehydes 
derived from lipid peroxydation can play a negative role on cell physiology potentially 
inactivating selected enzymes (Chen and Yu, 1994) and affecting, as mutagenic factors, DNA 
integrity (Marnett et al., 1985). 
Nucleic acids can be directly modified by free radicals and this can induce DNA coiled strand 
breaks and formation of complexes with other molecules (Beckman and Ames, 1998). 
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Beside lipid membranes and nucleic acids, proteins are one of the most important targets of 
free radical action. Proteins vary regarding their susceptibility to the action of free radicals by 
virtue of their sequence and structure (Beckman and Ames, 1998). Principally, oxidation of 
sulphydril groups and oxidation catalyzed by presence of metals in specific protein sites can 
affect protein structure, which in turn impairs polypeptide function and leads to disposal by 
fragmentation (Stadtman, 1990; Starke-Reed and Oliver, 1989). 
Antioxidant systems. 
The ability of the organism to counteract the action of free radicals is exerted by enzymic and 
non-enzymic factors. 
 
Enzymic antioxidants 
The most known enzymic antioxidants are superoxide dismutase, catalase and thioredoxin 
reductase. The conversion of superoxide anion to hydrogen peroxide is performed by 
superoxide dismutase by the following reaction. 
 
2 O2 · - + 2 H+  H2O2 + O2 
 
The conversion of hydrogen peroxide to water is achieved by the following reaction catalyzed 
by catalase: 
 
2 H2O2  2 H2O + O2 
 
Thioredoxin is a NADPH dependent enzyme involved in maintenance of the reduced conditon 
of proteins: thioredoxin reductase restores functional (reduced) thioredoxin pool (Beckman 
and Ames, 1998). 
 
Finally, glutathione (GSH) peroxidase catalizes hydrogen peroxyde reduction to water by the 
dimerization of glutathione:  
 
H2O2 + 2 GSH  H2O + GSSG 
 
Glutathione reductase is a NADPH dependent enzyme restoring monomeric reduced 
glutathione from the dimeric oxidized form (GSSG). 
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GSSG + NADPH + H+  2 GSH + NADP+. 
Non-enzymic antioxidants. 
Several molecules were previously reported to scavenge free radicals thus inhibiting their 
action. They are: ascorbic acid, tocoferols (Vitamin E), flavonoids, carotenoids and ubichinol 
(Beckman and Ames, 1998). Availability of these molecules is principally dependent on 
dietary intake of fruits, vegetables or of appropriate supplements (Beckman and Ames, 1998). 
The glutathione system 
The most important non-enzymic antioxdant in the organism is glutathione: it is a thiolic 
tripeptide formed by glutammic acid, cysteine and glycine (Pastore et al., 2003). Synthesis of 
this tripetide is independent of mRNA. Glutathione synthesis is, in fact, achieved by the action 
of two ATP dependent enzymes γ-glutamil cysteine synthetase (catalyzing the bond between 
glutamic acid and cysteine) and glutathione synthetase. The reaction catalyzed by the first 
enzyme is the rate limiting step in the synthesis of this antioxidant factor (Lu, 1999). The 
following reaction is rapid and occurs immediately after the first, leading to the final 
formation of reduced glutathione (Majerus et al., 1971). γ-glutamil cysteine synthetase action 
is regulated by negative feed-back action of synthesized glutathione; the enzyme is a dimer 
constituted of a catalitic and a regulatory (modifier) subunit: availability of both these 
polypeptides can affect glutathione synthesis (Lu, 1999). Glutathione synthetase is not 
specifically regulated and fails to significantly influence glutathione synthesis rate. 
Glutathione is further processed, within the γ-glutamate cycle, by γ-glutamyl transpeptidase 
leading to the formation of a γ-glutamil amino acid and to the dipeptide cisteinglycine (Pastore 
et al., 2003). γ-glutammil amino acid is then transformed to 5-oxoprolin and glutamic acid by 
actions of g-glutamil cyclotransferase and oxoprolinase. Glutamic acid is then utilized to 
synthesize again glutathione (Pastore et al., 2003). Cysteinglycine is then catabolized by a 
dipeptidase to provide free cysteine and glycine amino acids. Cysteine is a limiting substrate 
for glutathione synthesis, but also glutamate and glycine, as direct glutathione precursors, can 
affect the synthesis rate of this antioxidant tripeptide (Bannai, 1984). 
Glutathione availability. 
Glutathione is synthesized in almost all human cells: intracellular concentrations are normally 
in the range of 0.5-10 mM, while urine and plasma concentrations are extremely lower (50-
100 µM). Within the cell, glutathione can be detected in cytoplasm (90%), while the 
remaining part is imported in mitochondria from cytoplasm (Meredith and Reed, 1982). 
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Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 shows pathways of glutathione synthesis and utilization as well as 
enzymatic regulation. 
GCL, glutamate-cysteine ligase; GR, glutathione reductase; GP, glutathione 
peroxidase; GS, glutathione sinthetase, γ-GTP: γ-glutammil transpeptidase 
 
Biological functions of glutathione. 
Antioxidant activity. 
The abovementioned antioxidant activity of glutathione is primarily based on the action of 
glutathione peroxidase that catalyzes hydrogen peroxide conversion to water. This enzyme 
involves the oxidation of 2 molecules of reduced glutathione to form the glutathione dimer  
(Pastore et al., 2003). This important action allows the maintenance of protein sulphydril 
groups in a reduced state, thus contributing to preserve protein structure and function. 
Maintenance of reduced sulphydril groups can occur both by enzymic and non enzymic 
processes (Mannervik et al., 1983). Such thiol-disuphide balance is known to directly affect 
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enzyme activity and transport efficiency (DeLeve and Kaplowitz, 1991). Glutathione 
reductase converts oxidized glutathione in two molecules of reduced glutathione utlizing 
NADPH as cofactor: in this way the pool of available reduced glutathione can be 
reconstituted. 
 
Effects on protein stability and function. 
Glutathione can affect protein function by a process called glutathionilation that leads to the 
formation of a chemical bond between glutathione and thiolic gropus of the protein. This 
process affects protein stability of the cytoskeleton (Cotgreave and Gerdes, 1998) or 
transactivation capacity of selected transcription factors (Pastore et al., 2003). 
 
Leukotriene synthesis. 
Glutatione is required for synthesis of leukotrienes, important factors involved in promotion 
of inflammatory processes. Glutathione transferase leads to the formation of leucotriene C4: 
additional modifications mediated by selected peptidases can lead to the formation of 
leucotriene Dq and E4 (Anderson et al., 1982). 
Glutathione and health 
Aging 
Aging is known to be associated to enhanced free radicals production as well as to lowered 
antioxidant system efficacy (Dogru-Abbasoglu et al., 1997). In aging subjects glutathione 
availability was shown to significntly decrease and this effect was demonstrated to be 
independent from gender (Lang et al., 1992). Moreover the decrease in glutathione availability 
is related to pathologic features that can be ascribed to enhanced free radicals production, as 
alterations of cognition and of immune system functionality (Weber et al., 1997). 
 
Glutathione involvement in diseases 
Previously published works demonstrated that glutathione depletion could interfere with 
immune system function. In particular, glutathione function is required for activation of 
lymphocytes (Droge et al., 1986) and NF-kB can be hypothesized to be the molecular 
mechanism underlying this process (Staal et al., 1990). 
Additionally, different pathologies of the central nervous system, such as Alzheimer and 
Parkinson’s diseases or schizophrenia, are associated to decreased availability of glutathione 
(Schulz et al., 2000). Human Immunodeficiency Virus infected patients display an average 
increase of oxidative stress damage coupled with a depletion of glutathione both in plasma 
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and in red blood cells: this effect was hypothesized to be related to increased sensitivity to 
infections as well as to the muscle atrophy, which is characteristic of these patients (Staal et 
al., 1990). In addition glutathione depletion is frequently encountered in pathologies known to 
be associated to oxidative damage such as liver cyrrhosis (Altomare et al., 1988), chronic 
obstructive pulmonary disease or acute respiratory distress syndrome (Anderson, 1997) and 
cardiovascular pathologies (Morrison et al., 1999). This evidence of glutathione depletion in 
such illnesses demonstrates that glutathione synthesis rate and availability can be considered 
as a marker of previously occurred oxidative damage. 
Glutathione and physical exercise 
Physical exercise is related to enhanced fuel utilization through pathways of energy 
metabolism as well as to increased oxygen flux (100 folds), when compared to resting 
conditions (Sen et al., 1992). Concomitantly increased mitochondrial activity significantly 
enhances free radical production (Reid et al., 1992) and paves the way to oxidative stress 
onset which is strictly related to muscle fatigue and efficiency (Dillard et al., 1978; Reid et al., 
1992). Regular exercise was previously demonstrated to enhance total and reduced glutathione 
availability (Sen and Packer, 2000). Moreover, the ratio between reduced and oxidized 
glutathione, a reliable marker of glutathione system activation is increased by exercise (Ji, 
1995). Physical training, moreover, was shown to induce glutathione incorporation in muscle 
from blood (Leeuwenburgh and Ji, 1995). In the same work, enhanced de novo synthesis and 
release of glutathione from liver was observed as a consequence of regular physical activity 
(Leeuwenburgh and Ji, 1995). Activity of enzymes related to glutathione metabolism as 
glutathione peroxidase and glutathione reductase were shown to be coherently upregulated by 
moderate exercise (Ortenblad et al., 1997): this shows that glutathione system is activated by 
muscle contractions. Moreover, long term training was shown to decrease glutathione 
oxidation rate, when compared to untrained subjects performing a single bout of exercise 
(Michelet et al., 1995). Otherwise, intermediate intensity of exercise can transiently lower the 
reduced-to-oxidized glutathione ratio (Sen and Packer, 2000), while short term intensive 
exercise fails to affect glutathione redox balance (Sen, 1999). Several bouts of exercise, 
instead, can upregulate oxidized glutathione levels, expecially in trained subjects (Sastre et al., 
1992). Summation effect of such oxidative damage observed after acute exercise can account 
for upregulation of glutathione availability and enzymatic efficiency of glutathione system in 
trained subjects (Kretzschmar et al., 1991). Thus, increased availability of glutathione 
tripeptide, can be considered, in healthy subjects, as an active response of the organism to a 
previous release of free radicals. 
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Stable isotopes for the assessment of fractional synthesis rate of glutathione in human 
muscles. 
Fractional synthesis rate of a small peptide can be assessed in humans by coupling the 
infusion of  stable isotopic amino acid precursors and the analysis (performed by gas 
chromatography-mass spectrometry) of changes in the enrichment of isotopic product in 
seriated biological samples after precursor steady state achievement (see Methods section). 
This approach was, in fact, previously adopted to measure glutathione synthesis in red blood 
cells (Badaloo et al., 2002; Jahoor et al., 1995; Lyons et al., 2001). 
In principle, at least two biological samples are required to assess changes in precursor 
incorporation after achievement of steady state. Nevertheless, the requirement of multiple 
sampling is a limitation of the method for application to muscles: repeated muscle biopsies 
are, in fact, difficult to perform due to ethical reasons, and due to possible local inflammatory 
processes potentially plaguing reliability of measurements. In this work, to assess muscle 
glutathione synthesis rate in healthy humans a new validated approach is used. This method 
involves two parallel infusions of different isotopes of the same amino acid precursor of 
glutathione: infusions are started with a calculated time shift and are terminated together 
concomitantly with muscle sampling. Measurement of enrichments of the two different 
isotopic products, as reflecting different times of precursor infusion and incorporation, allows 
the determination of glutathione synthesis rate in muscle (see Methods section). 
Markers of oxidative stress 
Previously published works assessing oxidative stress changes in a living organisms allowed 
the validation of several biomarkers as useful tools to assess activity of pro-oxidant and anti-
oxidant system. In general, the biochemical modifications mediated by free radicals on 
selected molecules are utilized to quantify oxidative stress induction. 
 
Malondialdehyde 
Malondialdehyde is an end-product of lipid peroxidation and their concentration can be 
assessed by spectrophotometry after reaction with thiobarbituric acids (TBARS). Possible 
cross reactivity with aldehydes can reduce reliability of this assay (Mayne, 2003). 
 
Specific anti-oxidized low density lipoproteins (LDL) antibodies  
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Oxidized LDL can induce the production of specific antibodies aimed to limit endothelium 
permeability for its protection (Roth et al., 2004). Quantification of concentration of such 
antibodies is considered to be a reliable marker of oxidative stress. 
 
F2-Isoprostanes 
Isoprostanes are product of peroxidation of arachidonic acids that are released from cell 
membranes (Roberts and Morrow, 1997). Increased release of isoprostanes was clearly shown 
in subject affected by pathologies correlated to oxidative stress (Lawson et al., 1999). 
 
Protein carbonylation 
Action of free radicals on proteins is known to induce the modification of selected amino acid 
(proline, arginine, lysine, and threonine) by stable addition of carbonyl groups (Roth et al., 
2004). Protein carbonylation, can lead to altered enzyme structure and activity (Stadtman, 
2001). When compared to other oxidative modifications, carbonyls are obtained by relatively 
complex mechanisms and in contrast to, for example, methionine sulfoxide and cysteine 
disulfide bond formation, carbonylation is an irreversible oxidative process (Dalle-Donne et 
al., 2003). In addition, carbonyl modifications on lysine, cysteine, and histidine can be 
achieved by secondary reactions with carbonyl compounds of carbohydrates (glycoxidation 
products), lipids, and advanced glycation/lipoxidation end products. (Requena et al., 2003). 
Increased levels of protein carbonylation were shown in patients affected by neurological 
diseases such as Alzheimer and Parkinson’s diseases, as well as on myopathies as Duchenne 
muscular dystrophy or amyotrophic lateral sclerosis (Stadtman, 2001). Carbonylation level 
was, previously demonstrated to be a reliable marker of oxidative stress occurrence 
(Greilberger et al., 2008).  
Oxidative stress and proteolysis 
Oxidative stress is known to be involved in the regulation of complex pathways leading to 
protein and muscle wasting. Oxidative stress can, in fact, induce perturbations of intracellular 
ionic homeostasis (Kondo et al., 1994), as reactive aldehydes (i.e. 4-hydroxy-2,3-trans-
nonenal) can decrease ATPase dependent Ca2+ removal from the cell (Siems et al., 2003): 
thus interactions between oxidative stress and calcium availability changes can effectively 
trigger calpains action (Primeau et al., 2002). This event can activate other calcium-activated 
proteases augmenting proteolysis of cytoskeletal proteins and release of myofilaments for 
degradation by proteasome (Tidball and Spencer, 2002; Goll et al., 2003). Moreover, 
oxidative stress can induce skeletal muscle atrophy, controlling factors in turn inducing 
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caspase-3 activity (Primeau et al., 2002). Oxidative stress can directly affect muscle protein 
degradation at proteasome level (Betters et al., 2004): it, in fact, has been shown to upregulate 
the expression of muscle atrophy F-box/atrogin1 and MuRF-1 in myotubes (Li et al., 2003). 
Increased expression of such E3 ubiquitin ligases in skeletal muscle can enhance proteolysis 
and muscle atrophy (Bodine et al., 2001a). Furthermore, ther is evidence that the 
aforementioned oxidatively modified proteins by carbonylation, can be selectively degraded 
by the 20S core proteasome without ubiquitination (Grune et al., 2003; Grune and Davies, 
2003). In addition, to avoid accumulation of damaged peptides, carbonylated proteins were 
shown to be more efficiently scavenged by proteolytic degradation than their nonoxidized 
counterparts (Dukan et al., 2000; Bota and Davies, 2002; Grune et al., 2003). Moreover, 
changes in protein carbonylation are significantly associated with disease progression in 
muscle wasting patients with leukemia (Ahmad et al., 2008), as well as to myopathies as 
Duchenne muscular dystrophy or amyotrophic lateral sclerosis (Stadtman, 2001). Thus, such 
evidence directly correlates muscle protein carbonylation with rate of protein degradation and 
muscle atrophy. 
Inactivity and oxidative stress: possible impact on proteolysis. 
Low levels of physical activity can promote oxidative stress onset: studies performed in 
animals showed that regular housing, when compared to constant training, increased lipid 
peroxidation and ROS release (Laufs et al., 2005). This condition, in parallel with enhanced 
low grade inflammation (Pradhan et al., 2001; Hansson, 2005; Alberti et al., 2006) can be 
considered as a risk factor for cardiometabolic diseases such as type 2 diabetes, 
arteriosclerosis and metabolic syndrome (Hopps et al., 2009; Lastra and Manrique, 2007). It is 
noteworthy, that inactive lifestyle is known to be per se the primary and underlying cause of 
metabolic syndrome (Zhu et al., 2004). 
Nevertheless, evidence suggests that inactivity mediated oxidative stress can promote muscle 
atrophy, as a typical consequence of immobility. Previously published evidence showed, in an 
animal model of muscle unloading, that inactivity can increase muscle oxidative stress with 
concomitantly impaired antioxidant defenses. In particular, experimental unloading increased, 
in soleus, lipid hydroperoxide levels and oxidation of selected target substrates (Lawler et al., 
2003) In addition, in unloaded soleus Cu,Zn-superoxide dismutase increased while, catalase 
and glutathione peroxidase, significantly decreased, together with non-enzymatic antioxidant 
capacity (Kondo et al., 1994; Lawler et al., 2003; Kondo et al., 1992). Moreover, muscle 
unloading was shown to induce a decrease in antioxidant heat shock proteins as well as in 
glutathione peroxydase activity (Lawler et al., 2006). Otherwise, other published data showed 
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that muscle unloading can upregulate heme-oxygenase response in virtue of a previously 
occurred oxidative damage (Hunter et al., 2001). An important work investigating, by 
microarray approach, alterations in gene expression of unloaded muscle demonstrated that 
factors promoting oxidative stress as well as ubiquitination and protein degradation are 
significantly upregulated by immobility (Stevenson et al., 2003). As reviewed by Scott K. 
Powers (Powers et al., 2005; Powers et al., 2007), oxidative stress can effectively induce 
muscle atrophy activating specific intracellular pathways triggering upregulation of specific 
proteases and of apoptosis processes. Muscle inactivity is, in fact, associated with oxidative 
stress mediated calcium deregulation and calpain activation (Kourie, 1998), factors known to 
induce muscle wasting. Interestingly, lowered oxidative stress induction in unloaded muscles, 
achieved by supplementation of antioxidant vitamin E, can reduce protein wasting and muscle 
atrophy (Appell et al., 1997). Muscle wasting is an important clinical feature of several 
chronic diseases and oxidative stress has been suggested as pathogenetic factor in such 
process (Moylan and Reid, 2007). Unfortunately, knowledge of direct links between oxidative 
stress and muscle inactivity is currently incomplete, but it seems plausible that inactivity can 
trigger oxidative stress (e.g. protein carbonylation) in muscle by interaction of at least five 
different oxidant production pathways (Kondo et al., 1993): 1) generation of ROS by the 
xanthine oxidase pathway (Whidden et al., 2009); 2) production of NO via increased NOS 
activity (Kondo et al., 1993); 3) formation of ROS by increased cellular levels of reactive iron 
(Kondo et al., 1992) ; 4) potential activation of NADPH oxidase by increased availabitity of 
calcium through protein kinase C-ERK1/2 pathway (Javesghani et al., 2002) and 5) 
contribution of mitochondrial production of superoxide radicals (Muller et al., 2007). 
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Figure 5 
 
 
 
 
 
 
Figure 5 summarizes experimental evidences obtained in animal models 
suggesting relationships between inactivity mediated oxidative stress and 
regulation of protein degradation. 
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Homocysteine 
Synthesis and metabolism 
Homocysteine is a non proteinogenic sulfur amino acid, intermediary in the metabolism of 
cysteine and methionine. Methionine transmethylation is the reaction leading to homocysteine 
synthesis. This reaction is divided into different steps: methionine is transformed in S-
adenosylmethione by methionine adenosil transferase. S-adenosylmethione is in turn 
converted to S-adenosylhomocysteine by methyltransferase or by glycine N-methyltrnsferase 
(coupled to conversion of glycine to sarcosine). S-adenosylhomocysteine is then hydrolyzed 
to homocysteine with the release of homocysteine (Loenen, 2006). Specific mechanisms 
transport homocysteine from the intracellular pool to plasma, where concentration reach the 
average level of 10 µmol × L-1. Homocysteine degradation occurs by two catabolic pathways, 
transulfuration and remethylation, leading respectively to cysteine synthesis and to methionine 
recycling. Transsulfuration occurs by the action of cystationine β-synthetase and by the 
following action of α-cystationinase, converting cystathionine to cysteine. Remethylation 
occur by two parallel pathways. The first and more frequent, occurs by methionine synthase 
involving vitamin B12 as cofactor and converting N5-methyltetrahydrofolate to 
tetrahydrofolate: this is transformed to N5-N10methylentetrahydrofolate and then recycled to 
N5-methyltetrahydrofolate by methylentetrahydrofolate reductase (Lee and Frenkel, 2003). 
The second reaction leading to methionine from homocysteine is catalyzed by betaine-
homocysteine methyltransferase, requiring betaine conversion to dimethylglycine. This minor 
pathway is required to preserve methionine concentrations in low folate conditions (Durand et 
al., 2001). 
Regulation of homocysteine metabolism: 
S-adenosylmethione is a key regulator of homocysteine metabolism: it regulates 
transmethylation reaction and when it is sufficiently available it can reduce remethylation rate 
inhibiting methylentetrahydrofolate reductase (Finkelstein, 2000). Moreover, to limit the 
cytotoxic effects of homocysteine, S-adenosylmethione promotes transsulfuration by 
stimulation of related enzymes (Finkelstein, 2000). For such reasons high protein and amino 
acid diet, enhancing availability of S-adenosylmethione can promote homocysteine disposal 
by transsulfuration route: otherwise, remethylation is favoured in conditions of normal or low 
protein dietary intake (Ueland and Refsum, 1989).  
Dietary intake of folates is also a crucial regulator of homocysteine metabolism, by provision 
of N5-methyltetrahydrofolate: lowered folates availability reduces remethylation and 
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accelerate transmethylation rate by influencing S-adenosylmethione concentrations. Low 
levels of S-adenosylmethione, in turn, can inhibit transsulfuration pathway. Thus low folate 
intake can cause blood accumulation of homocysteine enhancing its cytotoxic effect (Lee and 
Frenkel, 2003). 
Physiologic factors determining homocysteine availability. 
Gender 
Previously published studies assessed that gender can be considered as a crucial factor 
determining homocysteine availability. In particular, efficient remethylation pathway accounts 
for a 21% lower homocysteine concentration in blood of female subjects when compared to 
males (Fukagawa et al., 2000). Moreover, homocysteine concentration seem to be related to 
age and race (Nygard et al., 1995) 
 
Genetic factors 
Specific genetic factors can alterate homocysteine availability in blood. Mutations of 
cystationine β-synthetase can, expecially in homozygosity condition, induce severe 
hyperhomocysteienemia through inhibition of transsulfuration pathway (Crowther and Kelton, 
2003). Additionally, another genetic mutation, affecting remethylation pathway, was found in 
position 677 of methylentetrahydrofolatereductase (MTHFR) gene: this leads to a unstable 
form of protein associated to lowered remethylation efficiency (Deloughery et al., 1996). 
 
Physical activity 
A relationship between physical exercise and homocysteine availability in blood was recently 
demonstrated. Acute physical exercise was shown to induce an immediate increase in plasma 
homocysteine concentration, while regular and moderate training lowered resting plasma 
concentrations of homocysteine when compared to untrained subjects (Duncan et al., 2004). 
Moreover, particularly fatiguing endurance exercises can upregulate homocysteine 
concentrations and related cardiovascular risk (Herrmann et al., 2003). Reasons explaining 
such observed effect are presently unknown. Additional studies showed no association 
between physical activity level and homocysteine concentrations in moderately training young 
humans (Di Santolo et al., 2009). Other reported evidences showed increased 
homocysteinemia following submaximal acute aerobic exercise but not after submaximal 
aerobic training, independently from duration or intensity (Gelecek et al., 2007). 
A previously published epidemiological study showed that sedentary lifestyle was associated 
with increased concentrations of plasma homocysteine (Metsios et al., 2009), but mechanistic 
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explanations for this effect were not provided. To fully address the humans kinetic reasons 
underlying this effect, metabolic investigation by isotopic tracers must be applied to a model 
of physical inactivity. 
Homocysteine forms 
Homocysteine is found in human blood in two forms: the reduced one (homocysteine) and the 
oxidized and dimerized one called homocystine. Homocystine represents almost the 90% of 
total homocysteine in plasma (Jacobsen, 1998). 
Mechanisms of cytotoxic effects of blood homocysteine. 
Several studies and metanalyses associated hyperhomocysteinemia to coronary diseases 
(Clarke et al., 1991; Graham et al., 1997; Boushey et al., 1995) and to “unhealthy lifestyle” 
(Cleophas et al., 2000). Moreover, homocysteine level was demonstrated to be a predictive 
value of mortality in patient’s with established coronary artery disease (Nygard et al., 1997). 
Hyperhomocysteinemia is, in fact, known to be associated to atherogenic and trombotic 
effects: multifactorial causes can lead to this effect as a rise in procoagulant and 
proinflammatory substances in blood. Mild hyperhomocysteinemia in young patients, in fact, 
was associated to endothelial dysfunction and to increased levels of von Willebrand factor, of 
thrombomodulin as well as to impaired endothelial dependent vasodilation (van den et al., 
1995). Oxidative stress is considered to be the principal effector of homocysteine mediated 
endothelial damage. Plasma homocysteine, in fact, rapidly auto-oxidize to homocystine, in 
turn leading to ROS production. Previous evidences (Harker et al., 1974) showed that 
homocysteine can induce endothelial damage exposing vessel matrix and smooth muscle cells 
to an increased conncentration of hydrogen peroxide that promotes cell proliferation, platelet 
activation and lipidic peroxidation. Additionally, homocysteine was shown to promote 
oxidative damage inhibiting function of antioxidant systems as glutathione peroxidase 
(Upchurch, Jr. et al., 1997). Despite this direct pro-oxidant effect, inhibition of glutathione 
peroxidase by hyperhomocysteienemia can lower the capacity of endothelial cells to 
synthesize the S-nitrous-homocysteine: as S-nitrous-homocysteine reduces homocysteine 
cytotoxicity, this is another way by which hyperhomocysteiemia can enhance oxidative tissue 
damage (Mezzano et al., 1999). 
Hyperhomocysteinemia was, moreover, shown to enhance the pro-inflammtory condition by 
promoting arachidonic acid metabolism that, in turn, was shown to increase proinflammatory 
and procoagulant thromboxane A2 release (Di Minno et al., 1993). 
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 displays regulation of homocysteine metabolism and the related 
biological role. 
S, synthesis; B, breakdown; MAT, methionine adenosil transferase; MT, 
methyltransferase; CBS, cystationine β-synthetase; MS, methionine synthase; 
BHMT, betaine-homocysteine methyltransferase; MTHFR, 
methylentetrahydrofolatereductase. 
 
Glutamine 
Glutamine turnover and regulation 
Glutamine is an highly abundant amino acid, largely synthesized by skeletal muscle and then 
released in plasma. Liver, adipose tissue and lung also contribute to glutamine production. In 
human healthy subjects, glutamine concentration in muscle is about  20 mM, being 200-500 
higher than all other essential amino acids (Biolo et al., 1995a). On the contrary, in plasma, 
glutamine is normally around 0.6 mM. Tracer kinetic studies in healthy subject estimated that 
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approximately 80 g of glutamine appear every day in the bloodstream from body tissues, 
while 5-10 g are derived from nutrient intake (Biolo et al., 1995a). Glutamine is endogenously 
synthesized from glutamate and ammonia by glutamine synthase (Krebs, 1935). Activity of 
such enzyme is affected by several hormones. Glucocorticoids (Max et al., 1988; Darmaun et 
al., 1988) promote glutamine synthesis while growth hormone down-regulates this process 
(Biolo et al., 2000). Moreover, glutamate, as a precursor of glutamine, is synthesized by 
transamination of the branched chain amino acids leucine, isoleucine and valine. So, adequate 
activation of pyruvate dehydrogenase and of the tricarboxylic acid (TCA) cycle is required to 
provide anaplerotic precursors for amination of alpha-ketoglutarate leading to glutamate 
synthesis (Gibala et al., 1998). This suggests glutamine synthesis is linked to substrate 
utilization for energy production. Additionally, glutamine availability can be affected by 
nutrients (Darmaun et al., 1994; Biolo et al., 2006). On the contrary, glutaminase is the key 
enzyme for glutamine utilization which leads to glutamate, aspartate, alanine, and lactate 
production (Curthoys and Watford, 1995). 
Glutamine as immunomodulator 
Glutamine involvement in cell function and regulation was firstly stated by Krebs (Krebs, 
1935). In particular, glutamine is utilized by rapidly dividing cells as enterocytes (McCauley 
et al., 1998) and immune cells, expecially lymphocytes or monocytes (Ardawi and 
Newsholme, 1982). For such reasons, glutamine was considered as conditionally essential and 
named as “fuel of immune system” (Ardawi and Newsholme, 1982). The importance of its 
role in activation of the immune system was investigated in different models. Glutaminase, a 
key enzyme for glutamine utilization, is expressed on the cell membrane of human neutrophils 
(Castell et al., 2004) and it is specifically activated in immune cells to provide useful 
substrates for proliferation (Newsholme and Calder, 1997). The conversion of glutamine to 
glutamate, aspartate, alanine and lactate represents the 85 % of the total amino acid utilized by 
cultured neutrophils (Curi et al., 1997). In this way glutamine metabolism provides precursors 
and intermediates needed for immune cell proliferation as well as protein synthesis 
(Newsholme et al., 1985). In vitro studies, underlined the regulative role of glutamine 
availability on immune cells. Evidence showed that cultured immune cells mostly utilizes 
glutamine among other amino acids culture medium (Sakagami et al., 2009). Artificial 
reduction of glutamine concentrations in culture medium below physiological levels decreased 
cell proliferation rate (Parry-Billings et al., 1990). 
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Glutamine and physical activity  
Physical exercise leads to changes in energetic substrate utilization (Willis and Jackman, 
1994), insulin sensitivity (Colberg and Grieco, 2009) and protein turnover (Biolo et al., 
1995b). Changed plasma amino acid pattern can be evidenced after exercise. Interestingly, 
concentrations of two amino acids related to glutamine metabolism are known to be affected 
by exercise: alanine was demonstrated to be enhanced while glutamate was reduced 
(Blomstrand and Essen-Gustavsson, 2008). In particular, exercise can differentially affect 
glutamine availability in plasma and in muscles. Previously published studies assessed the 
impact of physical activity on glutamine in untrained healthy volunteers. Plasma 
concentrations measured after an acute session of eccentric resistance exercise (Miles et al., 
1999) as well as after intermittent high intensity bouts (Walsh et al., 1998a) were decreased 
when compared to baseline values. Moreover, exhausting bouts of aerobic exercise induced, in 
male volunteers, a significant decrease in plasma glutamine (Brodan et al., 1976) and, 
interestingly, prolonged exhausting exercise sessions were displayed to induce a major 
negative effect on glutamine concentrations when compared to short exercise sessions 
(Robson et al., 1999). Such decreased glutamine availability following exhaustive exercise 
can be hypothesized to be due to enhanced glutamine uptake for anaplerotic processes and 
gluconeogenesis (Henriksson, 1991) as well as to reduced synthesis, as evidenced by lowered 
synthetase activity (Dos Santos et al., 2009). In contrast, three hours of moderate aerobic 
exercise were shown not to acutely affect glutamine rate of appearance into blood but to 
significantly increase alanine, as determined by a tracer kinetic study performed in fasting 
state  (Williams et al., 1998). Indeed, selected kind of sports differently affected glutamine 
concentrations (Hiscock and Mackinnon, 1998): endurance and resistance sports characterized 
by prolonged and intense energy expenditure were associated to the worst decreases in 
glutamine availability. Sessions of moderate exercise were not usually associated with 
significant changes in circulating glutamine.  
Glutamine uptake from activated immune system cells can contribute to glutamine depletion 
following intense exercise. Physical exercise was, in fact, previously suggested to increase the 
uptake of glutamine from plasma for utilization in immune system (Newsholme and Calder, 
1997).  Studies regarding glutamine depletion in blood and after heavy physical training 
periods showed reduced glutamine concentrations for one or two weeks after the last exercise 
session (Keast et al., 1995). For such reasons a decrease in plasma glutamine concentrations, 
below 500 microM as arbitrary threshold (Walsh et al., 1998b), can be considered as marker 
of the so called “overtraining syndrome” (Rowbottom et al., 1996). In contrast to exhaustive 
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exercise, evidence strongly suggests that optimal, moderate training can increase glutamine 
availability. Volunteers trained at low intensity showed lower plasma glutamine decreases 
after a physical exercise session, when matched to untrained control group or to exhaustively 
trained group (Kargotich et al., 2005; Santos et al., 2007). Strikingly, in moderately trained 
animals, short-term or endurance exercise could even enhance resting plasma glutamine 
concentrations (Hood and Terjung, 1994). Finally, in humans athletes, progressive increase of 
training intensity over a medium term period (6 weeks) significantly ameliorated resting 
plasma glutamine concentrations (Kargotich et al., 2007). This suggest that physiological 
adaptation, which is likely to occur during moderate training, is needed to protect the 
organism from glutamine depletion. So, summation of transiently enhanced glutamine 
concentrations following repeated and non-fatiguing exercise sessions (moderate training) 
could play a protective role on glutamine concentrations maintenance (Dos Santos Cunha et 
al., 2004). Repeated muscle contractions were, in fact, demonstrated to be linked to enhanced 
intermediates flux in TCA cycle (Gibala et al., 1998) thus potentially leading to higher 
glutamine synthesis and release (van Hall et al., 1999). Training levels thresholds or specific 
programs aimed to maximally improve glutamine turnover in blood were still not defined. 
Figure 7 
 
Figure 7 shows mechanisms underlying changes in glutamine availability during 
physical exercise. 
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Glutamine and antioxidant systems. 
Expression profile analysis by microarray demonstrated that glutamine dietary 
supplementation can upregulate synthesis of genes involved in antioxidant response in the 
animal intestine (Wang et al., 2008). Moreover, in the same work, glutamine administration 
was shown to increase by almost 30% glutathione synthesis, thus demonstrating the actual 
impact of this nutritional treatment on intestinal antioxidant potential. Studies testing the 
efficacy of glutamine supplementation in patients undergoing surgery demonstrated a 
significant correlation between glutamine delivery and glutathione levels in blood (Engel et 
al., 2009). Other works performed in a mouse model of colitis demonstrated that enhanced 
glutamine availability was able to lower expression of genes involved in oxidative stress (NF-
kB) and inflammation (tumor necrosis factor) induction, thus ameliorating intestinal tissue 
damage (Kretzmann et al., 2008). These and other published works strongly suggest that 
glutamine availability is important to determine antioxidant response potential in tissues. The 
stimulatory effect of glutamine on antioxidant systems as well as on cell proliferation of 
intestine and immune system provide indications for glutamine supplementation in clinical 
practice with critically ill patients (Wernerman, 2008). 
 
Nutrition, inactivity and muscle atrophy 
Energy balance 
Dietary energy balance can be defined as the difference between energy intake and 
expenditure. Energy expenditure for physical activity, beside resting energy expenditure, 
strongly affects total body energy requirements (Muller et al., 2004). For this reason, when 
physical activity is reduced, energy intake should be modified in order to become adequate to 
new requirements. Under ambulatory conditions, energy balance is universally accepted to be 
a determining factor for body weight and composition, i.e. the relative content of fat and lean 
mass of the body. Under strict physical inactivity a different situation may be encountered. 
Physical inactivity and energy metabolism 
In a previously published work (Krebs et al., 1990a) the effect of physical inactivity and diet 
on body weight and composition was analysed. Volunteers were fed with conventional foods 
on average daily caloric content of 2,600 kcal. Comparing 5 weeks of continuous bed rest with 
6 weeks of ambulation no change in energy absorption or total body weight during bed rest 
were observed, but  a significant decrease in LBM and a significant increase in total body fat 
was demonstrated. Other published evidences (Gretebeck et al., 1995) used doubly labeled 
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water to measure total energy expenditure in nine healthy adult men before and during a bed 
rest period of 10 days. Authors showed that mean energy expenditure was 21% lessened by 
bed rest and displayed that resting energy expenditures failed to change. This implies that the 
reduced energy expenditure is linked to lowered physical activity. During the bed rest period, 
energy intake was higher than energy expenditure but body weight did not change. This 
suggests that body weight alone is not a reliable marker of energy balance during bed rest as a 
mass compensation occurs when the reduction in LBM is replenished by fat mass. Other 
authors (Stein and Leskiw, 2000), in fact, observed after 17 days of bed rest only a slight 
reduction of food intake (250 kcal × day-1) and confirmed that LBM was reduced (-1.4 kg) 
while fat mass was increased (+1.4 kg) determining a stable maintenance of body mass.  
In a previously published work (Murgatroyd et al., 1999) the relationship between inactivity, 
diet composition and energy balance was investigated. Authors analyzed two groups of 
subjects fed with ad libitum diets characterized by respectively 35% and 60% energy as fat. 
Measurements of energy expenditure and substrate oxidation were performed: inactivity was 
shown to induce a more strongly positive energy balance in subjects fed by 60% fat diet 
versus 35% fat. Thus, in this work lack of adaptation to energy requirements during bed rest 
was further demonstrated. Nevertheless, in a previously published study (Blanc et al., 1998) a 
12% reduction in energy intake after 42 days of simulated weightlessness was observed. 
Intakes of proteins, lipids, and carbohydrates decreased coherently with energy intake: this 
suggests that such changes could raise from the metabolic effects of bed rest and not from a 
voluntary change in subjects eating behaviour. As the reduction in energy intake occurred in 
parallel with a decrease of energy expenditure, subjects failed to display any change in fat 
mass. Nevertheless a loss of body weight was observed as the result of LBM reduction 
without significant changes in fat mass. 
 
These evidence demonstrate thats loss of body weight alone does not always accurately reflect 
the subject’s energy state, and that spontaneous adaptation to energy requirements is a rare 
condition during experimental inactivity. So, during inactivity, energy intake should be 
artificially adapted to new metabolic requirements: fat mass gain is the most evident result of 
positive energy balance during inactivity. Muscle mass wasting due to inactivity could 
compensate fat mass changes leaving unaffected total body mass. 
Overfeeding and related consequences 
Results derived from bed rest campaigns are in perfect accordance with epidemiologic studies 
showing sedentary lifestyle is strictly associated to obesity (Chaput and Tremblay, 2009). 
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Lowered energy expenditure characterizing inactive lifestyle, especially when combined with 
overfeeding, in fact, can rapidly induce a significant fat gain. Previous publications showed, in 
fact, that reduced energy expenditure for daily activities can cause a significant increase in 
abdominal fat mass, despite controlled energy intake (Olsen et al., 2008). Overfeeding and fat 
accumulation leads to the condition of overweight (body mass index > 25 kg × m-2) or of 
obesity (body mass index > 30 kg × m-2). Physical activity, enhancing metabolic processes of 
energy substrate consumption is considered, in parallel with adjusted dietary energy intake, as 
an optimal choice to manage obesity and overweight states (Veiga et al., 2009). Obesity is 
strictly related to cardiovascular risk (Wei et al., 1999), insulin resitance (Karakelides et al., 
2010) and type 2 diabetes (Venables and Jeukendrup, 2009). In obese subjects affected by 
type 2 diabetes, exercise significantly ameliorates glucose disposal by insulin action 
(O'Gorman et al., 2006; Krook et al., 2003). Moreover, enhanced lipid oxidation secondary to 
low intensity exercise training can decrease triglycerides and low density lipoproteins in 
plasma of obese subjests, thus reducing coronary disease risk and body mass (Despres and 
Lamarche, 1994). 
Obesity and inflammation: influences on sarcopenia 
Obesity was shown, both in animals and humans, to be associated to an increased level of 
inflammation (Elmarakby and Imig, 2009) and such effect was shown to be associated with 
increased cardiovascular risk (Police et al., 2009). Obesity can, in fact, be associated with 
upregulated inflammation as fat mass accumulation enhances synthesis of selected cytokines 
from adipose tissue. As released cytokines are directly synthesized by fat mass, these factors 
are called “adipokines” and for the same reeasons, fat mass can be considered as an 
“endocrine organ”.  
Fat mass accumulation characterizing severely obese subjects can be coupled to muscle mass 
reduction, leading to the so called “sarcopenic obesity”, a metabolic status linked to increased 
mortality in chronic diseases (Honda et al., 2007). Increased inflammation characterizing 
obese subjects can be associated to observed sarcopenia, due to the potential of several pro-
inflammatory factors to induce muscle wasting (Acharyya et al., 2007; Civatte et al., 2005; 
Tracey and Cerami, 1994). 
Proinflammatory adipokines 
Leptin 
Leptin is a protein encoded by the Obese (Ob) gene, synthesized by adipose tissue and aimed 
to control food intake and energy expenditure (Yadav et al., 2009). Plasma leptin 
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concentrations are positively correlated to adipose tissue accumulation (Baratta, 2002) and in 
addition, leptin was demonstrated to trigger pro-inflammatory factors as tumor necrosis factor 
alpha (Zhao et al., 2005), IL-6 (Fenton et al., 2006) and to activate the release of ROS 
(Yamagishi et al., 2001). Thus, leptin can be considered not only as marker of adiposity but 
also as index of inflammation (Cai et al., 2009). Leptin resitance is considered to be a possible 
link between chronic inflammation and cardiovascular risk or muscle tissue damage in obese 
subjects (Martin et al., 2008). Morphology of skeletal muscle of Ob knock-out mice resembles 
muscular architecture of wild type aged animals (Warmington et al., 2000). Leptin is 
considerd to be the antagonist hormone of ghrelin, an hunger stimulating hormone secreted 
mainly by the specific cells of stomach: it revealed anti-cachectic properties, through 
regulation of energy intake and expenditure, adiposity and growth hormone secretion 
(Balasubramaniam et al., 2006). After a meal consumption ghrelin levels are known to 
decrease, but in obese subjects, ghrelin availability is not lowered in postprandial state, 
suggesting obesity can be linked to ghrelin resistance (Mittelman et al., 2010). 
 
Tumor necrosis factor alpha 
Another proinflammatory cytokine released by fat mass is tumor necrosis factor alpha. 
Upregulation of its expression was shown to be associated to obesity both in humans and in 
animal models (Hotamisligil et al., 1993). Tumor necrosis factor alpha, even though released 
in plasma to exert its biological role at whole body, can play a localized action in fat mass. 
Mice characterized by lowered affinity for tumor necrosis factor alpha in fat mass receptors 
are less susceptible to the development of experimental diabetes (Uysal et al., 1997). Tumor 
necrosis factor upregulation was shown to be crucial for the increase of proinflammatory 
leptin characterizing sarcopenic obese subjects (Kirchgessner et al., 1997). 
 
Interleukin-6 
Interleukin-6 in synthetized in fat mass by the stimulatory effect of tumor necrosis factor 
alpha (Rotter et al., 2003) and plays both pro- and anti-inflammatory effects at whole body. 
Exogenous interlukin-6 injection in obese rodents was associated to a decrease in fat mass, 
suggesting the beneficial lipolytic effect of this molecule to contrast obesity (Wallenius et al., 
2002). Emerging evidences showed that interleukin-6 can be released in muscle: for such 
reasons this molecule can be defined as “miokyne”. In particular, contracting muscles, in 
opposition to resting miofibres, were shown to release interlukin-6: this effect was related to  
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increased lytic activity on muscle glycogen stores (Keller et al., 2001). Thus, fat and muscle 
mass can be hypothesized to actively cooperate in regulation of metabolic processes. 
Anti-inflammatory adipokines  
Adiponectin 
Adiponectin is secreted by fat tissue and is characterized by a collagenous domain, and by a 
globular trimerization domain. Adiponectin plays a crucial role in glucose and lipids 
metabolism.  
Adiponectin is secreted by fat tissue cell types and exists as a trimer of the full-length protein 
or as a proteolytic cleavage fragment (globular). The trimer can further dimerize leading to an 
hexamer which can in turn create a polymer with different biological activities (Scherer et al., 
1995). Adiponectin is recognized by at least two cell membrane receptors (ADIPOR1 and 
ADIPOR2) in this way regulating different pro- and anti-inflammatory cytokines. The 
principal anti-inflammatory function is exerted by reduction of tumour-necrosis factor 
synthesis (Maeda et al., 2005) and of interferon-γ (Yokota et al., 2000). Additionally, 
adiponectin can induce, in human leukocytes, the expression of anti-inflammatory factors as 
interleukin-10 and interleukin-1 receptor antagonist (Wolf et al., 2004). Interestingly, reduced 
adponectin levels characterize subjects with diagnosed type 2 diabetes and are considered as 
maker of predisposition to insulin resistance (Spranger et al., 2003). Exogenous injections of 
recombinant adiponectin in diabetic mice reduces glucose production from liver, thus 
ameliorating hyperglycemia without rising plasma insulin concentrations (Berg et al., 2001). 
Physical exercise was shown to upregulate plasma adiponectin availability in female 
adolescents (Ischander et al., 2007). A significant decreased level of plasma adiponectin vas 
reported in bedridden female patients, when compared to age matched healthy controls in 
ambulatory conditions (Kanda et al., 2005). 
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Figure 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 displays the endocrine cross-talk between muscle and fat mass 
potentially occurring in conditions of physical inactivity or exercise. 
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Macrophage infiltration in fat mass. 
Inflammatory condition linked to obesity might derive from adipokines mediated infiltration 
of macrophages in increasing fat mass (Xu et al., 2003). Previous publications in animal 
models, in fact, suggested that in obese subjects, both cell number and size of macrophages in 
fat mass are significantly higher when compared to lean subjects (Weisberg et al., 2003). 
Tumor necrosis factor alpha was shown to play crucial role in macrophage recruitment into 
adipose tissue by stimulation of monocyte chemoattractant protein-1, as factor promoting 
migration of macrophage precursor cell into fat mass (Wellen and Hotamisligil, 2003). 
Calorie restriction 
Dietary calorie restriction is a frequent nutritional approach in hospitalized patients due to 
illness conditions or to surgery interventions. In addition, dietary energy intake reduction, 
normally associated with physical exercise programs, is a well established therapy for weight 
loss in obese subjects (Larson-Meyer et al., 2010). Moreover, in the same work, combined 
energy restriction and physical exercise were demonstrated to ameliorate insulin sensitivity 
and to reduce LDL cholesterol (Larson-Meyer et al., 2010). Long term calorie restriction per 
se was shown to ameliorate insulin sensitivity indexes measured in fasting human subjects 
(Fontana et al., 2009). Interestigly, calorie restriction was associated to improved life 
expectancy in virtue of reduced incidence of cardiovascular diseases (Fontana, 2009b). In 
animals, alternate-day fasting was shown to protect from left ventricle fibrosis mediated by 
oxidative stress, as typical feature of aging, and to reduce activation of pro-inflammatory NF-
kB factor (Castello et al., 2009). 
Additionally, lowered cancer incidence was also associated to anti-inflammatory action and to 
lowered release of growth factors mediated by long term calorie restriction (Hursting et al., 
2010). 
Inactivity and calorie restriction 
The potential of calorie restriction to ameliorate metabolic disorders related to physical 
inactivity was previously investigated in a previously published work (Bosutti et al., 2008). As 
above mentioned, authors described that experimental inactivity in eucaloric conditions 
upregulated plasma CRP and the ratio between plasma pro- and anti-inflammatory cytokines 
in plasma and white blood cells. Interestingly in the same work, a mild calorie restriction was 
shown to blunt bed rest mediated changes in CRP and pro- or anti-inflammatory cytokines: 
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this suggests that calorie restriction could significantly ameliorate metabolic changes mediated 
by physical inactivity. Such results were obtained in subjects involved within the STBR-IP 
study. Additional published results (Biolo et al., 2007b) obtained within the same 
experimental frame showed that calorie restriction significantly affected muscle mass 
metabolism. In particular, low energy intake significantly interacted with inactivity to increase 
leucine oxidation, as marker of protein wasting. Moreover, the catabolism of lean mass, 
known to normally occur during physical immobility, was shown to be particularly 
upregulated when low energy diet was associated to physical inactivity. This effect seems not 
to involve inflammation as energy restriction was shown to prevent inactivity-induced 
inflammation. Nevertheless, these data suggest that calorie restriction could exacerbate 
detrimental effects of physical inactivity on muscle mass and metabolism: this is a common 
condition in immobilized patients characterized by underfeeding and malnutrition. 
Amino acid intake and protein synthesis: exercise and inactivity. 
Protein intake and amino acid availability are the key regulators of muscle protein synthesis. 
Amino acid administration acutely upregulates muscle protein synthesis and such effect is 
greatly enhanced when resistance or aerobic exercise is performed (Biolo et al., 1997). Amino 
acid administration displays a major anabolic effect than insulin and glucose administration 
both in the resting state and after exercise (Biolo et al., 1999). While endurance exercise 
increases the oxidation of essential amino acids, thus raising the requirement for dietary 
protein (Tarnopolsky, 2004), resistance exercise results in a decrease in nitrogen excretion, 
lowering dietary protein needs (Phillips, 2004). In contrast to exercise, the anabolic efficiency 
of amino acid administration is decreased during inactivity. The stimulatory effect of an 
amino acid load on whole body protein synthesis in healthy volunteers at the end of a period 
of experimental bed rest was, in fact, shown to be reduced (-20%) when compared to normal 
physical activity (Biolo et al., 2004). In addition, the rate of protein turnover in the fasting 
state was decreased both at muscle and whole body levels during bed rest (Biolo et al., 2004). 
Other results indicated that dietary protein restriction (i.e., 0.6 g protein × kg-1 × d-1 ) led to 
23% suppression of whole body protein turnover in the fasting state when compared to 
adequate (i.e., 1.0 g protein × kg-1 × d-1) protein intake levels (Stuart et al., 1990). Further 
increases in dietary protein content (1.5 g protein × kg-1 × d-1) during bed rest periods were 
shown to better maintain myocardial mass (Dorfman et al., 2007). In an additional study, 
supplementation with about 50 g of essential amino acids during 4 weeks bed rest maintained 
leg mass and ameliorated the muscle strength decrease (Paddon-Jones et al., 2004). 
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Amino acid supplementation: cardiovascular risk, inflammation and oxidative stress. 
Amino acid supplementation is known to influence cardiovascular risk affecting an important 
metabolic parameter as insulin resistance. Interestingly oral administration of L-arginine to 
cardiopathic patients was shown to decrease endothelial dysfunction, as assessed by changes 
of nitric oxide availability, and insulin sensitivity as evidenced by glucose tolerance tests 
(Lucotti et al., 2009). Nevertheless, published metanalysis taking into account trials testing 
arginine efficacy cardiovascular diseases, showed that supplementation displayed only a 
tendency to reduce of 7% mortality of treated patients (Sun et al., 2009). 
Interestingly, a high dietary content of casein was previously shown in an animal model to 
increase homocysteine disposal via transsulfuration pathway, thus potentially reducing 
cardiovascular risk condition (Ohuchi et al., 2009). Interestingly, protein supplementation was 
shown to reduce the production of reactive oxygen species and apoptosis in mice embryos 
(Esfandiari et al., 2005). In parallel, glutamine supplementation was shown to ameliorate 
inflammatory markers and to ameliorate the expression of the antioxidant glutathione in 
postoperative cardiac patients (Engel et al., 2009). Thus, the ability of amino acid 
supplementation to downregulate inflammatory processes or oxidative stress onset could 
account for the beneficial role exerted on cardiovascular system. 
Nutritional proteins: whey and casein 
The concept of nutritional protein quality includes ability to provide specific amino acid 
patterns and digestibility. The major milk proteins are casein and whey: these two proteins 
differ in amino acid composition and digestion rate. 
Whey is a fast-digesting protein and casein is a slow-digesting protein (Dangin et al., 2003). 
Casein is an excellent source of all the essential amino acids in balanced proportion relatively 
to individual requirements in healthy subjects. Whey is characterized by higher content of 
leucine and cysteine: leucine interacts with the insulin signaling pathway to stimulate 
downstream signal control of protein synthesis (Anthony et al., 2007) and cysteine is rate 
limiting for synthesis of glutathione, the main intracellular antioxidant system (Bannai, 1984). 
Whey ingestion was shown to promote protein anabolism in the elderly (Dangin et al., 2003) 
and in bed resting young subjects (Antonione et al., 2008) better than casein. Different 
mechanisms could be responsible for a greater whey anabolic efficiency during inactivity. The 
slow rate of amino acid absorption from casein may limit protein synthesis stimulation during 
inactivity, whereas a higher and short-term increase of aminoacidemia after whey ingestion 
could counteract inactivity-induced inhibition of protein anabolism (Biolo et al., 2004). 
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Moreover, increased leucine availability after whey ingestion could enhance, during inactivity, 
the intracellular signaling of muscle protein synthesis stimulation (Anthony et al., 2007). 
Finally, whey-mediated increased cysteine availability could activate the glutathione system 
thereby improving muscle redox balance and decreasing catabolism (Powers et al., 2007).
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AIMS 
The present thesis investigates the effects of physical inactivity on: 
1. oxidative stress and inflammation 
2. muscle atrophy 
3. glutamine metabolism 
Additionally, this work focusses on the impact of dietary energy balance and protein intake 
control during inactivity on above mentioned metabolic changes. 
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MATERIALS AND METHODS 
The present thesis is principally intended to elucidate the effects of inactivity on oxidative 
stress, inflammation, muscle atrophy. The bed rest model is known to be a reliable approach 
to study the impact of muscle unloading on human metabolism (Biolo et al., 2005a). In 
parallel, the same experimental setting is a suitable tool to investigate, on earth, the impact of 
microgravity on human physiology during space flights (Biolo et al., 2005a). 
Results reported in the present thesis were collected during five different bed rest campaigns: 
1) Short term bed rest-integrated physiology (STBR-IP) at the Clinical Research Center of the 
DLR-German Aerospace Institute (Cologne, Germany); 2) Women International Space 
Simulation for Exploration (WISE) at MEDES Clinical Research Facility of the Rangueil 
University Hospital (Toulouse, France); 3) Valdoltra Bed Rest 2006; 4) Valdoltra Bed Rest 
2007; 5) Valdoltra Bed Rest 2008, Valdoltra Orthopaedic Hospital, (Ankaran, Capodistria, 
Slovenia). 
 
1) Short Term Bed Rest-Integrated Physiology (STBR-IP) at the Clinical Research 
Center of the DLR-German Aerospace Institute (Cologne, Germany) 
The Short Term Bed Rest-Integrated Physiology (STBR-IP) study was organized at the 
Clinical Research Center of the German Aerospace Institute (DLR - Cologne, Germany) as a 
complex study involving different international scientific groups. In the frame of STBR-IP, 
the impact of physical inactivity and microgravity on glutamine turnover was assessed. The 
experimental protocol was in accordance with the local ethical standards on human 
experimentation and approval was obtained from the Ethics Committee of the Árztekammer 
Nordrhein (Düsseldorf, Germany). The study was performed in accordance with the 
Declaration of Helsinki for human studies and relative amendments. Each subject signed an 
informed consent form upon admission. 
 
As previously published (Biolo et al., 2007b) nine healthy volunteers (age: 24 ± 1 year; body 
mass index: 23 ± 1 kg × m-2) participated in a four phase study. During the first and second 
phases (July–August 2001 and February–March 2002, respectively), subjects received, 
eucaloric diets in either bed rest or ambulatory conditions in order to keep a constant body 
weight. In contrast, during the third and fourth phases (July–August 2002 and February– 
March 2003, respectively), subjects received diets characterized by lowered calorie intake 
containing almost 80% of total energy requirement in either bed rest or ambulatory conditions. 
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Calorie restriction was achieved by reduction fat intake. The cross over design was applied as 
follows: four subjects were studied in ambulatory conditions during the first and third phases 
and in bed rest conditions during the second and fourth phases; the other five subjects were 
studied in bed rest conditions during the first and third phases and in ambulatory conditions 
during the second and fourth phases. During the 14 days of bed rest, participants were exposed 
to 6° head-down-tilt bed rest for 24 hours per day. Some activities (ie, food intake, using the 
toilet, showering, and weighing) were performed in near-horizontal position. 
During the ambulatory periods, participants were in the normal upright position during the day 
and were allowed to walk around in the ward. During the ambulatory periods subjects 
performed light muscular workload (including bicycle ergometry for 10 min 3 times/d). 
Diet control 
During the entire study period diet was strictly controlled. Before each study period, resting 
energy expenditure (REE) of each subject was estimated according to the FAO/WHO 
equations (Muller et al., 2004). Dietary energy content was reduced during bed rest and 
hypocaloric periods: within the eucaloric phases, participants received a diet containing 1.4 
and 1.1 times their calculated REE during the ambulatory and the bed rest periods, 
respectively; otherwise, within the hypocaloric phases, participants received a diet containing 
1.1 and 0.9 times their REE during the ambulatory and the bed rest periods, respectively. Total 
energy intake was almost 20% lower during the hypocaloric phases when compared to the 
correspondent eucaloric phases both in bed rest or ambulatory conditions. Subjects received a 
constant protein intake of 1 g protein × kg-1 × d-1 in all study phases. Fatty acid intake was 
composed by both saturated and polyunsaturated fatty acids: during the hypocaloric periods, 
energy restriction was achieved by decreasing fat intake to a minimum of 60 g × d-1. The 
remaining energy was composed of carbohydrates. Daily intakes of water (50 mL × kg-1), 
sodium (2.5 mmol × kg-1), calcium (1000 mg) and vitamin D (400 IU) were monitored during 
the experimental periods. No caffeine, methylxanthine, or alcohol was allowed. Six meals 
were given daily (breakfast, lunch, dinner and 3 snacks). All foods were exactly weighed for 
each participant, and volunteers were asked to consume the complete meal.  
Body composition 
The body composition of all subjects was measured by DXA at the end of the adaptation 
period and at the beginning of the recovery period with the use of the Hologic QDR-2000 
(Waltham, MA). The enhanced whole-body scans were analyzed for lean tissue mass. 
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Metabolic test 
In order to assess the impact of inactivity on glutamine metabolism, on the morning of the last 
day of bed rest or ambulatory periods in eucaloric or hypocaloric conditions, after a 12 h 
overnight fast, a metabolic study involving infusion of stable isotopes was performed: a 
polyethylene catheter was inserted into an antecubital vein for infusion of all test substances. 
A second polyethylene catheter was inserted in a wrist vein of the opposite hand, which was 
heated (+50°C) to obtain arterialized venous blood. After baseline determinations of α-[1-
13C]ketoisocaproic ([13C]KIC) acid and L-[5-15N]glutamine ([15N]glutamine) enrichments in 
arterialized plasma, a primed (5.4 µmol × kg-1) continuous (0.09 µmol × kg-1× min-1) infusion 
of L-[5-15N]glutamine (Cambridge Isotope Laboratories, Andover, MA, USA) was started and 
continued for 8 h. Two hours later, a L-[1-13C]leucine ([13C]leucine) (Cambridge Isotope 
Laboratories) primed (5.4 µmol × kg-1) continuous (0.09 µmol × kg-1× min-1) infusion was 
started and continued for 6 h. Blood samples were obtained at 280, 290 and 300 min to 
determine [13C]KIC and [15N]glutamine enrichments as well as amino acid concentrations in 
arterialized plasma. After the fifth hour, a primed-constant intravenous infusion of a 
glutamine-free amino acid solution (Freamine III 8.5%; Clintec, Milan, Italy) was initiated 
and continued for 3 h (prime dose: 0.13 g × kg LBM-1, constant infusion rate: 0.13 g × kg 
LBM -1 × h-1 ). The amino acid concentrations reported by the manufacturer (expressed as mg 
per 100 ml) were as follows: isoleucine 590; leucine 770; lysine 870; methionine 450; 
phenylalanine 480; threonine 340; tryptophan 130; valine 560; alanine 600, arginine 810; 
histidine 240; serine 500; cysteine 18; glycine 1190. Plasma amino acid concentrations and 
isotopic enrichments were determined at minutes 460, 470 and 480.  
Analytical procedures 
Plasma amino acid concentrations 
Plasma glutamine, glutamate, leucine, valine and isoleucine concentrations were determined 
by high pressure liquid chromatography (Beckman Instruments Inc, San Ramon, CA). 
A plasma volume of 1ml was deproteinized by addition of sulfosalicylic acid (SSA, 100 µl, 
30%) in ice for 60 min. After centrifugation 50 µl of the upper phase were added to 25 µl of 
internal standard solution (containing known homoserine concentrations in appropriated 
borate buffer), and diluted to the final volume of 1250 µl by borate buffer and bidistilled 
water. Solutions containing known amounts of amino acids and  homoserine in borate buffer 
were prepared for standard analyses. Derivatization was performed by o-phthaldialdehyde 
(OPA) (Sigma Chemical Co, St Louis, MO) in methanol, borate buffer and β-
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mercaptoethanol. For analysis appropriate fractions of a Phase A solution composed by 50 ml 
sodium acetate (1 M) in 1000 ml bidistilled water and of a Phase B composed by methanol 
were used. Concentrations were calculated from peak areas according to internal standard 
concentrations and after normalization by homoserine peak area. 
 
Plasma isotopic enrichments 
[13C]KIC isotopic enrichments were measured by gas chromatography mass spectrometry 
(Agilent – HP 5973 Mass Spectrometer, Albertville, MN,USA) as follows: 200 µl of plasma 
were deproteinated with ethanol (1 ml), and after evaporation under N2 flux and dissolution in 
water p-phenylendiamine (Sigma Chemical Co, St Louis, MO) (200 µl, 2% in 4N HCl) was 
added. After etilacetate extraction and evaporation under N2 flux, N,Obis (trimethylsilyl)-
trifluoroacetamide with 1% trimethylchlorosilane (Pierce Chemical, Rockford, IL) (50 µl) was 
added to form the silylquinoxalinol derivative of KIC. Analyses were performed in single ion 
monitoring mode at m × z-1 232 and 233 (Wolfe, 2004). 
 
[15N]glutamine enrichments 
A plasma aliquot of 300 µl was treated with SSA (300 µl, 30%). After centrifugation, amino 
acids were purified by a cationic resin column (AG50W-X8; Bio-Rad, Hercules, CA) and 
elution with NH4OH (3M). After evaporation under N2 flux and liophilization, 50 µl 
acetonitrile + 50 µl N-Methyl-N-(Tert-Butyldimethylsilyl)trifluoroacetamide (MTBSTFA) 
(45 min, 90° C) were added for derivatization. Analyses were performed in single ion 
monitoring mode at mass-to-charge ratio (m × z-1) 431 and 432 (Wolfe, 2004). 
Calculations 
Glutamine total rate of appearance (Ra) was calculated by standard equation, dividing 
[15N]glutamine infusion rate by [15N]glutamine isotopic enrichment (Wolfe, 2004). 
Glutamine Ra from proteolysis was determined on the base of leucine Ra from proteolysis 
multiplied by 0.47, i.e .a constant factor representing the average ratio between glutamine and 
leucine in mixed human muscle protein (Biolo et al., 2006). Glutamine de novo synthesis was 
assessed as difference between total glutamine Ra and Ra from proteolysis. 
During 8 h primed-continuous infusion of [15N]glutamine no label can be detected in alanine 
(Biolo et al., 1995a): this suggest that nitrogen derived from glutamine amide deamination is 
diluted into the large ammonia pool and does not significantly recycle back to amino acids. 
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Glutamine de novo synthesis can be, therefore, reliably measured by this approach. In steady 
state conditions total glutamine Ra equals the rate of disappearance (Rd). Glutamine clearance 
was assessed as ratio between total glutamine Rd and plasma glutamine concentration. All 
kinetic data were expressed as ratio to LBM as detected by DXA. 
Statistical analysis 
All data were expressed as means±S.E.M. Results in the four different experimental 
conditions (ambulatory with eucaloric diet, bed rest with eucaloric diet, ambulatory with 
hypocaloric diet, and bed rest with hypocaloric diet) were analyzed using a repeated measures 
analysis of variance (ANOVA) with activity (ambulatory or bed rest) and diet (eucaloric or 
hypocaloric) as the two factors. Post hoc analysis was performed, when appropriate, by using 
Student’s t test with Bonferroni’s adjustment. Amino acid-mediated changes from the 
postabsorptive state in the ambulatory and bed rest conditions with eucaloric and hypocaloric 
diets were compared by using Student’s paired t test. Statistical analysis was performed with 
SPSS software (version 12; SPSS Inc., Chicago, IL, USA). P-values <0.05 were considered as 
indicating significant differences. 
 
2) Women International Space Simulation for Exploration (WISE) at MEDES Clinical 
Research Facility of the Rangueil University Hospital (Toulouse, France) 
Sixteen healthy female subjects (age: 32.1 ± 4 years, BMI: 21 ± 2 kg × m-2) were enrolled for 
the present study at MEDES Clinical Research Facility of the Rangueil University Hospital 
(Toulouse, France).  All subjects were physically active before the study beginning. The study 
was performed in accordance with the Declaration of Helsinki for human studies and relative 
amendments. Each subject signed an informed consent form upon admission. All sixteen 
subjects performed a 60 days period of strict 6° head-down-tilt bed rest. All subjects remained 
in the HDT position during the whole experimental period except for meals assumption when 
they were allowed to elevate on one elbow. 
Dietary control 
Subjects were divided in two groups: eight subjects (standard protein intake) received a 
tailored diet containing a standard protein content of 1 g × kg-1 × d-1 , while the other eight 
subjects (high protein intake) received a diet containing an increased protein intake (1.45 g × 
kg-1 × d-1) and a fixed supplementation of free branched-chain amino acids (BCAA) (3.6 g × d 
free leucine, 1.8 g × d free isoleucine, and 1.8 g × d free valine) (Friliver, Bracco, Italy) at the 
three main meals. Energy intake was tailored on each subject on the base of REE, which was 
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determined before bed rest by indirect calorimetry and body composition assessment and 
adjusted every 15 days. The maximum liquid intake of the standard and high protein intake 
groups was 60 ml × kg-1 × d-1. For all subjects, sodium intake was 1.2 to 1.6 mmol × kg-1 × d-
1
, potassium intake was 0.9 to 1.1 mmol × kg-1 × d-1, calcium intake was 1 g × d-1, and 
phosphorus intake was 1.2 to 1.6 mmol × kg-1 × d-1. Dietary folate intake was strictly kept 
constant during all study phases at 400 µg × day-1. 
 
Body composition 
Body composition was measured before and every 15 days using bioimpedance analysis 
(Human IM Plus; DS Dietosystem, Milan, Italy) accordingly to manufacturer’s instructions. 
 
Metabolic test 
In order to assess the impact of inactivity on homocysteine metabolism, on the morning of the 
last day of bed rest periods both in high or standard energy intake conditions, after a 12 h 
overnight fast, a metabolic study involving infusion of stable isotopes was performed: a 
polyethylene catheter was inserted into an antecubital vein for infusion of all test substances. 
A second polyethylene catheter was inserted in a wrist vein of the opposite hand, which was 
heated (+50°C) to obtain arterialized venous blood. After baseline determinations of [ring-
2H5]phenylalanine, [ring-2H4]tyrosine, [3,3-2H2]tyrosine, [methyl-2H3,1-13C]methionine (i.e. 
m+4) and of [1-13C]methionine (i.e. m+1) enrichments in arterialized plasma, primed 
continuous infusions of [ring-2H5]phenylalanine (infusion rate 4.8 µmol × kg-1 × h-1, priming 
dose 4.8 µmol × kg-1), [3,3-2H2]tyrosine (infusion rate 1.2 µmol × kg-1 × h-1, priming dose 1.2 
µmol × kg-1), [methyl-2H3,1-13C]methionine (infusion rate 4.4 µmol × kg-1 × h-1, priming dose 
4.4 µmol × kg-1) and a single bolus of [ring-2H4]tyrosine (0.45 µmol × kg-1) were started. 
Isotopic amino acids (Cambridge Isotope Laboratories, Andover, MA, USA) infusion was 
maintained for 8 hours. After the fifth hour an hyperinsulinemic-euglycemic clamp was 
performed administering 1mU × kg-1 × min-1 of insulin and an amino acid mixture at an 
infusion rate of 0.128 g × kg-1 × h-1 (Vintene, Baxter, Deerfield, IL, USA). To assess 
enrichment changes over time, blood samples were taken 280, 290, 300 and 460, 470, 480 
minutes after onset of infusion. 
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Analytical procedures 
To assess plasma enrichments of isotopic tyrosine and phenylalanine the same technical 
procedure applied for glutamine was used. Phenylalanine and [ring-2H5]phenylalanine were 
measured at m × z-1 336 and 341, respectively. Tyrosine, [3,3-2H2]tyrosine and [ring-
2H4]tyrosine were measured at m × z-1 466, 468 and 470, respectively. 
 
To analyze enrichments of sulphur amino acids, after treatment with 2-mercaptoethanol (3 µl) 
samples were evaporated under N2 flux and treated with SSA (200 µl, 15%). After 
centrifugation, amino acids were purified from the upper phase by a cationic resin (AG50W-
X8; Bio-Rad, Hercules, CA) and eluted by NH4OH (3M). After ammonia elimination under 
gentle N2 flux and liophilization, 50 µl acetonitrile + 50 µl MTBSTFA (45 min, 90° C) were 
added for derivatization. To assess homocysteine concentrations, a known amount of [2H8]-
homocysteine was added as internal standard to 200 µl of plasma before analysis. To assess 
methionine and cysteine concentrations known amount of L-[1-13C, methyl-2H3]methionine, 
and L-[3,3-2H2]cysteine (Cambridge Isotope Laboratories) were added. Measurements were 
performed in single ion monitoring mode at m × z-1 496 and 497 and 500 for natural [12C] 
homocysteine, for [13C] homocysteine and for the internal standard. For methionine and 
cysteine concentrations m × z-1 ratios 320/324 and 406/408 were analyzed respectively 
(Wolfe, 2004).  
Calculations 
Homocysteine kinetics were calculated adapting a previously published model (Storch et al., 
1988). Principally, the method is based on isotopic methyl release from [methyl-2H3,1-
13C]methionine tracer (m + 4) during transmethylation reaction, while isotopic carbon (m + 1) 
is maintained during remethylation reaction. 
 
Thus, turnover rate of methionine labeled with isotopic methyl and carbon can be calculated 
as 
Qm = Imet / Em + 4  
 
while, turnover rate of methionine labeled with isotopic carbon can be calculated as 
 
Qc = Imet / (Em + 4 + Em + 1) 
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where Qm and Qc are turnover rates of methyl group of methionine and carbon backbone of 
methionine, respectively. Imet is [methyl-2H3,1-13C]methionine tracer infusion rate and 
Em+4 and Em+1 are [methyl-2H3,1-13C]methionine and [1-13C]methionine enrichments, 
respectively. Em + 4 must be taken into account in Qc formula as this isotope includes an m + 
1 mass. 
 
In a steady state condition, methionine production equals methionine output. Thus 
 
N + B + RM =  Qm = S + TM 
 
and 
 
N + B = Qc = S + TS 
 
where N is the contribution of diet, B of protein breakdown, RM of remethylation, TM of 
transmethylation and TS of transsulfuration. Qc is not affected by RM as isotopic carbon is 
maintained along with homocysteine metabolism. 
 
In the postabsorptive state, N=0: thus rate of remethylation (RM) can be calculated as  
 
RM = Qm – Qc.  
 
Methionine transmethylation (TM) can be calculated as  
 
TM = RM + TS 
 
In postabsorptive state, B can be calculated as  
 
B = Qc  
 
and in simulated postprandial state (pp) as  
 
B(pp) = Qc – IAA 
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where IAA is exogenous methionine infusion rate.  
 
TS can be calculated as 
 
TS = Qc - S 
 
S can be calculated as  
 
S = PheS × 0.63 
 
where PheS is phenylalanine utilization for protein synthesis determined by [ring-
2H5]phenylalanine and [3,3-2H2]tyrosine infusion and 0.63 is the molar ratio between 
methionine and phenylalanine.  
 
In particular, 
 
PheS = PheB – PheOx 
 
PheB can be calculated as 
 
PheB = IPheD5 ×EPheD5 
 
where IPheD5 is the infusion rate of [ring-2H5]phenylalanine and EPheD5 is the enrichment of 
[ring-2H5]phenylalanine 
 
PheOx is the rate of phenylalanine hydroxylation to tyrosine an can be calculated as follows 
 
PheOx = (IRTyrD2 × ETyrD4) × (ETyrD2 × EPheD5) 
 
where IRTyrD2 is the infusion rate of [3,3-2H2]tyrosine, ETyrD4 is the enrichment of [ring-
2H4]tyrosine, ETyrD2 is the enrichment of [3,3-2H2]tyrosine and EPheD5 is the enrichment of 
[ring-2H5]phenylalanine. 
 
Thus, TS and TM can be calculated as 
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TM = Qm - S 
or  
TM = RM + TS 
 
The assessment of homocysteine concentrations was performed taking into account the 
concentration of the internal standard. 
 
[Homocysteine] = [I.S.] × EHomocysteineD4-1 × Pl.Vol.-1 
where [I.S.] is the concentration of the added internal standard, EHomocysteineD7 is the 
enrichment of D4 homocysteine and Pl.Vol. is the volume of analyzed plasma. 
 
3) Valdoltra Bed Rest studies 2006 - 2007 - 2008, Valdoltra Orthopaedic Hospital, 
University of Koper (Capodistria, Slovenia). 
 
Thirty healthy young male subjects (mean ± S.E.M.; age 23.3 ± 0.4 years; body mass index 
23.6 ± 0.4 kg m -2) were selected for three separated 35-day bed rest studies performed at the 
Valdoltra Hospital, University of Primorska, Ankaran-Capodistria, Slovenia, in July–August 
2006 (A), 2007 (B) and 2008. 
 
The projects were approved by the ethical committee of the University of Ljubljana and the 
experimental protocol was in accordance to the Declaration of Helsinki (2002). A written 
informed consent was obtained by each subject upon enrolment. All subjects were physically  
active before the admission to the Valdoltra Hospital (Slovenia). None of the subjects was 
under medication and their body weight was stable during the previous month. Preliminary 
standard anthropometric measures and routine medical screening were performed. Volunteers 
were admitted at the hospital one week before the bed rest period for dietary and 
environmental adaptation period (Ambulatory period). At the end of the ambulatory period, 
each subject underwent 35 days of strict bed rest in which all daily activities were performed 
in horizontal clinostatic conditions. Subjects involved in 2008 study were in a 6°-head-down-
tilt condition. Subjects were under periodical medical control and constant nursing assistance. 
Dietary control: studies A, B and 2008 
During the ambulatory and bed rest periods, diet composition and energy intake were daily 
monitored by a dietician. Individual diet composition reflected previous dietary habits. 
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Individual dietary preferences were collected by appropriate questionnaires received by each 
subject upon study enrolment and implemented during the ambulatory and bed rest periods in 
order to maintain individual dietary habits. Six meals were administered daily: 3 main meals 
(breakfast, lunch, and dinner) and 3 snacks. The three bedrest periods were preceded by an 
ambulatory adaptation period of 1 week, in which each subject received a weight-maintaining 
diet containing 1.4 times his resting energy expenditure, calculated by using the FAO/WHO 
equations (Muller et al., 2004). The diet contained almost 60% of energy as carbohydrate, 
25% as fat, and 15% as protein. During the 35 days bed rest period of study A, a diet with the 
same energy, frequency, and relative macronutrient content of that planned in the ambulatory 
adaptation period was offered to subjects. Subjects were not required to consume all served 
food, but they were allowed to adapt spontaneously to decreased energy requirements during 
inactivity. Leftover food was monitored semiquantitatively by a dietitian to assess the relative 
macronutrient intake. Otherwise, during the 35 days bed rest period of studies B and 2008, 
each subject received an activity adjusted diet containing 1.2 times his resting energy 
expenditure and with the same meal frequency and relative macronutrient content of that 
planned in study A. Subjects were required to consume all served food. 
Body composition 
During A and B studies, fat mass and fat-free mass were monitored by multifrequency 
bioelectrical impedance (Human IM Plus; DS Dietosystem, Milan, Italy). Before and after 
studies A and B, the thickness of the vastus lateralis muscle was measured while the subject 
was in the supine position, by using ultrasound imaging on a portable ultrasound device 
(MyLab25; ESAOTE, Genoa, Italy) fitted with a 10–15-MHz linear probe (Reeves et al., 
2004). Sagittal ultrasound images were obtained at 50% of muscle length measured along the 
midsagittal axis, after identification of the proximal and medial bone insertions of muscle. To 
ensure that all scanning measurements were taken in the same anatomical location, the 
ultrasound probe was positioned in the midsagittal plane, orthogonal to the mediolateral axis 
and its positioning was marked on acetate paper using moles and small angiomas (which may 
be assumed to maintain a fixed position) as reference points. Muscle thickness was measured 
in 8 subjects in Study B. Values were expressed in cm, as the vertical distance between 
muscle superficial and deep aponeuroses at an equidistant point from right and left borders of 
the image. Only in study A, in addition to the thickness of the vastus lateralis, the thicknesses 
of the gastrocnemius medialis, tibialis anterior, and biceps brachii muscles were measured. 
Then, a mean value of the thickness of representative postural and nonpostural muscles was 
calculated. 
 61 
 
Vastus lateralis muscle architecture was measured in the supine position using realtime B-
mode ultrasonography (ATL-HDI 3000, Bothell) with a 40 mm, 7.5 MHz linear-array probe. 
Scans were taken before and after bed rest with knee joint in anatomical position (passively 
fully extended). Measurements were performed at 50% of muscle length (previously estimated 
with ultrasound), in the midsagittal plane. To ensure that all scanning measurements were 
taken in the same anatomical location, the ultrasound probe was positioned in the midsagittal 
plane, orthogonal to the mediolateral axis and its positioning was marked on acetate paper 
using moles and small angiomas (which may be assumed to maintain a fixed position) as 
reference points. In each ultrasound image obtained at rest, the fascicular path was determined 
as the interspaces between echoes coming from the perimysial tissue surrounding the fascicle. 
Pennation angle was measured using Matlab (Matlab, The MathWorks Inc., S. Natik, MA, 
USA). Pennation angle was calculated as the angle between the fascicle and the deep 
aponeurosis of the muscle. In each scan, the average length and pennation angle of three 
fascicles was used for analysis (de Boer et al., 2007). Ultrasonographic analyses could be 
performed only on 9 subjects in study B for technical problems occurred during baseline 
measurements. 
Metabolic test in study A: erythrocyte glutathione turnover rate 
Glutathione turnover rates were determined during the postabsorptive state at the end of both 
the ambulatory adaptation and the bed-rest periods in study A. After background blood 
sampling, a primed continuous infusion of L-[3,3-2H2]cysteine (Cambridge Isotope 
Laboratories, Andover, MA) (priming dose: 150 µmol; continuous infusion rate: 150 µmol/h) 
was started at 07.00 or 08.00 AM and continued for 5 h. A total of 10 mL arterialized venous 
blood was obtained at times 3, 4, and 5 h to measure hematocrit and the concentration and 2H2 
enrichment of erythrocyte-free cysteine and glutathione (Lyons et al., 2001). Whole blood was 
immediately centrifuged, and plasma and leukocytes were removed and replaced with an 
equal volume of cold distilled water. Both plasma and erythrocyte solutions were frozen at -80 
°C for later analysis. Plasma and erythrocyte concentrations of glutathione and of glutathione 
amino acid precursors were measured in the background sample. At 1200 or 1300, isotope 
infusion was discontinued. 
Markers of inflammatory and enzymic-antioxidant response in study A. 
During metabolic tests, selected plasma hormone, mediator, and metabolite concentrations 
were measured in plasma. Glutathione peroxidase activity and protein concentrations in the 
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catalytic and modulatory subunits of glutamate cysteine ligase were measured in erythrocytes. 
Moreover, fatty acid membrane composition was assessed. 
Analytical procedures (study A) 
Glutathione synthesis rate in erythrocytes 
The procedure for analysis of erythrocyte glutathione and cysteine isotopic enrichments was 
adapted from Lyons et al (Lyons et al., 2001). Erythrocyte suspension obtained from 400 µL 
whole blood was placed into pre-chilled tubes containing 1 mL ice-cold dithiothreitol (20 
mmol × L in 1 M acetic acid). Proteins were precipitated with 400µL sulfosalicylic acid (30%) 
and centrifuged for 15 min at 10 000 × g at 4 °C. The supernatant fluid was transferred to a 
column containing 2 mL of a cation-exchange resin (AG50W-X8; Bio-Rad, Hercules, CA). 
After washing with Milli-Q water (5 mL × 2; Millipore, Bedford, MA), glutathione was eluted 
from the column by using NH4OH (3 mol/L) and collected into derivatization tubes (10 mL). 
Ammonia was eliminated under gentle nitrogen flow at room temperature. Samples were 
frozen, lyophilized, and reacted with 500 µL dithiothreitol solution (20 mM in 0.5 M acetic 
acid) at 100 °C for 1 h to reduce any dimerized glutathione and then dried again in nitrogen 
flow. Each sample was reacted with 300µL HCl/methanol solution (250 µL 36% HCl in 7.5 
mL methanol), incubated for 30 min at 80 °C, and dried in nitrogen flow at 65 °C before being 
further reacted with 50 µL MTBSTFA and 50 µL acetonitrile for 40 min at 90 °C. Afterward 
the sample was injected into a gas chromatograph–mass spectrometer [(GC-MS) HP 5890; 
Agilent Technologies, Santa Clara, CA]. The derivative was measured under electron-impact 
ionization by selective ion monitoring at a nominal m × z-1 of 363/365 for glutathione 
enrichment and of 406/408 for cysteine enrichments.  
 
Glutathione concentrations in plasma and erythrocytes 
Total glutathione concentrations in plasma and erythrocytes obtained from background 
samples were measured by using GC-MS and the internal standard technique. Briefly, known 
amounts of [13C2-15N-glycine]glutathione (Cambridge Isotope Laboratories, Andover, MA) 
were added as internal standard to erythrocyte suspension obtained from 400 µL whole blood 
and to 200 µL plasma. Samples were processed as described above. The derivative was 
measured under electron-impact ionization by selective ion monitoring at a nominal m × z-1  
of 363/366. Plasma and erythrocyte concentrations of glutathione precursor amino acids 
(glycine, glutamine, glutamate, methionine, homocysteine, and cysteine in plasma; glycine, 
glutamine, glutamate, methionine, and cysteine in erythrocytes) were measured in background 
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samples by using GC-MS and the internal standard technique. Briefly, known amounts of L-
[15N]glicine, L-[15N]glutamate, L-[15N]glutamine, DL-[3,3,3’,3’,4,4,4’,4’-2H8]-homocysteine, 
L-[1-13C, methyl-2H3]methionine, and L-[3,3-2H2]cysteine (Cambridge Isotope Laboratories) 
were added as internal standards to an erythrocyte suspension obtained from 400 µL whole 
blood and to 200 µL plasma. Samples were processed as described. The derivative was 
measured under electron-impact ionization by selective ion monitoring at a nominal m × z-1 of 
218/219 for glycine, 432/433 for glutamate, 431/432 for glutamine, 496/500 for 
homocysteine, 320/324 for methionine, and 406/408 for cysteine.  
 
Plasma markers 
Plasma leptin concentrations were measured by using an enzyme-linked immunosorbent assay 
(human Leptin Quantikine kit; R&D Systems, Minneapolis, MN). Plasma C-reactive protein 
(CRP) concentrations were measured by using a high-sensitivity enzyme-linked 
immunosorbent assay kit (Diagnostics Biochem, London, Canada). Plasma insulin 
concentrations were measured by using a radioimmunoassay (Adaltis insulin kit; Adaltis Inc, 
Montreal, Canada). Total plasma ghrelin concentrations were measured by using a 
radioimmunoassay (Total Human Ghrelin, GHRT-89HK; Linco, St Charles, MO). Plasma 
glucose, total cholesterol, HDLcholesterol, and triglyceride concentrations were measured by 
commercially available kits (Olympus System Reagents; Olympus Diagnostica GmbH, 
Hamburg, Germany) by using an autoanalyzer (Olympus AU400 System; Olympus, Tokyo, 
Japan). With antibodies obtained from rabbits and guinea pigs, neutrophil myeloperoxidase 
plasma concentrations were measured with the use of an enzyme-linked immunosorbent assay 
(Franck et al., 2005). Serum immunoglobulin G was isolated by affinity chromatography after 
immunization with purified human neutrophil myeloperoxidase. A reference curve was 
performed with purified human myeloperoxidase. Total –SH (thiol) functions (free –SH or 
bound to proteins) were measured in plasma by using spectrophotometry (at 412 nm) after the 
reaction of –SH with 5,5’ dithiobis-2-nitrobenzoic acid (Sedlak and Lindsay, 1968). A 
reference curve was performed with reduced glutathione. Total –SH values were expressed as 
mol/g protein. Total proteins were measured by using the Bio-Rad Protein Assay reagent and 
expressed in mg × mL-1. 
 
Red blood cell markers 
Glutathione peroxidase activity was determined in erythrocytes according to Paglia and 
Valentine (Paglia and Valentine, 1967) and expressed as µmol metabolized NADPH × min-1 × 
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g protein-1 in the presence of an organic hydroperoxide (cumolhydroperoxide) and of reduced 
glutathione as enzyme cofactor.  
 
Catalytic and modulator subunit expression of glutamatecysteine ligase in erythrocytes was 
measured by Western blot analysis (Thompson et al., 2000). Briefly, proteins were extracted 
from red blood cells by using a lysis buffer (45 mmol/L Tris-HCl, 0.2% Nlaurylsarcosine; 
Sigma-Aldrich, St Louis, MO) containing proteinase and phosphatase inhibitors (0.2 mM 
phenylmethanesulfonyl fluoride, 1 mM dithiothreitol, 2 µg aprotinin/mL, 2 µg pepstatin× mL-
1
, 0.1 mmol NaF × mL-1, and 0.1 mM Na3VO4; all: Sigma-Aldrich). After centrifugation (10 
min, RT, 16 00 × g), proteins were separated by sodium dodecyl sulfate–polacrylamide gel 
(12%) electrophoresis and transferred to a nitrocellulose membrane (Protran; Perkin Elmer, 
Boston, MA). Proteins were recognized by using commercial antibodies raised against the 
catalytic (GCLc: sc-22755) and modulator (GCLm: sc-22754) (both: Santa Cruz 
Biotechnology Inc, Santa Cruz, CA) subunits of the glutamate-cysteine ligase. 
Glyceraldehyde-3-phosphate dehydrogenase was recognized by commercial antibody (sc-
25778; Santa Cruz Biotechnology Inc). A goat anti-rabbit horseradish peroxidase– conjugated 
immunoglobulin G (Sigma-Aldrich) was used as secondary antibody. Protein complexes were 
detected by enhanced chemiluminescence (Amersham Life Sciences, Arlington Heights, IL) 
on photographic film (Kodak Biomax Light Film; Sigma-Aldrich). Protein concentrations in 
the catalytic and modulator subunits of glutamate-cysteine ligase were measured by band 
densitometry as a ratio with glyceraldehyde-3-phosphate dehydrogenase protein concentration 
(Model 45–700 Imaging Densitometer; Bio-Rad). 
Calculations (study A) 
LDL cholesterol was calculated by using the Friedewald equation: 
 
LDLcholesterol = total cholesterol – HDLcholesterol – (triglycerides × 5). 
Metabolic test in study B: muscle glutathione turnover rate 
During 2007 study, in the morning of the last day of the ambulatory period (baseline) and of 
the thirty-third day of bed rest (day 33), a metabolic test with stable isotope tracer infusions 
and a single vastus lateralis muscle biopsy was performed in order to assess muscle and red 
blood cells glutathione synthesis rate. In the morning of the seventh bed rest day (day 7) a 
metabolic study with the only stable isotope tracer infusions was performed to detect 
glutathione kinetics in red blood cells. In each study day, two subjects were analyzed. After a 
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12-h over-night fast (postabsorptive state) blood samples were taken before starting infusions, 
in order to assess in erythrocytes by gas chromatography and mass spectrometry (GC-MS) 
baseline natural enrichments of [2H2]glycine, [15N]glycine, L-[2H2]glutathione and L-
[15N]glutathione. At 07.00 or 08.00 (t0), a polyethylene catheter was inserted into an 
antecubital vein and a [2H2]glycine primed constant infusion (priming dose 26.5 µmol × kg-1; 
infusion 26.5 µmol × kg-1 × h-1 was started and maintained throughout 7 hour, i.e. until 14.00 
or 15.00. Four hours after the beginning of [2H2]glycine infusion (1100 or 1200), a 
[15N]glycine primed constant infusion (priming dose 26.5 µmol × kg-1; infusion 26.5 µmol × 
kg-1 × h-1) was started and maintained for 3 hours. Arterialized blood samples were collected 
from a second polyethylene catheter inserted in a controlateral heated wrist vein after 3 (t3) 
and 7 (t7) hours from the beginning of [2H2]glycine infusion. The last blood sample (t7) was 
taken at the end of [2H2]glycine (7 hours) and [15N]glycine (3 hours) infusions.  
Infusions performed on day 7 in one volunteer were stopped for technical reasons. 
Moreover, during metabolic tests performed before and after bed rest, fatty acid membrane 
composition was assessed. 
Muscle sampling (Study B) 
At baseline and day 33, after local anesthesia, at t7 (i.e at 1400 or 1500), a muscle biopsy was 
taken from the vastus lateralis in sterile conditions using a conchotome forceps according to 
standard techniques; muscle fibres were immediately cleaned from visible fat or connective 
tissue and accurately dried to remove blood with a sterile gauze. Quality of the procedure was 
monitored by microdissection microscope. Samples (averaging in mass 120 mg) were 
immediately frozen in liquid nitrogen and stored at -80°C. At the end of muscle biopsy 
procedure, both infusions were stopped and catheters removed. Muscle sampling in one 
subject failed to be completely performed for technical problems at day 33. 
Analytical procedures (study B) 
Glutathione kinetics and concentration evaluations in muscle could be performed only on nine 
subjects. The procedure for gas chromatography and mass spectrometry (GC-MS) analysis of 
muscle glutathione and glycine isotopic enrichments was adapted from abovementioned 
protocol (Lyons et al., 2001). Total glutathione concentrations were determined using GC-MS 
and the internal standard technique. Defrosted biopsies were weighted, homogenized in 500 µl 
SSA (6.5%) and known amounts (6.4 nmol final) of [glycine-13C215N]glutathione (Cambridge 
Isotope Laboratories, Andover, MA) were added as internal standard. After centrifugation, 1 
ml of ice-cold dithiothreitol (DTT, 20 mM in 1 M acetic acid) was added to supernatant. 
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Proteins were precipitated with 400 µl of sulphosalicylic acid (SSA) 30% and 15 min 
centrifugation at 10,000 g at 4°C. The supernatant was transferred to an ion exchange column 
(AG 50W-X8 cation exchange resin, Bio-Rad, Hercules, CA), washed with Milli-Q water (5 
ml x2). Glutathione was eluted using NH4OH (3 M, 4 ml). Frozen, lyophilized samples 
reacted with 500 µl of DTT solution (20 mM in 0.5 M acetic acid) at 100°C and dried again in 
nitrogen flow. After reaction with 300 µl of HCl/methanol solution (250 µl of 36% HCl in 7.5 
ml methanol), incubation for 30 min at 80 °C and drying under nitrogen flow, samples further 
reacted with 50 µl MTBSTFA and 50 µl of acetonitrile for 40 min at 90°C before injection 
into a gas chromatography-mass spectrometer (GC-MS) (HP 5890, Agilent Technologies, 
Santa Clara , CA, USA). The derivative was measured under an electron impact ionization by 
selective ion monitoring at a nominal mass-to-charge ratio (m × z-1) of 363, 364 and 365 for 
glutathione enrichment, and of 218, 219 and 220 for glycine enrichment. To measure [glycine-
13C215N]glutathione (internal standard) enrichments the derivative was measured at a nominal 
mass-to-charge ratio (m × z-1) of 363 and 366. 
A direct assessment of natural (before infusion beginning) isotopic enrichments in muscle 
could not be performed for reasons related to the study design. To estimate values of natural 
isotopic enrichments in muscle biopsies, red blood cells samples collected at t0 in each subject 
were analyzed. Repeated measures were performed on specific amounts of red blood cells 
selected in order to provide glutathione chromatographic peak areas comparable with those 
obtained in muscle biopsies (t7). Mean values were chosen as representing baseline natural 
isotopic enrichments in muscle. We adopted such approach because background glycine 
isotopic enrichments in circulating erythrocytes were previously demonstrated, in animals, to 
approximate enrichments measured in other tissues (bone marrow)(Hibbert et al., 2001). To 
assess glutathione concentrations in muscles a standard calibration curve was generated. A 
known amount of [glycine-13C215N]glutathione (internal standard) was added to prepared 
solutions containing different concentrations (serial dilution) of unlabelled glutathione 
(Sigma-Aldrich, Inc, MO, US). Glutathione and [glycine-13C215N]glutathione isotopic 
enrichments were measured monitoring appropriate mass-to-charge ratios following the same 
extraction and derivatization procedure adopted for muscle biopsies. Ratios between measured 
enrichments (m × z-1 363 and 366) allowed standard calibration curve assessment. By 
interpolation analysis unlabelled glutathione concentrations could be measured in muscle 
biopsy samples. 
Glutathione synthesis rate measurements in red blood cells were performed in ten subjects 
before and after bed rest while analyses at day 7 could be performed only in nine subjects. The 
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procedure to determine glutathione kinetics in red blood cells was adapted from 
abovementioned protocol used for study A with appropriate mass analysis. 
 
Protein carbonylation. To directly assess muscle protein oxidation level, about 20 cryosections 
(12 µm) of each biopsy were solubilized at 4°C in 0.01% tetrafluoroacetic acid containing 
protease inhibitors, 5 mM EDTA and 2% beta-mercaptoethanol. Oxyblot can detect carbonyl 
groups formed in protein side chains as a consequence of oxidation. The Oxyblot Oxidized 
Protein Detection Kit (Chemicon – Millipore; Billerica, MA 01821). Derivatization using 2,4-
dinitrophenylhydrazine was performed for 15 min following manufacturer’s instruction on 6 
µg of protein (Vescovo et al., 2008). Protein final mixture was separated by electrophoresis on 
10% SDS polyacrylamide gel. Proteins transferred to nitrocellulose membranes were stained 
by Red Ponceau and scanned. Specific proteins were detected by blots incubation with anti-4-
dinitro phenyl hydrazine antibody followed by chemiluminescent development. Densitometry 
was performed on scanned autoradiographic films using an NIH image system. To allow the 
comparison of oxidation level between different samples the oxidative index (Oxy RP-1) was 
defined as ratio between densitometric values of the oxyblot bands (oxidation level) and Red 
Ponceau stained bands (protein content). This value directly reflects the degree of myofibrillar 
protein oxidation. On each gel two standard samples (one positive and one negative control) 
were always loaded. The Oxyblot analysis was performed at day 33 in only 9 subjects 
because, as above mentioned, muscle sampling in one subject failed for technical reasons. 
 
Calculations (study B) 
In red blood cells, enrichments of [15N]glycine were calculated as tracer-to-tracee ratios as 
follows: 
 
(Eq.1) 
 
 
 
 
 
where E15N-Gly is [15N]glycine enrichment, PAR is peak areas ratio between areas measured 
for m × z-1 values indicated in brackets, ti is one of the sampling times after steady state 
achievement (t3 or t7) and t0 is the time of sampling before isotope infusion beginning (for 
natural enrichments). 
 
E15N-Gly(ti) = [PAR(219/218)ti – PAR(219/218)t0] 
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To calculate [2H2]glycine enrichment in red blood cells, correcting the influence of 
[15N]glycine infusion, the following equation was applied:  
 
(Eq. 2)  
 
 
 
where ED2-Gly is enrichment of [2H2]glycine and the other definitions are the same as in Eq. 
1.  
In muscle biopsies, enrichments of [15N]glycine were calculated as follows:  
 
(Eq. 3) 
 
 
where Muscle refers to measurements performed in muscle biopsies and the other definitions are 
the same as in Eq. 1 and 2.  
Similarly, in muscle biopsies, enrichments of [2H2]glycine were calculated as follows: 
(Eq. 4)  
 
 
 
where definitions are the same as in equation 1, 2 and 3. Noteworthy, in Eq. 3 and 4, t0 
measurements were performed in red blood cells (see Eq. 2 and Eq. 1).  
 
Enrichments of [15N]glutathione were assessed as follows: 
 
(Eq. 5)  
 
 
 
where E15N-GSH is enrichment of [15N]glutathione and other definitions are the same as in 
previous equations. Enrichments of [2H2]glutathione were assessed as follows:  
E15N-GSH(ti) = [PAR(364/363)ti – PAR(364/363)t0] 
ED2-Gly(ti) = [PAR(220/218)Muscle – PAR(220/218)t0] – [E15N-Gly(ti)  × PAR(219/218)t0] 
E15N-GlyMuscle= [PAR(219/218)Muscle – PAR(219/218)t0] 
ED2-Gly(ti) = [PAR(220/218)ti – PAR(220/218)t0] – [E15N-Gly(ti)  × PAR(219/218)t0] 
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(Eq. 6)  
 
 
 
where ED2-GSH is enrichment of [2H2]glutathione and other definitions are the same as in 
previous equations. To calculate glutathione fractional synthesis rate (FSR) by stable isotope 
tracers and using enrichment data obtained in a single tissue sample we have developed the 
following equation:  
 
(Eq. 7)  
 
 
 
where ED2GSH(t7) and E15N-GSH(t7) are respectively L-[2H2] and L-[15N]glutathione 
enrichments at the seventh hour of the metabolic study; ED2-Gly(t7) and E15N-Gly(t7) are 
respectively precursor enrichments of L-[2H2] and L-[15N]glycine at the seventh hour of the 
metabolic study; D2-Gly inf. duration and 15N-Gly inf. duration are respectively duration of 
[2H2] and [15N]glycine tracer infusions. To express FSR as % day-1, 100 and 24 coefficients 
were applied. The present equation relies on two parallel and separate infusions of different 
isotopes of the same precursor, [2H2]glycine and [15N]glycine, started at the beginning of the 
metabolic study (t0) and four hours later, respectively. Precursor enrichments at steady-state 
([2H2]glycine and [15N]glycine) and product enrichments after 3 ([15N]glutathione) and 7 
hours ([2H2] glutathione) of infusion were measured in a single biological sample taken at the 
end of the metabolic study period (7 hours). So, the evaluation of product enrichment changes 
over time (the core parameter for FSR assessment) was obtained as difference between two 
single differently labeled product enrichments measured within only one biological sample. In 
this method L-[15N]glutathione enrichment, in fact, reflects short term tracer incorporation as 
[15N]glycine infusion is started three hours before the single final biological sampling. On the 
contrary, L-[2H2]glutathione enrichment reflects long term tracer incorporation as [2H2]glycine 
infusion is started seven hours before the single final biological sampling. By this approach, 
FSRone-sample,double-tracer= 
[ED2-GSH(t7) / ED2-Gly(t7)] – [E15N-GSH(t7) / E15N-Gly(t7)] 
D2-Gly inf. duration  –  15N-Gly inf. duration 
× 100 × 24 
ED2-GSH(ti) =   [ PAR(365/363)ti – PAR(365/363)t0] - [E15N-GSHti × (PAR (364/363)t0] 
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glutathione FSR can be calculated over a net four hours incorporation period, as difference 
between differently labeled product enrichments measured at the same time point. 
Additionally, each product enrichment is normalized by precursor isotopic tracer enrichment 
at steady state. To validate the new equation, the traditional approach was applied to calculate 
glutathione FSR within the same experimental frame.  
Glutathione FSR in red blood cells was calculated taking into account isotopic enrichments of 
L-[2H2]glutathione measured after achievement of the steady state condition for [2H2]glycine 
precursor enrichment in three different biological samples taken 3 (t3) and 7 (t7) hours after 
metabolic study beginning. 
 
(Eq. 8)  
 
 
 
where Slope ED2-GSH (t3→t7) is the slope of L-[2H2]glutathione product enrichments 
measured at t3 and t7, Steady-state ED2-Gly (t3→t7) is the enrichment of [2H2]glycine precursor 
at steady state. To express FSR as %/day, 100 and 24 coefficients were applied. 
The absolute synthesis rate (ASR) was calculated as the product between FSR and glutathione 
concentration ([GSH]) values in studied tissues:  
 
ASR = FSR × [GSH] 
Statistical analysis (Study A and B).  
Data are presented as mean±SEM. In order to detect significant changes mediated by 5-weeks 
bed rest we applied the Student’s t test for paired samples. p-values lower than 0.05 were 
chosen as threshold for statistical significance. Relationships between variables were analyzed 
by bivariate correlation using the Spearman’s or Pearson’s test where appropriate. Statistical 
analysis was performed using SPSS statistical software (version 12; SPSS, Inc., Chicago, IL). 
FSRmultiple-sample,single-tracer= 
Slope ED2-GSH (t3→t7) 
Steady-state ED2-Gly (t3→t7) 
× 100 × 24 
 71 
Evaluated parameters in bed rest study 2008 
Fatty acid membrane composition in red blood cells as well as plasma insulin and glucose 
concentrations were analyzed from single blood drawings taken before and after the bed rest 
period. 
Analytical procedures (Bed rest 2008) 
Membrane composition 
Whole blood was immediately centrifuged after drawing: plasma and erythrocyte aliquots 
were stored at -80 °C until analysis. Fatty acid membrane compositions of red blood cells 
were analyzed modifying a previously published method (Burdge et al., 2002). Organic 
solvents and buffering salts were purchased from Sigma–Aldrich, Inc, MO, US. Erythrocytes 
(200 mL) were washed six times with decreasing concentrations (10 mmol/L, 2.5 mmol/L; 
1.25 mmol/L; 0.625 mmol/L; 0.312 mmol/L) of phosphate buffered saline (PBS). Total lipid 
extraction was performed in 5 mL of a chloroform–methanol (2:1) solution, containing 50 
mg/L of butylhydroxytoluene (Sigma–Aldrich, Inc, MO, US) as antioxidant, and 1 mL of 1 M 
NaCl solution. After centrifugation, the lower lipid phase was collected and dried under 
nitrogen flux at 40 °C. Pellets were dissolved in toluene (500 mL) and, after the addition of 1 
mL methanol solution containing 2% of H2SO4, samples were heated at 50 °C for 2 h. A 
neutralizing solution (1.0 ml, 0.25 M KHCO3 and 0.5 M K2CO3 in deionised H2O) and 
hexane (1 mL) were added and, after centrifugation, the hexane layer, containing fatty acid 
methyl esters (FAMEs), was collected; organic solvents were removed by nitrogen flux. 
Extracted lipids were resuspended in hexane (150 mL) and analyzed by gas-chromatography–
flame ionization detection (GC-FID; GC 6850 Agilent Technologies, Santa Clara, CA, USA). 
Helium was used as carrier gas. Detector temperature as well as injector temperature were set 
at 300 °C. Column oven temperature started at 115 °C (constant for 2 min) and increased 
afterwards by a gradient ramping of 10 °C/min until 200 °C. Temperature remained constant 
at 115 °C for 11.5 min and reached 245 °C by a gradient ramping of 60 °C/min. Temperature 
remained constant at 245 °C for 8 min. Specific FA standards were used to identify FAMEs 
by retention times in erythrocyte samples. A commercial mixture of purified fish oil FAs 
(Menhaden oil, Sigma–Aldrich, Inc, MO, US) was used to detect: oleic acid (18:1, n-9), 
elaidic acid (trans 18:1, n-9), eicosapentaenoic acid (20:5, n-3), docosapentaenoic acid (22:5, 
n-3) and docosahexaenoic acid (22:6, n-3). Retention times of myristic acid (14:00), palmitic 
acid (16:00), palmitoleic acid (16:1, n-7), stearic acid (18:00), linoleic acid (18:2, n-6), a-
linolenic acid (18:3, n-3), eicosaenoic acid (20:1, n-9), eicosadienoic acid (20:2, n-6), dihomo-
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γ-linolenic acid (20:3, n-6) as well as arachidonic acid (20:4, n-6) were identified by 
commercial standards purchased from Sigma–Aldrich, Inc, MO, US. Adrenic acid (22:4, n-6) 
and docosapentaenoic acid (22:5, n-6) were identified by commercial standards purchased 
from Nu-Check Prep, Inc, MN, US.  Area-under-the-curve of each selected peak was 
determined by highly standardized hand integration performed using commercial software 
(HP Chem station; Agilent Technologies, Santa Clara, CA, USA). 
 
Plasma markers 
Plasma insulin concentrations were measured by using a radioimmunoassay (Adaltis insulin 
kit; Adaltis Inc, Montreal, Canada). Plasma glucose, total cholesterol, HDL cholesterol, and 
triglyceride concentrations were measured by commercially available kits (Olympus System 
Reagents; Olympus Diagnostica GmbH, Hamburg, Germany) by using an autoanalyzer 
(Olympus AU400 System; Olympus, Tokyo, Japan). 
 
Calculations (Bed rest 2008) 
Insulin sensitivity 
Insulin sensitivity was determined according to the homeostasis assessment model (HOMA), 
i.e., [fasting insulin (mU × L-1) × fasting glucose (mg × dL-1)] × 405-1.  
 
Membrane fatty acid composition 
Red blood cell membrane level of each enlisted fatty acid was expressed as percent ratio 
between area-under-the-curve of each selected FAME peak and the sum of all measured 
FAME peaks. Total saturated fatty acids content was calculated as the sum of myristic acid 
(14:0), palmitic acid (16:0), stearic acid (18:0) membrane levels. Results of elaidic acid are 
not reported because of uncompleted chromatographic separation from oleic acid. Results of 
elaidic acid were included in the monounsaturated FAs sum. Monounsaturated total 
contentwas calculated as the sum of palmitoleic acid (16:1, n-7), oleic acid (18:1, n-9), elaidic 
acid (trans 18:1, n-9) and eicosaenoic acid (20:1, n-9) membrane levels. n-6 Polyunsaturated 
total content was defined as the sum of linoleic acid (18:2, n-6), eicosadienoic acid (20:2, n-6), 
dihomo-γ-linolenic acid (20:3, n-6), arachidonic acid (20:4, n-6), adrenic acid (22:4, n-6) and 
docosapentaenoic acid (22:5, n-6) membrane level. D5 desaturase index was defined as ratio 
between arachidonic acid (20:4, n-6) and dihomo-γ-linolenic acid (20:3, n-6) membrane 
levels. n-3 Polyunsaturated sum was calculated as the sum of a-linolenic acid (18:3, n-3), 
eicosapentaenoic acid (20:5, n-3), docosapentaenoic acid (22:5, n-3) and docosahexaenoic 
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acid (22:6, n-3) membrane levels. D9 desaturase index was calculated as ratio between oleic 
(18:1, n-9) and stearic (18:0) acid contents. Arachidonic-to-eicosapentaenoic acid ratio was 
calculated as ratio between arachidonic acid (20:4, n-6) and eicosapentaenoic acid (20:5, n-3) 
membrane levels. 
Statisical analysis 
Wilcoxon testwas applied to determine significant changes between the ambulatory and the 
experimental period in fatty acids membrane composition (Studies A, B and 2008). p values 
lower than 0.05 were considered statistically significant. 
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RESULTS 
 
Effect of bed rest on whole body inflammatory and oxidative stress status. 
Effect of bed rest on erythrocyte membrane composition. 
Valdoltra Bed Rest studies 2006 (A), 2007 (B) and 2008. 
 
Body composition (pooled subjects) 
In pooled subjects, free-fat mass, as determined by bio-impedance, significantly decreased 
following bed rest as compared to the baseline ambulatory condition. Body fat mass 
significantly but slightly increased during the experimental period. (Table 1). 
 
Table 1 effect of bed rest on body composition in pooled subjects 
 
 
Ambulatory Bed rest P1 
Body weight 74.8±1.7 72.7±1.7 <0.01 
Free-fat mass 63.2±1.2 60.4±1.1 <0.01 
Fat mass 11.7±1.0 12.3±1.0 0.01 
    
 
Values (kg) are expressed as mean±SEM. n=30. Body composition was assessed 
by bioimpedance (see Methods). 1, Wilcoxon statistical test performed on absolute 
values of ambulatory vs bed rest conditions 
 
Insulin resistance 
Plasma insulin concentration significantly increased (+50.1±10.0%; p<0.01) while glucose 
level did not significantly change (-0.1±1.2; p=0.8) during the experimental period. 
Consequently, the HOMA index for insulin resistance significantly (p <0.01) increased from 
1.4±0.1 at baseline to 2.0±0.2 after the experimental period. 
 
Alterations of red blood cell membrane composition. 
In order to investigate the effect of physical inactivity on whole body inflammatory status, the 
distribution of fatty acids in red blood cell membranes was analyzed. Table 2 displays the 
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relative content of selected fatty acids in erythrocyte membrane before and after 35 days of 
bed rest. 
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Table 2 Effects of 35 days bed rest on major fatty acid composition (%) in 
erythrocyte membranes. 
 
 
Ambulatory Bed rest P1 
Saturated FAs    
Myristic 14:0 0.33±0.2 0.33±0.2 0.75 
Palmitic 16:0 22.32±0.62 21.68±0.67 0.06 
Stearic 19.46±0.31 19.19±0.33 0.14 
Sum 42.31±0.92 41.48±1.02 0.10 
    
Monounsaturated FAs    
Palmitoleic 16:1 n-7 0.25±0.02 0.24±0.01 0.56 
Oleic 18:1 n-9 13.97±0.36 13.31±0.32 0.002 
Eicosaenoic 20:1 n-9 0.24±0.01 0.23±0.01 0.04 
Sum 15.57±0.40 14.87±0.34 0.003 
    
n-3 Polyunsaturated FAs    
a-Linolenic acid 18:3 n-3 0.31±0.04 0.29±0.05 0.05 
Eicosapentaenoic 20:5 n-3 0.39±0.02 0.35±0.01 0.05 
Docosapentaenoic acid 22:5 n-3 3.91±0.20 4.15±0.15 0.01 
Sum 7.12±0.19 7.34±0.17 0.06 
    
n-6 Polyunsaturated FAs    
Linoleic acid 18:2 n-6 12.10±0.24 11.60±0.30 0.02 
Eicosadienoic acid 20:2 n-6 0.39±0.03 0.38±0.02 0.36 
Dihomo-γ-linolenic 20:3 n-6 1.72±0.07 2.08±0.08 <0.001 
Arachidonic acid 20:4 n-6 16.20±0.63 17.18±0.59 0.01 
Adrenic 22:4 n-6 4.20±0.19 4.47±0.19 0.01 
Docosapentaenoic 22:5 n-6 0.80±0.04 0.93±0.09 0.003 
Sum 35.45±0.90 37.16±0.42 0.005 
 
FA, fatty acid; values are percent of total FAs (mean±SEM); measurements were 
performed on 30 subjects. 1, Wilcoxon statistical test, performed on absolute 
values ambulatory vs bed rest conditions 
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Saturated fatty acids total content was unaffected by unloading. On the contrary, 
monounsaturated fatty acids total content was significantly reduced. In particular, oleic and 
eicosaenoic acid were significantly decreased at the end of the bed rest period. Unloading 
failed to significantly affect n-3 PUFAs total content, but selected n-3 fatty acids levels were 
differently influenced by physical inactivity: a-linolenic and eicosapentaenoic acid levels were 
significantly decreased, whereas docosahexaenoic acid level was significantly increased. 
Otherwise, bed rest enhanced n-6 polyunsaturated fatty acids total content. In particular, levels 
of dihomo-γ-linolenic, arachidonic as well as adrenic and docosapentaenoic acids were 
increased after 35 days of bed rest. Notably, linoleic acid levels were significantly decreased 
by bed rest. 
 
Figure 9 
 
 
Estimated ∆5 (A) and ∆9 (B) desaturase activities before and after 35 days bed 
rest. n = 30, **p<0.001, *p<0.05. Wilcoxon statistical test performed on absolute 
values of ambulatory vs bed rest conditions 
 
∆5 (Figure 9A) and ∆9 (Figure 9B) desaturase indexes, as estimated from product-to-
precursor ratio, significantly diminished following the experimental period. Additionally, 
arachidonic-to-eicosapentaenoic acid ratio was significantly increased after bedrest (Figure 
10). 
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Figure 10 
 
Arachidonic to eicosapentaenoic acid ratio before and after 35 days of bed rest. 
n=28, *p<0.01, Wilcoxon statistical test performed on absolute values of 
ambulatory vs bed rest conditions. 
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Effect of bed rest on homocysteine metabolism 
Women's International Space Simulation for Exploration (WISE) study; MEDES clinic, 
Toulouse, (France) 
 
Effect on homocysteine and on selected plasma amino acids concentrations 
 
Table 3 bed rest effects on plasma methionine, cysteine and homocysteine 
concentrations 
 
  Adequate protein diet (n = 8)  
  Ambulatory Bed rest P1 
Methionine 
Baseline  21±1 24±1 0.07 
Infusion  119±62 142±62 0.02 
Cysteine 
Baseline  215±5 208±4 0.08 
Infusion  194±52 201±4 0.13 
Homocysteine 
Baseline  8.6±1.3 10.3±1.0 0.01 
Infusion  12.0±2.0 11.3±0.92 0.70 
 
Table 3 displays methionine, cysteine and homocysteine plasma concentrations 
(µmol × L-1) measured at baseline postabsorptive state (Baseline) and after 
intravenous infusions of amino acid mixture, insulin and glucose (Infusion). All 
measurements were performed before (Ambulatory) and after an experimental 
bed rest period (Bed rest) performed on subjects respectively fed by adequate 
protein levels. Data are shown as mean±SEM. 1, “Ambulatory” vs “Bed rest”, 
paired Student's t-test; 2, p<0.05 vs “Baseline”, paired Student's t-test 
 
 
At baseline postabsorptive state, methionine and cysteine plasma concentrations were not 
significantly affected by bed rest (Table 3). Counterwise, homocysteine concentration were 
shown to be significantly upregulated by bed rest. Intravenous amino acid, insulin and glucose 
infusion significantly increased plasma methionine concentrations both in ambulatory and bed 
rest conditions (Table 3). The same infusions significantly downregulated cysteine availability 
only in ambulatory condition. Homocysteine concentrations were significantly upregulated by 
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amino acid, insulin and glucose infusions only after bed rest. Physical inactivity significantly 
elevated the increase of methionine concentrations induced by intravenous infusions. 
Nevertheless, physical activity level did not display significant effects on plasma cysteine or 
homocysteine concentrations after amino acid, insulin and glucose intravenous infusions 
(Table 3). 
 
Effects on homocysteine kinetics parameters 
Bed rest significantly upregulated baseline rates of homocysteine transsulfuration, while 
remethylation was reduced. Transmethylation rate was unaffected by unloading (Table 4). 
 
Table 4. Plasma homocysteine kinetics measured at baseline postabsorptive state 
and after intravenous amino acid, insulin and glucose infusions. 
 
 
  
Adequate protein intake 
(n = 8)  
  Ambulatory Bed rest P1 
Transmethylation 
Baseline  4.1±0.2 4.3±0.3 0.34 
Infusion  40.7±1.7 38.2±1.6 0.13 
Remethylation 
Baseline  2.5±0.1 2.3±0.2 0.03 
Infusion  6.5±0.7 4.7±0.7 <0.01 
Transsulfuration 
Baseline  1.7±0.1 2.0±0.1 0.03 
Infusion  34.2±1.9 33.5±1.3 0.60 
 
Table 4 displays homocysteine kinetics values (µmol × min-1) measured at 
baseline postabsorptive state (Baseline) and after intravenous infusions of amino 
acid mixture, insulin and glucose (Infusion). All measurements were performed 
before (Ambulatory) and after an experimental bed rest period (Bed rest) on eight 
subjects fed by standard protein levels (see Methods). Rates of metabolic 
reactions were assessed by primed constant infusions of isotopic tracers coupled 
with gas chromatography-mass spectrometry analyses (see Methods). 1, Data were 
analyzed by paired Student's t-test. Data are shown as mean±SEM. Kinetic values 
measured after intravenous infusions are all significantly different from baseline. 
 
Intravenous amino acid, insulin and glucose infusion significantly increased homocysteine 
transmethylation, remethylation and transsulfuration rate before and after bed rest (p<0.05, 
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paired Student’s t-test). Bed rest decreased remethylation rates changes mediated by 
intravenous infusions (Table 4). 
 
Figure 11 
 
 
Homocysteine clearance changes by remethylation and transulfuration, mediated 
by bed rest at different protein intake. 
*
, p<0.02 vs clearance by remethylation; **, p<0.05 different from zero.  
 
Bed rest, in association to normal protein intake, sharply reduced homocysteine clearance by 
remethylation, leaving unaffected clearance by transulfuration pathway (Figure 11).  
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Effect of bed rest on glutamine metabolism. 
Short-Term Bed Rest-Integrated Physiology (STBR-IP) study; Clinical Research Center of the 
German Aerospace Institute (Cologne, Germany).  
 
Effect of bed rest on body composition 
Data describing changes in body composition were previously published (Biolo et al., 2007b). 
 
Effect of bed rest on glutamine concentrations and kinetics 
Figure 12 shows the effect of bed rest on glutamine concentrations and on selected glutamine 
kinetic parameters in normal eucaloric dietary conditions. 
 
Figure 12 
 
 
Percent changes of concentrations and metabolic parameters of glutamine 
mediated by bed rest; *, significant (p<0.05) bed rest effect. Data were analyzed as 
explained in table 10 and in table 11. 
 
Bed rest significantly decreased glutamine de novo synthesis, rate of appearance and 
concentrations. Glutamine clearance was not affected by bed rest. 
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Effects of bed rest on muscle atrophy and oxidative stress 
Effects on muscle thickness, protein carbonylation and glutathione availability. 
Bed rest Valdoltra 2007 
 
Effect of bed rest on body composition 
Baseline body weight (72.8±3.3 kg) displayed a bed rest mediated significant reduction (-
2.3±0.2 kg, p=0.005) after 33 days. As assessed by bioimpedance, baseline fat free mass 
(59.6±2.0 kg) was significantly (p<0.001) reduced after 33 days of bed rest (-2.9±0.4 kg). In 
contrast, fat mass measured before bed rest failed to change significantly during the 
experimental period (from 13.8±2.0 kg at baseline to 13.1±1.8 kg at day 33, p=0.06). 
 
Bed rest induced atrophy and oxidative stress in skeletal muscle.  
In vastus lateralis both muscle thickness as well as fibre pennation angle were found to be 
significantly decreased from baseline ambulatory condition at bed rest day 33 (Figure 13). 
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Figure 13 
 
 
 
Values of vastus lateralis thickness, fibre pennation angle and protein 
carbonylation measured before (Baseline) and after 33 days of bed rest (Bed rest) 
are shown. Muscle thickness and fibre pennation angle were determined in supine 
position by ultrasonography approaches. Protein carbonylation was determined by 
Oxyblot analysis. Oxy × RP-1, ratio between quantified oxidized proteins and Red 
Ponceau stained total protein. **, p<0.001 vs Baseline; *, p<0.05 vs Baseline. 
Statistical analysis was performed by Student’s t test. 
 
In addition, muscle protein carbonylation levels were shown to be significantly increased after 
33 days of bed rest by Oxyblot analysis (Figure 13) (Dalla et al., 2009). Muscle protein 
carbonylation changes mediated by 33 days of bed rest were inversely correlated to Vastus 
lateralis thickness changes induced during the same experimental period (Table 5). 
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Table 5. Correlations between bed rest mediated changes in muscle atrophy 
markers and selected redox parameters in vastus lateralis. 
 
 
 
 
 
 
 
 
 
 
 
Data are values of correlation coefficients (R) between bed rest mediated changes 
in vastus lateralis muscle atrophy markers (Muscle thickness and Fibre pennation 
angle) both with changes in muscle protein oxidative stress (Protein 
carbonylation) and with muscle glutathione kinetics parameters. FSR, fractional 
synthesis rate; ASR, absolute synthesis rate. Relationships between variables were 
analyzed by bivariate correlation using the Spearman’s or Pearson’s test where 
appropriate. 1, p< 0.05 
 
Glutathione synthesis in erythrocytes: method validation. 
Steady state of [2H2]glycine enrichment in red blood cells was achieved after 3 hours of 
primed-continuous infusion and maintained for the following 4 hours (Figure 14). 
 
 
Changes in 
muscle thickness fibre pennation angle 
Protein carbonylation changes  -0.741 (n=8) -0.06     (n=9) 
Glutathione FSR change 0.14    (n=8) -0.671    (n=9) 
Glutathione concentration changes 0.05    (n=9) 0.45      (n=10) 
Glutathione ASR changes -0.14   (n=8) -0.51     (n=9) 
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Figure 14 
 
 
Red blood cells enrichments of isotopic tracers ([2H2] and [15N]glycine) and 
products ([2H2] and [15N]glutathione). (A) Steady state for [2H2]glycine (●) 
precursor pool is shown while steady state condition for [15N]glycine (□) pool is 
assumed. Diversity between tracer isotopes steady state values are due to intrinsic 
metabolic differences between 2H2 and 15N isotopes. (B) [2H2]glutathione (●) 
enrichment slope increase reflects linear tracer incorporation into glutathione 
products. Diversity between [2H2]glutathione and [15N]glutathione (□) product 
enrichments measured at the end of infusions (7th hour) is the result of different 
tracer incorporation times. [2H2]glycine was, in fact infused for 7 hours while 
[15N]glycine was infused for 3 hours. 
 
The mean value of steady state-[2H2]glycine enrichment at the end of bed rest was 
significantly greater when compared to the pre bed rest period (p<0.05). In all three phases 
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(baseline, day 7 and day 33) [15N]glycine enrichment mean values measured at the end of the 
infusion (7th hour) were greater (p < 0.05) than the corresponding [2H2]glycine enrichment 
values. To validate the single biopsy method against the traditional one to assess muscle 
glutathione synthesis rate, calculations were performed by both Eq. 7 and 8 (see “Methods”) 
in blood samples drawn during three metabolic tests (baseline, day 7 and day 33 of bed rest). 
Glutathione FSR (% × day-1) values measured in red blood cells at baseline, day 7 and day 33 
by “traditional” approach (Eq. 8) were comparable (no statistical difference) to values 
measured by “one-sample” method (Eq 7) (Figure 15). 
 
Figure 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Red blood cells glutathione fractional synthesis rate (FSR) values measured both 
by traditional (empty bars) and one-sample (solid bars) approaches at selected 
study phases (Baseline, Day 7 and Day 33). Significant differences between FSR 
measured by traditional and novel one-sample approaches failed to be displayed 
in each study phase. No significant influence of bed rest on FSR values was 
shown, independently from adopted equation. 
 
Independently from used calculations, no significant bed rest mediated changes in glutathione 
FSR were observed in red blood cells, either at early time points (day 7) or at the end of the 
experimental period (day 33) (Figure 15). Pooled absolute values of glutathione FSR 
measured in each study phase by “traditional” and “one-sample” approaches were displayed to 
be in significant (p<0.001) and high direct correlation (r=0.84; n=28) (Figure 16A). Equally, 
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pooled FSR changes from baseline to day 7 as well as from day 7 to day 33 measured by 
“traditional” and “one-sample” approaches were shown to be in high significant (p<0.001) 
correlation (r=0.91, n=18) (Figure 16B). 
 
Figure 16. 
 
 
Linear correlation between glutathione kinetics measurements in erythrocytes by 
traditional and by one-sample approach. (A) Glutathione fractional synthesis rate 
(FSR) absolute values measured in red blood cells by “traditional” and by “one-
sample” approach are in positive and significant (r=0.84, p<0.001) linear 
correlation (n=29). (B) Pooled changes of glutathione fractional synthesis rate 
from baseline to day 7 as well as from day 7 to day 33 measured by “standard” 
approach are in significant positive (r=0.91, p<0.001) correlation with analogous 
changes in glutathione FSR measured by “one-sample” approach (n=18). 
 
Bed rest effect on  muscle glutathione synthesis. 
Values of tracer-to-tracee ratios (TTR) for [15N] and [2H2]glycine as well as for L-[15N] and L-
[2H2]glutathione measured in muscle biopsy (see project schedule) at the end of isotopic 
infusions are shown Table 6. 
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Table 6. Muscle glycine and glutathione tracer-tracee ratios at the end of infusions. 
 
 
Baseline Bed rest 
[15N]glycine 0.0571±0.0040 0.0581±0.0062 
L[15N]glutathione 0.0138±0.0025 0.0103±0.0036 
[2H2]glycine 0.0421±0.0027 0.0411±0.0027 
L[2H2]glutathione 0.0273±0.0021 0.0317±0.0052 
 
 
Muscle glycine and glutathione tracer-to-tracee ratios measured in vastus lateralis 
muscle are shown. Data were derived from isotopic enrichments measured by gas-
chromatography and mass-spectrometry analyses (see “Methods”) performed in 
muscle biopsies taken at the end of metabolic tests performed in ambulatory 
conditions (Baseline) and after 33 days of bed rest (Bed rest) on nine subjects. 
When matched to baseline, bed rest values of tracer-to-tracee ratios failed to 
display significant differences. Data are presented as mean±SEM. Statistical 
analysis was performed by Student’s t test. 
 
Bed rest failed to significantly affect the enrichment of each precursor ([15N] and 
[2H2]glycine) as well as the enrichment of each isotopic product (L-[15N] and L-
[2H2]glutathione). In each study phase, [15N]glycine enrichment was found to be significantly 
higher than [2H2]glycine.  Glutathione fractional synthesis rate (FSR) displayed a tendency to 
be increased during bed rest (Table 7). 
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Table 7. Bed rest effect on vastus lateralis muscle glutathione kinetics parameters.  
 
 
Ambulatory Bed rest P1 
Glutathione    
FSR (% × day-1) (n=9) 268±61 408±47 0.07 
Concentration (mmol × kg wet tissue-1) 
(n=10) 2.3±0.2 2.7±0.1 0.30 
ASR (mmol × kg wet tissue-1 × day-1) 
(n=9) 5.5±1.1 11.0±1.5
 0.02 
 
Glutathione fractional synthesis rate (FSR), concentration and absolute synthesis 
rate (ASR) measured in vastus lateralis by metabolic tests in ambulatory 
conditions (Baseline) and after 33 days of bed rest (Bed rest). Values were 
derived from isotopic enrichments measured by gas-chromatography and mass-
spectrometry analyses performed in muscle biopsies taken at the end of metabolic 
tests. Concentration values were assessed by internal standard approach, while 
FSR and ASR were calculated by the novel one-sample, double-tracer approach. 
Data are presented as mean±SEM. 1, Statistical analysis was performed by 
Student’s t test. 
 
Glutathione concentrations did not change significantly during bed rest. Nevertheless, 
glutathione absolute synthesis rate (ASR) was significantly upregulated by bed rest at day 33 
when matched to baseline (Table 7). Glutathione FSR changes induced by 5 weeks of 
unloading were demonstrated to be significantly inversely associated to occurred pennation 
angle changes (Table 5). 
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Impact of nutrition on bed rest mediated alterations. 
Effects oh high protein diet on homocysteine metabolism 
Women's International Space Simulation for Exploration (WISE) study; MEDES clinic, 
Toulouse, (France) 
 
Table 8 Effect of bed rest at adequate or high protein intake on plasma 
methionine, cysteine and homocysteine concentrations 
 
  Adequate protein diet (n = 8) High protein diet (n = 8) p1 (Effect) 
  Ambulatory Bed rest Ambulatory Bed rest Activity effect 
Activity × 
diet 
interaction 
Methionine 
Baseline  21±1 24±1 22±1 23±1 0.08 0.35 
Infusion  119±62 142±62 129±52 130±92 0.06 0.08 
Cysteine 
Baseline  215±5 208±4 208±4 203±5 0.04 0.80 
Infusion  194±52 201±4 187±62 187±62 0.24 0.28 
Homocysteine 
Baseline  8.6±1.3 10.3±1.03 9.5±1.0 7.8±0.53 0.92 0.001 
Infusion  12.0±2.0 11.3±0.92 10.7±1.02 8.6±0.62 0.16 0.49 
 
The table displays methionine, cysteine and homocysteine plasma concentrations 
(µmol × L-1) measured at baseline postabsorptive state (Baseline) and after 
intravenous infusions of amino acid mixture, insulin and glucose (Infusion). All 
measurements were performed before (Ambulatory) and after an experimental 
bed rest period (Bed rest) performed on two groups of subjects respectively fed by 
standard protein levels and by high protein and BCAA dietary intake. 
Data are shown as mean±SEM. 1, Data were analyzed with 2-factor (activity × 
diet) ANOVA with interaction; 2, p< 0.05 vs “Baseline”; 3, p<0.05 vs 
“Ambulatory” condition (Wilcoxon test). 
 
At baseline postabsorptive state, methionine plasma concentrations were not significantly 
affected by bed rest (Table 8). Moreover, changes in  protein and BCAA dietary levels did not 
display significant effects on baseline methionine concentrations during bed rest. Baseline 
plasma cysteine concentrations were significantly reduced by bed rest, but changes in protein 
and BCAA dietary levels did not display significant effects on baseline cysteine 
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concentrations (Table 8). A significant diet × bed rest interaction was shown in affecting 
baseline plasma homocysteine concentrations: as confirmed by post hoc analysis, normal 
protein intake during bed rest induced a increase in plasma homocysteine concentrations, 
while high protein intake during bed rest was linked to a decrease in homocysteine plasma 
levels. Subjects supplemented by high protein diet, displayed significantly upregulated 
methionine and homocysteine but downregulated cysteine concentrations after intravenous 
amino acid, insulin and glucose infusions both in ambulatory and bed rest conditions (Table 
8). Nevertheless, neither physical activity nor protein and BCAA dietary levels displayed 
significant effects on plasma methionine, cysteine or homocysteine changes secondary to 
amino acid, insulin and glucose intravenous infusions (Table 8).  
 
Effects on homocysteine kinetics parameters 
Bed rest significantly upregulated baseline rates of homocysteine transsulfuration and 
transmethylation, while remethylation rate was reduced by unloading (Table 9). 
 
Table 9. Plasma homocysteine kinetics measured at baseline postabsorptive state 
and after intravenous amino acid, insulin and glucose infusions. 
 
  
Adequate protein intake 
(n = 8) 
High protein-high BCAA 
intake 
(n = 8) 
p1 (Effect) 
  Ambulatory Bed rest Ambulatory Bed rest Activity 
effect 
Activity × diet 
interaction 
Transmethylation 
Baseline  4.1±0.2 4.3±0.3 4.2±0.2 4.6±0.3 0.02 0.25 
Infusion  40.7±1.72 38.2±1.62 39.9±1.8* 40.0±1.82 0.46 0.42 
Remethylation 
Baseline  2.5±0.1 2.3±0.2 2.6±0.1 2.4±0.2 0.007 0.66 
Infusion  6.5±0.72 4.7±0.72 4.7±0.72 3.9±0.7 0.04 0.42 
Transsulfuration 
Baseline  1.7±0.1 2.0±0.1 1.6±0.1 2.3±0.2 <0.001 <0.05 
Infusion  34.2±1.92 33.5±1.32 35.2±1.92 36.1±1.22 0.92 0.47 
 
The table displays homocysteine kinetics values (µmol/min) measured at baseline 
postabsorptive state (Baseline) and after intravenous infusions of amino acid mixture, 
insulin and glucose (Infusion). All measurements were performed before (Ambulatory) 
and after an experimental bed rest period (Bed rest) performed on two groups of eight 
subjects respectively fed by standard protein levels and by an higher protein and BCAA 
dietary intake (see Methods). Rates of metabolic reactions were assessed by primed 
constant infusions of isotopic tracers coupled with gas chromatography-mass 
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spectrometry analyses (see Methods). 1, 1Data were analyzed with 2-factor (activity × 
diet) ANOVA with interaction. 2, significantly different from baseline. Data are shown 
as mean±SEM.  
 
Dietary supplementation with protein and BCAA significantly interacted with bed rest to 
enhance homocysteine transsulfuration rate, but transmethylation and remethylation rates 
failed to be affected by diet and activity interaction. In protein supplemented subjects, 
intravenous amino acid, insulin and glucose infusion significantly increased in ambulatory and 
bed rest conditions homocysteine transmethylation and transulfuration rates, while 
remethylation rate was significantly enhanced only in ambulatory conditions. Bed rest as well 
as diet control failed to affect increases in homocysteine transsulfuration and transmethylation 
rates induced by intravenous infusions (Table 9). Otherwise, bed rest negatively affected 
increases in remethylation rate induced by intravenous infusions. 
 
Figure 17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Homocysteine clearance changes by remethylation and transulfuration, mediated 
by bed rest at different protein intake. 
†, p<0.02 vs clearance by remethylation; $, p<0.05 different from zero.  
 
While bed rest, in association to normal protein intake, sharply reduced homocysteine 
clearance by remethylation, leaving unaffected clearance by transulfuration (Figure 11), 
protein and BCAA supplementation during experimental physical inactivity enhanced 
significantly homocysteine clearance by transulfuration, laving unaffected clearance by 
remethylation (Figure 17). 
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Effect of bed rest and energy intake on glutamine metabolism. 
Short-Term Bed Rest-Integrated Physiology (STBR-IP) study; Clinical Research Center of the 
German Aerospace Institute (Cologne, Germany).  
 
Plasma amino acid concentrations 
As shown in table 10, bed rest decreased baseline glutamine concentration in plasma. There 
were significant effects of both bed rest and hypocaloric diet to increase baseline plasma 
concentrations of all three branched-chain amino acids (BCAA), valine, leucine and 
isoleucine. No significant interaction was observed between the effects of bed rest and 
hypocaloric diet on BCAA concentrations. Plasma concentrations of all infused amino acids 
were increased as a consequence of the intervention (data not shown) (Biolo et al., 2007b). No 
significant effects of bed rest or hypocaloric diet was observed on amino acid infusion 
mediated changes of glutamine, glutamate and BCAA concentrations. 
 
Table 10. Concentrations of plasma glutamine and glutamine precursor amino 
acid in postabsorptive state (Baseline) and percent increases after intravenous 
amino acid infusion (AA). 
 
 Eucaloric Diet Hypocaloric Diet p1 (Effect) 
 Ambulatory Bed Rest Ambulatory Bed Rest Activity Diet Interaction 
Glutamine 
Baseline µmol × L-1 636±18 607±12 649±22 596±152 0.03 0.96 0.33 
AA (% change) 3±1 7±2 7±1 9±3 0.20 0.18 0.66 
Glutamate 
Baseline µmol × L-1 54±4 52±5 60±5 57±6 0.40 0.13 0.72 
AA (% change) 9±5 9±5 10±5 6±5 0.71 0.86 0.66 
Total BCAA 
Baseline µmol × L-1 424±16 457±202 494±242 529±202 <0.01 <0.01 0.90 
AA (% change) 142±4 142±13 143±6 142±5 0.97 0.86 0.93 
 
 
Data are mean±SEM; BCAA, branched-chain amino acids. Measurements were 
performed before (Ambulatory) and after (Bed Rest) a bed rest period of 14 days, 
both maintaining an energy intake balanced with activity determined requirements 
(Eucaloric Diet) or under dietary energy restriction (Hypocaloric Diet) calculated 
as 20% reduction of Eucaloric Diet. Amino acid infusion mediated changes from 
basal condition of selected amino acid concentrations are significantly different 
from zero (P<0.001, Student’s t test). 1, Data were analyzed with 2-factor (activity 
 95 
× diet) ANOVA with interaction. 2, p<0.01 versus Ambulatory Eucaloric Diet, 
based on Bonferroni’s post hoc analysis. 
 
Glutamine kinetics 
Figure 18 shows L-[5-15N]glutamine tracer-to-tracee ratios at steady state in baseline 
postabsorptive state and during primed constant intravenous infusions of glutamine-free 
amino acid mixture in bed rest or ambulatory conditions during eucaloric or hypocaloric diets.  
 
Figure 18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Steady state glutamine tracer-to-tracee ratios during baseline postabsorptive state 
(min. 280, 290 and 300)  and during a primed constant intravenous infusion of 
glutamine free amino acid solution (min. 460, 470 and 480). A = Ambulatory, 
eucaloric diet; B = Bed rest, eucaloric diet; C = Ambulatory,  hypocaloric diet; D 
= Bed rest,  hypocaloric diet. In all four conditions, mean steady state tracer-to-
tracee ratios significantly (p<0.001) decreased from baseline during amino acid 
infusions. 
 
In all four conditions, mean steady state tracer-to-tracee ratios significantly (p<0.001) 
decreased from baseline during amino acid infusions. As evidenced in table 11, in both 
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eucaloric and hypocaloric conditions, bed rest induced a significant decrease of baseline 
glutamine total rate of appearance (Ra) and de novo synthesis.  
 
Table 11. Whole body glutamine kinetics in the baseline postabsorptive state and 
percentage increase from baseline during intravenous amino acid infusion (AA). 
 
 
Data are mean±SEM. Ra, rate of appearance. AA, intravenous amino acid 
infusion. LBM, lean body mass. Measurements were performed before 
(Ambulatory) and after (Bed Rest) a bed rest period of 14 days, both maintaining 
an energy intake balanced with activity determined requirements (Eucaloric Diet) 
or under dietary energy restriction (Hypocaloric Diet) calculated as 20% reduction 
of Eucaloric Diet. Amino acid mediated changes from basal of total Ra, Ra from 
proteolysis and de novo synthesis are significantly different from zero (p<0.001, 
Student t test) in all conditions. 1, data were analyzed with 2-factor (activity × 
diet) ANOVA with interaction. 2, p<0.01 versus Ambulatory Eucaloric Diet, 
based on Bonferroni’s post hoc analysis. 
 
Bed rest did not significantly affect glutamine Ra from proteolysis as well as glutamine 
clearance. Significant effects of hypocaloric diet on glutamine kinetics were not observed. 
Intravenous infusion of glutamine-free amino acid solution significantly increased total Ra 
and de novo synthesis of glutamine in all conditions. Amino acid infusion significantly 
decreased glutamine Ra from proteolysis in all conditions. The effects of intravenous infusion 
of glutamine-free amino acid solution were not significantly different in bed rest or 
 
 Eucaloric Diet Hypocaloric Diet P1 (Effect) 
 
 Ambulatory Bed Rest Ambulatory Bed Rest Activity Diet Interaction 
Total Ra 
Baseline  µmol ×kgLBM-1 ×min-1 5.21±0.13 4.56±0.132 4.82±0.17 4.48±0.112 <0.001 0.16 0.28 
AA  % change 8±2 10±2 9±2 10±2 0.56 0.94 0.56 
Ra from 
proteolysis 
Baseline  µmol ×kgLBM-1 ×min-1 1.05±0.02 1.00±0.02 1.03±0.05 0.99±0.03 0.20 0.69 0.91 
AA  % change -15±2 -20±2 -12±4 -18±4 0.08 0.48 0.83 
De novo 
synthesis  
Baseline  µmol ×kgLBM-1 ×min-1 4.17±0.14 3.56±0.132 3.79±0.19 3.49±0.142 <0.001 0.19 0.27 
AA  % change 14±3 19±3 15±2 18±3 0.18 0.96 0.65 
Clearance 
Baseline  µmol ×min-1 8.3±0.4 7.5±0.3 7.5±0.3 7.6±0.3 0.15 0.15 0.37 
AA  % change 5±2 3±4 2±3 1±4 0.68 0.50 0.97 
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ambulatory conditions during eucaloric or hypocaloric diets. Glutamine clearance was not 
affected by amino acid infusion. 
Effect of bed rest and energy balance on inflammation oxidative stress and skeletal muscle 
atrophy 
Bed rest Valdoltra 2006 (study A) and Valdoltra 2007 (study B) 
 
Effects on body composition 
Baseline values of body weight, fat mass, fat-free mass, and vastus lateralis thickness did not 
differ significantly (unpaired t test) between subjects from Valdoltra 2006 (A) and 2007 (B) 
studies. During 5 wk of bed rest, body weight decreased (p < 0.001, repeated-measures 
ANOVA) from 76.5±2.9 to 75.4±2.8 kg in study A and from 76.3±3.7 to 73.9±3.5 kg in study 
B; fat mass increased (P < 0.02, repeated-measures ANOVA) from 10.2±1.6 to 11.9±1.6 kg in 
study A and from 13.6±2.1 to 14.4±2.3 in study B; fat-free mass decreased (p < 0.001, 
repeated-measures ANOVA) from 66.3±2.1 to 63.4±1.9 kg in study A and from 62.7±2.2 to 
59.4±1.9 kg in B; thickness of vastus lateralis decreased (p = 0.02, repeated-measures 
ANOVA) from 2.39±0.09 to 2.20±0.09 cm in study A and from 2.09±0.19 to 1.84±0.17 cm in 
study B. There were no significant group (Study A or study B) × bed rest interactions for body 
weight, fat mass, fat-free mass, or vastus lateralis thickness. In subjects from study B, the 
average thickness of the vastus lateralis, gastrocnemius medialis, tibialis anterior, and biceps 
brachii decreased significantly after bed rest (from 2.39±0.09 to 2.20±0.09 cm; p < 0.001, 
paired t test), and the decrease correlated directly with fat-free mass both before (r=0.67, 
P<0.05; n=10) and at the end of (r=0.63, P<0.05; n= 10) the bed-rest period. Bed rest–induced  
percentage changes in fat-free mass and average muscle thickness were directly correlated (R 
= 0.63, p <0.05; n=10). 
 
Effects on muscle atrophy 
To investigate the influence of energy balance on fat-free mass and muscle atrophy 
progression during 35 d of bed rest, pooled subjects from studies A and B were a posteriori 
divided into 2 groups accordingly to the median value of individual changes in fat mass (+ 1.4 
kg) as threshold. 
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Figure 19 
 
A posteriori subject stratification on the base of fat mass changes induced by 35 
days of bed rest. Groups were identified across the median value of individual 
changes in fat mass (+1.4 kg) 
 
The 10 subjects (7 from study A and 3 from study B) showing a fat mass gain greater than the 
median value were assigned to a group defined as higher energy balance (HEBAB). 
Conversely, the 9 subjects (3 from study A and 6 from study B) with fat mass changes lower 
than the median value were assigned to a group defined as lower energy balance (LEBAB) 
(Figure 19). Baseline body weight, fat-free mass, and vastus lateralis thickness did not differ 
significantly between the 2 groups (Table 12). 
Lower energy balance 
(LEBAB) 
n=9 
Higher energy balance 
(HEBAB) 
n=10 
-2
0
2
4
kg/5wk
Valdoltra 06 study (spontaneous dietary adaptation to energy requirements) 
Valdoltra 07 study (dietary intake adjusted for activity level) 
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Table 12. Effects of bed rest at different energy intakes on body weight, fat-free 
mass, and vastus lateralis thickness 
 
 
 
HEBAB, higher energy balance; LEBAB, lower energy balance, as identified 
according to the median value of inactivity-induced fat mass changes (increase of 
1.4 kg) measured in subjects of study A (spontaneous dietary adaptation to energy 
requirements) and study B (dietary intake adjusted for activity level). Fat-free 
mass and vastus lateralis thickness were measured by using bioelectrical 
impedance analysis and ultrasound imaging, respectively. All values are 
expressed as mean±S.E.M. 1, data were analyzed with the use of a 2-factor (group 
× activity) ANOVA. 2 Significantly different from the ambulatory adaptation 
condition, p<0.025 (Bonferroni’s post hoc analysis). 
 
There were significant bed-rest effects and group × bed rest interactions for fat-free mass and 
vastus lateralis thickness (Table 12). Bed rest–induced decreases in fat-free mass were greater 
in HEBAB (-3.8 ± 0.4 kg) than in LEBAB (-2.3 ± 0.5 kg) . In analogy, bed rest–induced 
decreases in thickness of vastus lateralis were greater in HEBAB (-0.32 ± 0.04 cm; i.e., -
14±2%) than in LEBAB (-0.09 ± 0.04 cm; i.e., -6 ± 5%)  
 
Baseline values of fat mass did not differ significantly between HEBAB (12.9 ± 2.3 kg) and 
LEBAB (10.6 ± 1.2 kg) groups. Changes in body fat in HEBAB and LEBAB groups averaged 2.1 
± 0.4 and 0.4 ± 0.3 kg, respectively. There were significant bed-rest effects (p < 0.001) and 
group × bed rest interactions (p = 0.01) for intracellular water, as determined by 
multifrequency bioimpedance analysis. Intracellular water decreased in HEBAB from 32.4 ± 
1.0 to 30.6 ± 1.0 kg and in LEBAB from 30.6 ± 1.0 to 29.6 ± 0.9 kg. Bed rest–induced 
decreases in intracellular water were greater in HEBAB (1.9 ± 0.2 kg) than in LEBAB (1.0 ± 0.2 
kg). 
 
 
HEBAB (n =10) LEBAB (n =9) p1(Effect) 
 
Ambulatory Bed Rest Ambulatory Bed Rest Diet  Activity Interaction 
Body weight (kg) 80.0±3.5   78.4±3.3 72.4±2.3 70.5±2.2 0.08 <0.01 0.66 
Fat-free mass (kg) 67.1±1.8 63.4±1.82 61.8±2.3 59.5±2.12 0.11 <0.01 0.03 
Vastus lateralis (cm) 2.43±0.13 2.10±0.132  2.04±0.15 1.95±0.15 0.19 <0.001 0.01 
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Effects of energy balance on plasma inflammatory markers and erythrocyte glutathione 
synthesis  
Valdoltra 2006 study (study A) 
 
To compare the influence of bed rest at different levels of energy balance on inflammatory 
markers and antioxidant defenses, subjects (n=10) from study A were considered. During this 
study volunteers were allowed to spontaneously adapt to decreased energy requirements. 
Similarly to abovementioned stratification, subjects were a posteriori divided in two groups 
accordingly to fat gain during the experimental period. The 5 subjects showing a fat mass 
accumulation greater than the median value (increase of 1.8 kg) were assigned to a group 
defined as HEBA. Conversely,  the 5 subjects with fat mass changes lower than the median 
value were assigned to a group defined as LEBA.  In pooled subjects, absolute values of fat 
mass measured before bed rest directly correlated with plasma leptin concentrations (r = 0.72, 
p < 0.05; n=10). Baseline values of fat mass did not differ significantly between HEBA (11.6 ± 
2.6 kg) and LEBA (8.8 ± 1.6 kg) groups. Changes in body fat in the HEBA and LEBA groups 
averaged 2.6 ± 0.3 and 1.0 ± 0.5 kg, respectively. 
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Table 13. Effects of bed rest at different energy intakes on plasma hormone, 
mediator, and substrate concentrations 
 
 
 
HEBA, higher energy balance; LEBA, lower energy balance; CRP, C-reactive 
protein; -SH, thiol function. 1, Data were analyzed after log-transformation by 
using a 2-factor (group × activity) ANOVA with interaction. 2, significantly 
different from the ambulatory adaptation condition, p<0.025 (Bonferroni’s post 
hoc analysis). All values are expressed as mean±S.E.M. 
 
Bed rest significantly increased plasma ghrelin and insulin concentrations, but there were no 
group × bed rest interactions for ghrelin and insulin. Plasma glucose did not change 
significantly after bed rest in either group. Plasma total thiol group concentrations did not 
change significantly after bed rest in either group. Finally, there was a significant bed-rest 
effect in increasing triglyceride and LDL-cholesterol concentrations (Table 13).  
There was a significant group × bed rest interaction and bed-rest effect for plasma leptin 
concentration and, as shown by post hoc analysis, leptin concentrations significantly increased 
after bed rest in HEBA group (Table 13). Moreover, there were significant group × bed rest 
interactions for plasma CRP and myeloperoxidase concentrations (Table 13).  
Bed rest–mediated changes in CRP and myeloperoxidase concentrations in pooled subjects 
were directly correlated (r = 0.94, p < 0.001, n = 10). 
 
HEBA (n =5) LEBA (n =5) P (Effect) 1 
 
Ambulatory Bed Rest Ambulatory Bed Rest Group  Activity Interaction 
Leptin (ng × mL-1) 3.4±1.2 6.9±2.6 2 2.1±0.6 3.2±1.2 0.51 0.01 0.04 
Ghrelin (ng × mL-1) 986±79 766±39 1083±212 929±119 0.52 0.004 0.21 
Insulin (µU × mL-1) 8.1±1.2 12.0±1.7 8.1±0.8 11.2±2.3 0.77 0.05 0.65 
Glucose (mg × dL-1) 88±1.2 89±2 92±3 87±3 0.59 0.41 0.32 
CRP (µg × mL-1) 0.4±0.2 0.8±0.5 1.5±0.6 0.7±0.2 0.32 0.35 0.02 
Myeloperoxidase (ng × mL-1) 327±18 381±25 345±25 326±22 0.54 0.21 0.02 
Total -SH (pmol × g protein-1) 3.7±1.0 3.2±0.5 4.1±0.7 4.30±0.8 0.41 0.79 0.60 
Triglycerides (mg × dL-1) 71±10 100±37 98±18 158±30 0.15 0.01 0.27 
HDL cholesterol (mg × dL-1) 43±2 40±2 45±3 40±2 0.78 0.09 0.58 
LDL cholesterol (mg × dL-1) 94±6 120±7 104±7 126±8 0.27 0.007 0.61 
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Effects on whole body glutathione (red blood cells) 
 
Table 14. Bed-rest effects at different energy intake levels on plasma and 
erythrocyte glutathione and glutathione precursor amino acid concentrations. 
 
 
HEBA, higher energy balance; LEBA, lower energy balance; 1, data were analyzed 
by using a 2-factor (group × activity) ANOVA with interaction. All values are 
expressed as mean±S.E.M. 
 
Plasma glutathione and glutathione precursor amino acid concentrations did not change 
significantly after bed rest in the HEBA or LEBA group (Table 14). We found a tendency (p = 
0.06) toward an effect of bed rest on glutathione and glycine concentrations in erythrocytes, 
but no significant changes were observed in the other amino acids. 
There was a significant (p < 0.01) effect of bed rest in increasing hematocrit both in the HEBA 
(from 48 ± 2% to 50 ± 2%) and LEBA (from 48 ± 2% to 51 ± 2%) groups. However, there was 
no group × bed rest interaction for hematocrit. 
 
 
HEBA (n =5) LEBA (n =5) P (Effect) 1 
 
Ambulatory Bed Rest Ambulatory Bed Rest Group  Activity Interaction 
Plasma (µmol × L-1)        
Glutathione 24±3 23±4 29±2 27±1 0.16 0.61 0.76 
Glycine 240±23 240±18 242±16 217±12 0.63 0.40 0.42 
Glutamine 501±33 562±17 514±35 487±31 0.25 0.64 0.24 
Glutamate 88±6 86±9 82±4 85±15 0.75 0.99 0.80 
Methionine 25±2 27±2 27±2 25±2 0.93 0.90 0.15 
Homocysteine 18±2 18±1 13±2 12±2 0.06 0.17 0.69 
Cysteine 27±1 26±1 27±2 25±2 0.96 0.22 0.47 
Erythrocyte (µmol × L-1)        
Glutathione 2152±209 2254±115 2160±85 2394±131 0.70 0.06 0.42 
Glycine 404±22 396±16 451 ۓ29  363±23 0.78 0.06 0.11 
Glutamine 475±33 483±10 496±22 451±32 0.88 0.23 0.09 
Glutamate 458±74 443±75 420±17 462±57 0.90 0.67 0.37 
Methionine 25±3 29±3 28±2 29±2 0.62 0.24 0.52 
Cysteine 67±13 75±13 69±16 66±11 0.82 0.80 0.64 
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Precursor 2H2-cysteine enrichment was measured in erythrocytes and reached steady state in 
all groups and conditions by the end of the third hour of isotope infusion, whereas the 2H2-
glutathione enrichment in erythrocyte increased linearly with time (Figure 20). 
 
Figure 20  
 
Figure 20 shows enrichments of 2H2-cysteine (precursor) and 2H2-glutathione 
(product) in red blood cell during primed continuous intravenous infusions of 2H2-
cysteine. 
Data are mean±SEM; TTRs, tracer to tracee ratios; ●, before bed rest; ○ after bed 
rest; HEB06, higher energy balance in Valdoltra 2006 study; LEB06, lower energy 
balance in Valdoltra 2006 study 
 
The effects of bed rest at different energy intake levels on the erythrocyte glutathione system 
are shown in Table 15. 
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Table 15. Effects of bed rest at different energy intake levels on the erythrocyte 
glutathione system 
 
HEBA, higher energy balance; LEBA, lower energy balance; FSR, fractional 
synthesis rate; ASR, absolute synthesis rate; GCL-C, glutamate cysteine ligase-
catalitic subunit; GCL-M, glutamate cysteine ligase-modifier subunit, GAPDH, 
glyceraldehydes-3-phosphate dehydrogenase; GPX, glutathione peroxidase. 1, 
Data were analyzed by using a 2-factor (group × activity) ANOVA with 
interaction. 2, Significantly different from the ambulatory adaptation condition, 
P<0.025 (Bonferroni’s post hoc analysis). All values are expressed as 
mean±S.E.M. 
 
Before bed rest, glutathione absolute synthesis rates directly correlated with cysteine 
concentrations in erythrocytes of pooled subjects (r = 0.74, p = 0.05; n = 10). No significant 
correlations were found between absolute glutathione synthesis rates and glutamate (r = -0.13; 
n = 10) or glycine (r = 0.50; n = 10) concentrations. Bed rest tended to increase glutathione 
fractional and absolute synthesis rates in erythrocytes. There were significant group × bed rest 
interactions for glutathione fractional and absolute synthesis rates in erythrocytes (Table 15). 
Bed rest–mediated changes in glutathione fractional and absolute synthesis rates in 
erythrocytes were greater in the HEBA group (+ 94 ± 18% and + 215 ± 42%, respectively) 
than in the LEBA group (- 28 ± 37% and -40 ± 88%, respectively). 
There was a tendency toward group × bed rest interaction for the effects of bed rest at 
different energy intake levels on the catalytic subunit for glutamate cysteine ligase, the key 
enzyme for glutathione synthesis; however, this trend was not statistically significant (Table 
15). Bed rest–mediated changes in the catalytic subunit for glutamate cysteine ligase tended to 
 
HEBA  (n =5) LEBA  (n =5) p (Effect) 1 
 
Ambulatory Bed Rest Ambulatory Bed Rest Group  Activity Interaction 
Glutathione FSR (% × day-1) 70±19 164±292 103±23 84±27 0.43 0.13 0.03 
Glutatione ASR (mmol ×  L-1 · day-1) 160±58 376±75 2 217±43 197±62 0.40 0.09 0.05 
GCL-C (fraction of GAPDH) 0.95±0.23 1.36±0.15 1.73±0.57 1.01±0.28 0.58 0.63 0.10 
GCL-M (fraction of GAPDH) 0.42±0.11 0.48±0.13 0.57±0.10 0.63±0.21 0.36 0.68 0.99 
GPX activity (µmol × min-1 × g 
protein-1) 1.04±0.13 1.01±0.31 1.18±0.54 1.46±0.32 0.48 0.71 0.65 
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be greater in the HEBA group (96 ± 65%) than in the LEBA group (-10 ± 35%). Bed rest at 
different energy intake levels did not significantly affect glutathione peroxidase activity. 
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DISCUSSION 
 
In this thesis, the impact of inactivity on inflammation, oxidative stress, and glutamine 
kinetics was investigated; in parallel, effects of dietary energy or protein intake changes on 
selected inactivity mediated alterations were studied. For this purpose, 5 bed rest campaigns 
(STBR-IP, WISE, Valdoltra 2006, 2007 and 2008 study) with different nutritional control 
approaches (see “Experimental design” section) and primary outcomes were organized. 
 
Bed rest effects on inflammation and oxidative stress 
 
Previously published evidences showed that chronic low grade inflammation (i.e. slight 
increase of proinflammatory cytokines) and oxidative stress are pathogenic factor of 
cardiometabolic diseases (Pradhan et al., 2001; Hansson, 2005; Alberti et al., 2006; Hopps et 
al., 2009; Lastra and Manrique, 2007). Inactive lifestyle is a demonstrated cause of 
cardiometabolic diseases (Zhu et al., 2004), and animal studies suggested unloading can 
enhance inflammation and oxidative stress (Fischer et al., 2007; Laufs et al., 2005). Thus, 
experimental inactivity can be hypothesized to induce in humans inflammation and oxidative 
stress, with potential metabolic and cardiovascular consequences.  
Effect of bed rest on membrane composition. 
Analysis of changes in membrane composition performed within Valdoltra bed rest 2006, 
2007 and 2008 studies display experimental physical inactivity can exert a pro-inflammatory 
role at whole body level in humans. 
The polyunsaturated fatty acids (PUFA) of the n-6 and n-3 series, are involved in up-
regulation and down-regulation of the inflammatory response, respectively. Red blood cell 
membrane composition reliably reflects average cell membrane composition in different 
tissues and the whole body inflammatory condition (Harris and Von Schacky, 2004). Bed rest 
mediated changes in erythrocyte membrane composition was investigated and a significant 
shift toward a proinflammatory pattern was shown. Bed rest, in fact, led to a significant 
increase in pro-inflammatory n-6 PUFA content, including arachidonic acid. Interestingly, bed 
rest increased long-chain n-6 PUFA in erythrocyte membrane, whereas n-6 precursor content 
was significantly decreased, suggesting an active role of bed rest in enhancing n-6 turnover. 
Arachidonic acid is the most important pro-inflammatory n-6 PUFA and, as previously 
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reported, its level is negatively influenced by exercise (Helge et al., 2001). Bed rest associated 
increases of arachidonic acid content can lead, in turn, to increased pro-inflammatory 
eicosanoid production. On the contrary, bed rest induced a significant decrease in n-3 PUFA 
eicosapentaenoic acid which is known to play a key role as anti-inflammatory agent (Babcock 
et al., 2000). Thus, these evidences show bed rest can directly affect n-6 and n-3 PUFAs 
metabolism, increasing inflammation level. The arachidonic-to-eicosapentaenoic acid ratio, 
calculated to monitor the competitive roles of arachidonic acid and eicosapentaenoic acid on 
inflammatory processes, was significantly increased after bed rest. This is an important bed 
rest mediated alteration as the balance between pro-inflammatory eicosanoids, principally 
produced from arachidonic acid, and anti-inflammatory molecules, mainly deriving from 
eicosapentaenoic acid, is a critical condition to maintain cell membrane functions (Serhan et 
al., 1996; Kelley, 2001). Additionally, n-3 and n-6 PUFAs are competitively metabolized by 
the same enzymes (Arterburn et al., 2006). Consequently, increased availability of n-6 PUFA 
could have negatively affected n-3 PUFA metabolism leading to decreased content of the n-3 
linolenic and eicosapentaenoic fatty acids in cell membranes. Interestingly, other stress 
conditions were associated with altered balance between n-3 fatty acids (Gudbjarnason, 1989). 
In contrast to linolenic and eicosapentaenoic fatty acids, docosahexaenoic acid proportion 
increased after bed rest: active eicosapentaenoic acid retrotransformation to docosahexaenoic 
acid (Conquer and Holub, 1997) can provide a mechanistic explanation for this effect. The 
proinflammatory effect of bed rest is further confirmed by significantly diminished ∆9 
desaturase index, as estimated from product-to-precursor ratio. Such impairment of ∆9 
desaturase activity led to significant decreases in monounsaturated fatty acids and a tendency 
towards increases in the saturated fatty acids. ∆9 desaturase, in fact, converts stearic and 
palmitic acids to monounsaturated oleic and palmitoleic acid, respectively (Ntambi and 
Miyazaki, 2004). Decreased monounsaturated relatively to unsaturated FAs can contribute to a 
pro-inflammatory status mediated by decreased clearance of pro-oxidant metabolites of 
saturated FAs, such as diacylglycerol and ceramides (Peter et al., 2009). 
Inactivity and enhanced inflammation lie at the base of metabolic syndrome and other insulin 
resistance conditions as type 2 diabetes (Zhu et al., 2004; Fischer et al., 2007). In this work, 
insulin sensitivity alterations mediated by experimental inactivity were assessed as changes in 
HOMA index: significant insulin resistance induction was demonstrated. Insulin resistance is 
known to rapidly develop following physical inactivity (Hamburg et al., 2007) and this effect 
is consistent with the proinflammatory effect of bed rest evidenced by changes in membrane 
fatty acids composition. Moreover, published data indicate that activities of ∆5, ∆6 and ∆9 
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desaturases are affected by insulin action (Brenner, 2003). In addition, decreased long-chain 
PUFA content, due to low ∆5 desaturase activity, alters cell membrane physical properties, 
potentially leading to altered receptor binding capacities and further impairment of insulin 
sensitivity (Borkman et al., 1993). A decrease of ∆5 desaturase activity was presently 
observed and can be considered to be caused by lowered insulin sensitivity. 
 
Previous studies have investigated the influence of exercise training on muscle skeletal 
membrane fatty acids content showing, coherently, an opposite pattern as compared to that we 
have observed in erythrocytes following inactivity. Exercise training was associated with 
decreased saturated fatty acids, (e.g., palmitic acid) and n-6 PUFAs as well as increased 
monounsaturated fatty acids (e.g., oleic and stearic acids) and n-3 PUFAs. (Andersson et al., 
2000; Helge et al., 2001). 
Interestingly, ∆5 desaturase activity was shown to be improved by exercise training in parallel 
with insulin sensitivity (Andersson et al., 2000). Thus, the decrease in ∆5 desaturase activity 
presently observed can be considered both as a consequence of inactivity and of increased 
insulin resistance. 
 
In conclusion, several changes in fatty acid composition of erythrocyte membranes following 
long-term bed rest in healthy volunteers were described and these alterations are consistent 
with a proinflammatory metabolic pattern induced by inactivity. Interestingly, inactivity-
mediated changes in insulin action have potentially affected desaturase activities leading to 
the observed relative changes in membrane fatty acids. 
 
Impact of inactivity on plasma leptin concentrations 
 
In the present work, other results contributed to underline the proinflammatory role of 
inactivity in humans: measurements performed in subjects enrolled in Valdoltra bed rest 2006 
study, demonstrated that bed rest can significantly upregulate plasma leptin levels. Leptin is a 
protein encoded by the Obese (Ob) gene, synthesized by adipose tissue and aimed to control 
food intake and energy expenditure (Yadav et al., 2009). Plasma leptin concentrations are 
positively correlated to adipose tissue accumulation (Baratta, 2002; Zhao et al., 2005), IL-6 
(Fenton et al., 2006) and to activate the release of ROS (Yamagishi et al., 2001). Thus, leptin 
can be considered not only as marker of adiposity but also as index of inflammation. Present 
results further show experimental bed rest in healthy volunteers can enhance the inflammation 
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status, significantly upregulating plasma leptin in parallel to increases in adipose tissue. 
Previously published results showed leptin concentrations can be upregulated by bed rest, 
independently from stress responses, changes in fat mass, body composition, energy intake or 
gender (Blanc et al., 2000a). Present results showing enhanced bed rest mediated 
inflammation as changes in membrane composition and increased leptin levels, further 
confirm previously published evidences obtained within the WISE study (Bosutti et al., 2008): 
this work showed a bed rest mediated upregulation of two related acute-phase reactants as 
PTX-3 and CRP, as well as of ratios between IL-6 and IL-10 further underlining that 
inactivity can effectively enhance plasma markers of inflammation. 
Influences of bed rest on homocysteine kinetics and availability. 
Inactivity effects on homocysteine metabolism and availability were investigated within the 
WISE study. Homocysteine is a non proteinogenic sulfur amino acid, and several studies 
associated hyperhomocysteinemia to coronary diseases (Clarke et al., 1991; Graham et al., 
1997; Boushey et al., 1995) and to “unhealthy lifestyle” (Cleophas et al., 2000). 
Hyperhomocysteinemia is, in fact, associated to endothelial damage and to related atherogenic 
and trombotic effects enhancing blood procoagulant and proinflammatory factors (van den et 
al., 1995). Oxidative stress is considered to be the principal effector of homocysteine mediated 
endothelial damage (Harker et al., 1974). Dietary intake of proteins and of micronutrients as 
vitamins, is known to affect homocysteine metabolism (Lee and Frenkel, 2003). Physical 
exercise is known to downregulate homocysteine concentrations: this confirms the positive 
effect of moderate training on cardiovascular risk reduction (Duncan et al., 2004). 
Nevertheless, the impact of physical inactivity on homocysteine kinetics and availability was 
poorly investigated. 
Primed continuous infusions of isotopic tracers, performed in women within the WISE study, 
allowed to assess kinetic changes leading to bed rest mediated effects on homocysteine 
availability. Bed rest was shown to significantly increase homocysteine concentrations in 
plasma. Epidemiological data show that in male human subjects average homocysteine 
concentrations reach an average value of 5-15 µmol × L-1 and that risk of coronary disease can 
be evidenced for values over 10 µmol × L-1 (Aguilar et al., 2004). Noteworthy, gender is a 
known factor influencing average plasma homocysteine concentrations: women display 
almost 20% lower homocysteine concentrations when compared to male subjects (Fukagawa 
et al., 2000). Thus, upregulation of homocysteine concentrations presently observed in female 
volunteers can be considered as a really relevant alteration. Analyses performed by isotopic 
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tracers approach, allowed to observe that bed rest significantly decreased remethylation and 
increased transsulfuration rates, while transmethylation was unaffected. To fully address 
metabolic alterations leading to accumulation of homocysteine, clearance changes by each 
disposal pathway of were analyzed. Interestingly, clearance by remethylation was 
significantly reduced by 60 days of bed rest, while clearance by transulfuration was 
unaffected. Thus, reduction of homocysteine catabolism, coupled with unaltered rate of 
homocysteine synthesis can be considered as an appropriate explanation of enhanced plasma 
homocysteine availability observed after bed rest. This is the first study showing the effect of 
physical inactivity on homocysteine availability and kinetics: interestingly, observed changes 
can be ascribed to the net effect of bed rest because nutrition, a key factor controlling 
homocysteine metabolism, was strictly controlled during the experimental period. Dietary 
levels of protein and folic acid, two pivotal regulators of homocysteine metabolism, were, in 
fact, tailored and monitored to be maintained constant during the experimental period. In this 
way, contribution of dietary macro and micro-nutrient availability changes can be excluded. 
Even though, contribution of specific genetic polymorphisms to observed changes in 
homocysteine availability and metabolism could not be assessed, present data strongly suggest 
that bed rest can effectively upregulate blood homocysteine concentrations. 
The impact of physical inactivity on homocysteine metabolism was never investigated in 
human healthy subjects, and reliable explanations about mechanisms leading to observed 
kinetic changes are not available. In conditions of normal or reduced protein availability, 
homocysteine is preferentially catabolized by MTHFR dependent remethylation (Ueland and 
Refsum, 1989): bed rest can be hypothesized to downregulate activity or availability of this 
enzyme, thus leading to the observed decrease in homocysteine clearance by remethylation. 
Further studies are needed to fully clarify molecular mechanisms underlining this process. 
Nevertheless, present results showing hyperhomocysteinemia in female healthy volunteers 
after a period of bed rest, suggest that physical inactivity can enhance oxidative stress 
induction at systemic level. Hyperhomocysteinemia, in fact, can potentially increase 
endothelial dysfunction (van den et al., 1995) reducing vasodilation (Tawakol et al., 1997): 
free radicals production secondary to homocysteine auto-oxidation is considered to be the 
mechanistic cause of vessel matrix and smooth muscle cell damage occurring in 
hyperhomocysteinemic patients (Harker et al., 1974). Moreover, lipid peroxidation linked to 
this process could contribute to atheromatose plaque induction (Huang et al., 2001). Thus, 
presently observed elevation of homocysteine availability due to bed rest can be related to an 
enhanced systemic oxidative stress condition that could also indicate increased carciovascular 
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risk secondary to inactivity. Interestingly, bed rest mediated cardiac atrophy (Dorfman et al., 
2007) occurred in parallel in volunteers enrolled in WISE study can underline reliability of 
hyperhomocysteinemia as marker of cardiovascular risk. 
Previously published evidences suggested that plasma homocysteine levels are directly related 
not only to oxidative stress, but also to inflammation increase in coronary heart disease 
patients (Jonasson et al., 2005): this data are in accordance with results discussed above, 
showing enhanced inflammation after prolonged bed rest period. 
 
Published evidences showing sedentary lifestyle is associated to an upregulation of 
homocysteine concentrations in plasma, independently from genetic factors, sex and age or 
from dietary intake of folates (Dankner et al., 2007; Nygard et al., 1995) support and confirm 
present results.  
Accordingly, a program of six months resistance training reduced blood homocysteine levels 
in both lean and obese adult subjects (Vincent et al., 2006). Noteworthy, published data 
showed physical exercise can reduce cardiovascular risk lowering endothelial damage 
performed by inflammation, and oxidative stress (Zoppini et al., 2006). 
 
Effects of infusion of amino acid, insulin and glucose mixture on homocysteine metabolism. 
In WISE study design, effect of intravenous infusion of amino acid mixture, glucose and 
insulin (see methods) was assessed before and after the experimental bed rest period. As 
expected, methionine concentrations significantly increased both before and after bed rest as a 
consequence of amino acid mixture intravenous administration as methionine was contained at 
relatively high concentrations in the infused solution: bed rest mediated increase of the 
upregulation of methionine concentration after intravenous infusions, can be ascribed to 
lovered stimulation of protein synthesis due to insulin resistance mediated by inactivity (Biolo 
et al., 2004). 
On the contrary, intravenous glucose, insulin and amino acid infusion decreased cysteine 
concentrations in the ambulatory condition, but not after bed rest. Cysteine concentrations in 
infused mixture were low, so effect of infused insulin can explain observed results. Insulin 
mediated enhancement of plasma amino acid uptake for protein synthesis could explain 
observed decrease of cysteine concentrations in baseline conditions: low cysteine 
concentration in administered amino acid mixture possibly failed to sufficiently compensate 
amino acid uptake mediated by insulin. Otherwise, reduced uptake for protein synthesis linked 
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to inactivity mediated insulin resistance could explain why cysteine concentrations were not 
significantly reduced after intravenous infusions performed after bed rest. 
Upregulation of homocysteine availability can be considered as a consequence of increased 
methionine concentrations. Homocysteine upregulation occurred only after bed rest probably 
because immobility was shown to significantly impair homocysteine remethylation and 
clearance by remethylation. Moreover, bed rest significantly reduced remethylation changes 
induced by intravenous infusions. 
The proinflammatory and pro-oxidant effect of bed rest: conclusions 
Results collected in Valdoltra 2006, 2007 and 2008 studies as well as in WISE study 
demonstrate and confirm that physical inactivity can increase inflammation and oxidative 
stress. Inflammation was shown to be increased in terms of changes in fatty acid membrane 
composition, while systemic oxidative stress was shown to be upregulayed by increased 
availability of plasma homocysteine. Inflammation and oxidative stress are normally linked 
together to play a negative role in pathogenesis of several diseases. As already mentioned, 
they are both considered as mechanistic causes of metabolic syndrome, cardiovascular 
diseases and diabetes (Pradhan et al., 2001; Hansson, 2005; Alberti et al., 2006). Oxidative 
stress has been, moreover, recently recognized to be involved in selected diseases as for 
example cancer or chronic obstructive pulmonary disease (Moylan and Reid, 2007). Thus, bed 
rest, a frequent care approach in several pathologies, could play a worsening role in disease 
outcome. Otherwise, physical exercise can play a beneficial effect on both inflammation and 
oxidative stress induction. Evidences derived from diabetic animal models show that, 
independently from changes in glycemia, moderate exercise can reduce activities of factors 
triggered by oxidative stress as caspase-3 and 8 as well as the expression of proinflammatory 
markers as tumor necrosis factor alpha (Ghosh et al., 2009). Moreover, the same work showed 
that exercise increased scavenging efficacy of antioxidant systems, thus reducing oxidative 
stress occurrence. Other evidences (Di Francescomarino et al., 2009) demonstrated that 
regular moderate exercise can protect endothelial system from the damaging actions of 
oxidative factors and of inflammation. A previously published study showed that regular and 
moderate physical exercise was linked to cardioprotection as evidenced by improved 
hemodynamic parameters and by analysis of coagulation factors: such positive effect was 
shown to be dependent from reduced inflammation mediated by exercise (Abramson and 
Vaccarino, 2002). Thus, an early patient remobilization can be hypothesized as an optimal 
choice in care strategy of different pathologies. 
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Impact of physical inactivity on glutamine metabolism 
 
Glutamine is a conditionally essential amino acid released from skeletal muscle and taken up 
by different tissues. Glutamine provides fuel for rapidly dividing cells as well as precursors 
for gluconeogenesis, DNA synthesis and urinary ammonia (Curthoys and Watford, 1995). Its 
availability is important for sustaining immune function (Ardawi and Newsholme, 1982) and 
depletion of free glutamine pools often occurs in pathological conditions as a consequence of 
accelerated whole body uptake and/or insufficient appearance from skeletal muscle (Biolo et 
al., 2000; Biolo et al., 2005b; Bongers et al., 2007). In critically ill patients, glutamine 
supplementation can improve clinical outcome (Bongers et al., 2007). Many illnesses are 
inevitably associated to bed rest and muscle unloading. In animal models muscle free 
glutamine concentration was shown to decrease following unloading (Jaspers et al., 1989).  
Impact of bed rest on glutamine kinetics 
The impact of physical inactivity on glutamine kinetics was assessed within the STBR-IP 
study. Obtained results principally demonstrate a down-regulation of glutamine kinetics 
occurring in short-term bed rest independently from changes in whole body protein turnover. 
Results regarding whole body protein turnover were previously published (Biolo et al., 2004): 
kinetics were determined by the by l[1–13C]leucine tracer data and the reciprocal pool model. 
In the basal postabsorptive state, leucine kinetics, as index of whole body protein turnover was 
shown to be not substantially affected by bed rest. Interestingly, bed rest mediated a reduction 
of glutamine rate of appearance and de novo synthesis, while glutamine release from 
proteolysis and glutamine clearance were left unaffected. The parallel decrease displayed by 
plasma glutamine concentrations further confirms the effect of inactivity on glutamine 
appearance from tissues. These are novel results adding new insights to glutamine metabolism 
during the inactive state. The relationship between immobility and glutamine metabolism has 
not been investigated in humans before. In animals, it is known that hind limb suspension or 
muscle denervation decreases glutamine and ammonia levels (Jaspers et al., 1989) as well as 
glutamine synthetase activity (Hundal et al., 1990). In addition, free muscle glutamine levels 
of rats exposed to 7 days of weightlessness were decreased (Steffen and Musacchia, 1986). 
Mechanisms involved in the suppression of glutamine production in human or animal inactive 
muscle may include reduced availability of precursors. Glutamine is synthesized from 
glutamate and free ammonia. Glutamate carbon skeleton derives from the tricarboxylic acid 
cycle intermediate α-ketoglutarate, while nitrogen mainly derives from BCAA transamination. 
During bed rest muscle energy requirements are reduced as a consequence of lowered energy 
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expenditure for physical exercise. Status of tricarboxylic acid cycle intermediates in unloaded 
muscle was found to be down-regulated (Berg et al., 1993) leading to lowered α-ketoglutarate 
conversion to glutamate. Intensive muscle contractions are known to produce free ammonia 
(Meyer and Terjung, 1979) as a result of adenylate deaminase action on an actively 
synthesized adenosine monophosphate (AMP). For such reasons, during physical inactivity 
lowered production of AMP and free ammonia can be hypothesized. Free ammonia released 
as a consequence of ATP conversion to AMP is partially utilized in the glutamine synthetase 
reaction that leads to glutamine synthesis from glutamate. Consequently, lowered ammonia 
appearance could contribute to the reduction of glutamine synthesis rate observed after 14 
days of bed rest. Glutamine synthetase is an important factor controlling glutamine de novo 
synthesis and the regulation of this enzyme was found to be lowered in an animal model of 
unloading (Hundal et al., 1990). In present results, bed rest impact on glutamine de novo 
synthesis was assessed at the whole body level without distinguishing between different 
source tissues. Nonetheless, glutamine rate of appearance has been consistently demonstrated 
to derive in its major part from skeletal muscle (Jaspers et al., 1989; Steffen and Musacchia, 
1986; Berg et al., 1993). In a previous study (Biolo et al., 1995a), the relative contribution of 
skeletal muscle to whole body glutamine appearance was assessed by combining tracer 
infusion with the leg arteriovenous balance technique in healthy young volunteers. Results 
showed that skeletal muscle accounts for 40–50% of total glutamine appearance in 
physiological conditions (Biolo et al., 1995a). Other tissues contributing to whole body 
glutamine appearance include liver, lung, adipose tissue and kidney (Frayn et al., 1991; 
Abcouwer et al., 1995; van de Poll et al., 2004). Regarding the present study, skeletal muscle 
contribution to whole body glutamine appearance may be speculated to play a key role in 
glutamine decrease mediated by prolonged inactivity. 
Inactivity as well as exposure to microgravity (Sonnenfeld et al., 2003) is known to be 
associated with alterations in the immune system (Kanikowska et al., 2008) potentially 
leading to lowered immune cell proliferation and reactivity. Lowered glutamine availability 
presently observed as a consequence of inactivity, is in accordance with such published data, 
and could be speculated to participate in mechanisms leading to such immunosuppressant 
effect. Severe glutamine depletion can occur also in the critically ill patient (Biolo et al. 2000; 
Biolo et al. 2005; Bongers et al. 2007) and bed rest is a common situation during severe 
illness: this underlines the importance of understanding glutamine turnover regulation during 
physical inactivity itself. This study suggests that inactivity could worsen illness condition in 
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critical patients (Biolo et al. 2000) contributing to glutamine depletion by impairing de novo 
synthesis.  
Differential effect of physical exercise and inactivity on glutamine metabolism. 
In contrast to inactivity, well trained athletes showed higher plasma glutamine concentration 
at rest when matched to sedentary people (Rowbottom et al. 1997; Kargotich et al. 2007) and 
are characterized by ameliorated immune defences. Several publications show the relationship 
existing between glutamine concentrations and immune functions in athletes (Newsholme & 
Parry-Billings, 1990). As previously reported (Nieman & Pedersen, 1999), beneficial effects 
on immune system linked to moderate exercise training could derive from summation of 
positive effects of each single exercise bout. Significantly higher glutamine concentrations 
were, in fact, observed after single exercise bouts (Poortmans et al. 1974; Parry-Billings et al. 
1992) as a consequence of higher synthesis rate and release from muscle (Bergstr¨om et al. 
1985). So, physical inactivity reduces glutamine de novo synthesis, while optimal exercise 
training ameliorates plasma glutamine status in virtue of a positive glutamine balance 
instauration. In contrast to well trained athletes, overtraining is characterized by decreased 
plasma glutamine and systemic inflammatory response (Rowbottom et al. 1996). In this 
condition, an accelerated glutamine clearance by immune cells could be hypothesized 
(Rowbottom et al. 1996) (see Figure 7). 
Principle and technique. 
The main objective of this study was to assess whole body glutamine de novo synthesis. 15N-
amide glutamine was used therefore to trace glutamine synthesis from glutamate. The first 
step of glutamine catabolism involves loss of amide nitrogen into the ammonia pool leading to 
glutamate synthesis. This latter amino acid can be transformed into α-ketoglutarate to enter the 
tricarboxylic acid cycle or reaminated to glutamine. 15N-amide tracer recycling among amino 
acids during prolonged L-[5-15N]glutamine infusion was previously shown to be not 
significant (Biolo et al., 1995a). Oxidative glutamine utilization can be assessed by labelling 
the carbon skeleton of the amino acid. In postabsorptive humans, about 40% of glutamine 
appearing in the bloodstream is oxidized. This proportion increased to about 60% when the 
labelled amino acid was infused via the nasogastric route (Bourreille et al., 2004). The 
physiological significance of plasma glutamine kinetic assessment based on isotopic tracers 
has been the subject of recent debate. Different experimental conditions led to contradictory 
conclusions about the potential of plasma glutamine turnover to reflect intracellular 
metabolism (Biolo et al., 1995a) or simply transmembrane exchange (Darmaun et al., 1986; 
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van Acker et al., 1998). Reasonably present kinetic results can reliably reflect intracellular 
glutamine metabolism for the following reasons. First, this approach was previously shown to 
allow the achievement of tracer steady state condition not only in plasma (see Figure. 18) but 
also in skeletal muscle cytoplasm (Biolo et al., 1995a). Second, bed rest mediated decreases in 
glutamine Ra were paralleled and confirmed by decreases in plasma glutamine concentrations. 
Finally, infusion of amino acid mixture not containing glutamine influenced glutamine rate of 
appearance, despite potential uncertainties in intracellular steady state achievement during 
short term metabolic perturbation. This indicates that the isotopic glutamine tracer approach 
can be considered as a suitable tool to assess changes in intracellular glutamine kinetics.  
 
Impact of experimental bed rest on muscle atrophy 
 
Several previous works showed that physical inactivity can significantly induce postural 
muscle atrophy (Kawakami et al., 2000; Akima et al., 2005) especially of lower limb (Alkner 
and Tesch, 2004; Berry et al., 1993).  Experimental evidence obtained in animal models 
demonstrate sharp induction of oxidative stress during unloading, as assessed by upregulation 
of oxidative stress markers and by activation of antioxidant system (Kondo et al., 1994; 
Lawler et al., 2003; Kondo et al., 1992) aimed to scavenge oxidized substrates (Lawler et al., 
2003). As reviewed by Scott K. Powers (Powers et al., 2005; Powers et al., 2007), oxidative 
stress was shown, in animal models, to induce muscle atrophy: upregulation of intracellular 
pathways triggering upregulation of specific proteases and of apoptosis were demonstrated to 
determine such outcome. Muscle wasting is an important clinical feature of several chronic 
diseases and oxidative stress has been recognized as pathogenetic factor in such process 
(Moylan and Reid, 2007). Immobility is frequently linked to acute and chronic diseases. The 
role of oxidative stress in inactivity mediated induction of muscle atrophy was not previously 
investigated in humans. 
Results obtained within Valdoltra bed rest studies 2006 and 2007, confirm experimental bed 
rest can induce muscle atrophy in terms of changes in fat free mass determined by 
bioimpedance and in muscle thickness measured by ultrasonography. Bioimpedance is a 
validated approach to assess changes in body composition (Lim et al., 2009). Muscle 
thickness reduction is a direct index of muscle atrophy, validated also in other model of 
muscle wasting (Pinet et al., 2004). As previously published (Tauler et al., 2006), present 
results show enhanced atrophy of the antigravity muscle vastus lateralis after prolonged bed 
rest in terms of decreased vastus lateralis thickness. Moreover, additional muscle 
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ultrasonography results show bed rest reduces pennation angle, i.e. orientation of muscle 
fibres with respect to aponeurosis. Pennation angle was previously demonstrated to be 
inversely correlated to muscle atrophy (Morse et al., 2005; Narici and Cerretelli, 1998; Reeves 
et al., 2002; de Boer et al., 2007). For such reasons, the decrease in pennation angle we 
observed can be considered as a strong marker of muscle atrophy occurrence. Thus, muscle 
atrophy induction mediated by 35 days of experimental bed rest was presently confirmed by 
analysis of two related indexes of muscle shape and architecture. Interestingly, additional 
results obtained by other research groups within the same experimental frame confirmed bed 
rest mediates atrophy in antigravity muscles as gastrocnemius medialis, while non-antigravity 
tibialis anterior and biceps brachii were not significantly affected (de Boer et al., 2008).  
Muscle atrophy induction was additionally assessed within the same experimental design as 
changes of another reliable index: cross sectional area of muscle fibres (Dalla et al., 2009). In 
particular, authors described a 18% reduction in fibre cross sectional area after 35 days of bed 
rest. In relation to these results showing muscle bulk reduction after bed rest, additional 
publications involving subjects of Valdoltra studies showed that contractile parameters 
(velocity of contraction) of selected muscles were significantly impaired by bed rest (Pisot et 
al., 2008). Moreover, similar data obtained by tensiomiography demonstrated that muscle 
stiffness was reduced after 35 days of bed rest (Pisot et al., 2008). 
Mechanisms of muscle atrophy induction triggered by inactivity 
In the present work, relationships between muscle atrophy and changes in oxidative status 
were investigated. An increase in protein carbonylation in atrophying muscles was observed 
by oxyblot analyses as a consequence of 35 days of bed rest: this reveals enhanced muscle 
fiber damage mediated by oxidative stress in vastus lateralis. 
Carbonyl derivatives are formed by an oxidative amino acid modification (Requena et al., 
2003). As protein carbonylation occurs following ROS action on carbon groups altering 
enzyme structure and activity (Stadtman, 2001), this posttranslational modification was, 
previously demonstrated to be a reliable marker of oxidative stress occurrence (Greilberger et 
al., 2008). Carbonylation is an irreversible oxidative process (Dalle-Donne et al., 2003): to 
avoid accumulation of damaged peptides, carbonylated proteins are efficiently scavenged by 
proteolytic degradation (Dukan et al., 2000; Bota and Davies, 2002; Grune et al., 2003): this 
suggests carbonylation can trigger or sustain muscle atrophy. Noteworthy, in this thesis a 
linear inverse relationship between changes in protein carbonylation and vastus lateralis 
thickness was shown, strongly suggesting that oxidative stress induced carbonylation in 
human muscle is one of the possible pathways leading to muscle atrophy. Other mechanisms 
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triggering protein degradation and subsequent muscle atrophy involve caspases, calpain (Du et 
al., 2004; Goll et al., 2003; Tidball and Spencer, 2002) and ubiquitin proteasome sytem 
regulation ((Furuno and Goldberg, 1986; Ikemoto et al., 2001; Purintrapiban et al., 2003). 
ROS production is known to affect activity of caspases and calpain, principally influencing 
calcium availability (Siems et al., 2003; Primeau et al., 2002). Moreover, oxidative stress, can 
upregulate E3 ubiquitin ligases as muscle atrophy F-box/atrogin1 and muscle ring finger-1 in 
myotubes (Li et al., 2003): these alterations could enhance skeletal muscle proteolysis and 
atrophy (Bodine et al., 2001a). Inactivity can trigger oxidative stress in muscle by interaction 
of at least five different oxidant production pathways (Kondo et al., 1993) involving xanthine 
oxidase, NOS activity (Kondo et al., 1993), reactive iron (Kondo et al., 1992), NADPH 
oxidase (Javesghani et al., 2002) and minor contribution of mitochondrial superoxide radicals 
(Muller et al., 2007). In the present experimental design, factors involved in all different 
pathways linking inactivity to muscle atrophy through oxidative damage could not be 
measured due to sampling limitations characterizing studies performed in human healthy 
volunteers. Nevertheless, data obtained from muscle biopsy showed that enhanced 
carbonylation, as peculiar oxidative damage leading to protein wasting, was increased in 
unloaded muscles. This event was directly related to muscle atrophy induction as measured by 
ultrasonography. Additionally, whole body oxidative stress was shown to be induced by 
inactivity in terms of upregulated homocysteine availability: even though this alteration failed 
to be related to worsened muscle atrophy, a possible contribution can not be excluded.  
Complexity of pathways linking inactivity to oxidative stress induction and to subsequent 
upregulation of proteolysis rate requires additional human studies to completely understand 
mechanisms underlining this process. 
Antioxidant defense activation in atrophying muscles during experimental bed rest. 
When excessive ROS production occur, antioxidant system activation is triggered (Pastore et 
al., 2003) in order to limit the final damage on biological substrates. Between several enzymic 
and non-enzymic mechanisms activated to reduce oxidative damage, the glutathione system is 
quantitatively the most important antioxidant in muscle (Dobrowolny et al., 2008). This 
tripeptide is synthesized in order to scavenge hydroperoxides by self-oxidation and 
dimerization. Physiological conditions associated to increased ROS production lead to 
increased glutathione availability (Biolo et al., 2008; Ji et al., 1992). Thus, kinetic assessment 
of glutathione pool effectively monitors oxidative stress onset. 
By the novel and validated (see below) one-sample and double isotopic tracer infusion 
approach we assessed bed rest impact on muscle glutathione synthesis rate. Our data 
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demonstrate that after 33 days of bed rest, muscle glutathione synthesis is significantly 
increased. This underlines that in humans, unloading can enhance muscle glutathione 
antioxidant system activity: such effect can be strongly hypothesized to be a response to an 
increased reactive oxygen species production. Previous animal studies yielded conflicting 
results about physical inactivity effect on muscle glutathione regulation. Glutathione 
concentrations were, in fact, shown to be negatively affected in rat unloaded muscle (Ikemoto 
et al., 2002b) and activities of glutathione system key enzymes as glutathione reductase and 
glutathione peroxidase were demonstrated to be increased (Sen et al., 1992), unaltered or 
downregulated (Tauler et al., 2006). Reasons leading to such a wide range of results can be 
ascribed to model and experimental design differences. Glutathione assays in muscle biopsies 
can be theoretically biased by presence of red blood cells within explanted fibres. This is an 
intrinsic limitation for muscle studies but, in this work, its impact was strongly minimized by 
accurate cleaning of each biopsy. 
In the present results, interestingly, an inverse correlation existing between glutathione 
synthesis rate and muscle pennation angle was observed: this suggests a link between muscle 
antioxidant potential and atrophy degree. Taking together this observation and the correlation 
existing between bed rest mediated changes in muscle oxidation level and muscle thickness, 
we can strongly suggest that high glutathione synthesis rate in human muscle can protect from 
atrophy by reduction of protein oxidation levels. So, maintenance of glutathione availability in 
muscle fibres of healthy inactive volunteers should be considered as a homeostatic response to 
counteract, at least partially, muscle atrophy (Gherghel et al., 2005). Decreased glutathione 
level and increased oxidative stress are implied in a wide range of critical illness (Biolo et al., 
2007a) influencing clinical outcome (Crimi et al., 2006), symptoms and severity (Najim et al., 
2007). Diseases downregulating muscle antioxidant systems are associated to cachexia 
(Laviano et al., 2007). Conversely, an increased bioavailability of glutathione precursors as 
cysteine or N-acetyl-cysteine was previously published to ameliorate glutathione system 
scavenging action (Badaloo et al., 2002) and to reduce, in an animal model, muscle protein 
ubiquitination (Ikemoto et al., 2002a). Thus, dietary glutathione precursor supplementation is 
likely to ameliorate clinical conditions of muscle wasted critically ill patients. 
Involvement of inflammation in inactivity mediated atrophy. 
Oxidative stress is not the only mechanism leading to muscle atrophy. Inflammation, in fact, 
is known to play an active role in this process. Tumor necrosis factor alpha, a known mediator 
of inflammation, was shown in cellular model to increase total protein loss, total 
ubiquitination and activation of NF-kB: the process was demonstrated to be triggered by 
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endogenous production of ROS (Li et al., 1998; Kramer and Goodyear, 2007). Similar 
evidences derive from other published works showing that diabetes induction by 
streptozotocin in rats, is paralleled by soleus muscle atrophy with activation of NF-kB. 
Noteworthy, inflammation is considered to be a pathogenetic factor of diabetes (Duncan and 
Schmidt, 2006) and streptozotocin induces inflammation and oxidative stress (Rossi et al., 
2006): thus NF-kB mediated muscle atrophy observed in diabetic rats is likely to be triggered 
by inflammation and oxidative stress. Additionally, sarcopenia and tissue damage associated 
to chronic obstructive pulmonary disease was linked to increased levels of circulating tumor 
necrosis factor alpha (Remels et al., 2007; Langen and Schols, 2007). Interestingly, another 
circulating proinflammatory factor - leptin, was shown to induce ROS production increasing 
fatty acid oxidation: this could contribute to insulin resistance and enhanced inflammation 
characterizing hyperleptinemic and sarcopenic subjects (Yamagishi et al., 2001). Implication 
of inflammation in muscle atrophy progression described in different models of diseases, 
allow to hypothesize that increased levels of proinflammatory markers mediated by bed rest, 
as discussed above and previously published (Bosutti et al., 2008), can be considered as an 
additional mechanism leading to enhanced muscle atrophy.  
Role of physical exercise on muscle morphology and on regulation of inflammation and 
oxidative stress. 
Abovementioned evidences showing muscle atrophy secondary to inactivity can be caused by 
oxidative stress and inflammation are further confirmed by data deriving from measurements 
performed in physically active subjects and athletes. 
Strength and resistive training are known to increase muscle mass especially in male athletes, 
when compared to females (Melnyk et al., 2009). Additionally, in elederly patients affected by 
sarcopenia, resistive training was shown to ameliorate, locomotor efficiency and changes in 
pennation angle of fibres (Narici and Maganaris, 2006). In parallel, other scientific evidences 
show that moderate training in rats can reduce muscle oxidative damage (Greathouse et al., 
2005). Moreover, in rats, ameliorated antioxidant efficiency was induced by exercise in 
selected muscles and as function of activity duration (Powers et al., 1994). Other evidences 
showed prolonged moderate exercise can reduce plasma markers of systemic inflammation 
(Abramson and Vaccarino, 2002). Additionally, recent data obtained in animal models show 
that a period of moderate intensity aerobic training downregulates skeletal muscle production 
of cytokines involved in the onset, maintenance and regulation of inflammation (Lira et al., 
2009). Thus, such published data strongly suggest that moderate exercise can protect from 
muscle atrophy by reduced inflammation and oxidative stress: this strengthen present results 
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demonstrating, in humans, the role of inflammatory and oxidative stress in muscle atrophy 
induction after experimental physical inactivity. 
Novel single-sample method to determine peptide synthesis by constant tracer infusions: 
validation.  
The core parameter for traditional determination of peptide FSR is the assessment of product 
enrichment changes over time during continuous infusion of isotopic precursor tracer (Wolfe, 
2004). When precursor incorporation into product is linear, FSR can be determined evaluating 
at least two single product enrichments in two separate biological samples taken at different 
times. Muscle glutathione synthesis rate was measured in a single tissue sample applying a 
modified precursor-product approach. Isotopic glycine was chosen as tracer (Jahoor et al., 
1995) and our novel method was based on performing two parallel and separate infusions of 
different isotopes, [2H2]glycine and [15N]glycine, starting at different times (four hours shift). 
In this way, as shown in “Calculations” section, the difference between L-[15N]glutathione 
and L-[2H2]glutathione enrichments measured in a single final biological sample, allowed FSR 
assessment. Linearity of precursor incorporation into the final product was previously (Biolo 
et al., 2008) shown. To directly validate in human red blood cells the “one-sample-double 
tracer” approach to measure glutathione kinetics in human muscle, several blood samples 
were drawn throughout each metabolic study. Glutathione FSR in red blood cells was assessed 
in two different ways: by the traditional approach (Eq. 8) and by the novel approach (Eq. 7) 
designed for muscle assay thus involving both tracer infusions and only the final blood sample 
(see “Calculations”). Comparing results obtained in red blood cells by both approaches, 
“traditional” and “one-sample” methods yielded comparable results. Additionally, validation 
of the present new method is confirmed by the high correlation existing between FSR values 
obtained by traditional and novel approaches. Reliability of this new approach is further 
confirmed by analyses shown in Figure 16 that underline the correlation between FSR changes 
from baseline to day 7 and from day 7 to day 33 measured by traditional approach with the 
same changes measured by one-sample equation. Finally, results fully demonstrate the 
reliability of this method to assess in vivo FSR and changes from baseline status. 
Absolute values of tracers steady-state enrichments were different: [15N]glycine enrichment 
was displayed to be higher than [2H2]glycine. Such a tendency for 15N isotopes to reach higher 
steady state enrichments in comparison to 2H isotopes was previously published for alanine 
tracer (Yang et al., 1984). Alanine shares metabolic pathways with glycine, so that published 
evidences can explain obtained differences in tracer steady state enrichments. However, this 
peculiar feature characterizing [15N]glycine, fails to affect reliability of our FSR estimation as 
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ratios between isotopic product and related tracer enrichments were introduced to exclude 
direct influences of precursor kinetics. In addition, as explained above, our method could be 
validated against the well assessed traditional one by separate correlation analyses. Two 
assumption were necessary to build our new equation. (i) While steady-state condition for 
[2H2]glycine enrichments was directly assessed three hours after infusion beginning (see 
Figure 14), it was assumed for [15N]glycine after the same time of an equal infusion. This 
seems to be acceptable by itself but also as [15N]glycine was previously published to reach 
steady state in plasma within, or even before, the third hour of infusion in similar conditions 
(Cryer et al., 1986). (ii) Tracer incorporation into the final product can be considered as not 
affected by isotopic labelling as this chemical feature of precursors is known not to influence 
product tracer incorporation itself (Wolfe, 2004). Principally for such reasons, differences in 
precursor isotopic labelling should not reasonably affect respective tracer uptake into the final 
product. 
The utility to assess protein or peptide FSR in a single sample stems from drawbacks linked to 
multiple sample collection. During investigations on small animals, the first tissue biopsy can 
determine animal’s death, while in bigger animals or in humans multiple tissue sampling can 
lead to inflammatory process activation. For the same reasons and for clear ethical 
implications, complex metabolic studies requiring multiple tissue sampling are impossible to 
be performed during surgery in human subjects. Approaches aimed to measure peptide FSR in 
a single biological sample were previously published. Dudley et al. employed for the first time 
a multiple-tracer and single-sample method (Dudley et al., 1998). The protocol was based on 
six staggered and overlapping isotopomer infusions. FSR was obtained designing a posteriori 
an enrichment curve. Protocol validation was indirectly performed by comparing plasma free 
amino acid turnover rates. An analogous technique aimed to measure muscle protein fractional 
breakdown rate (FBR) and FSR in a single muscle biopsy, has been also proposed by Zhang et 
al. (Zhang et al., 2002). In this method, three pulse tracer injections of three different isotopic 
amino acid precursors were staggered at different time points. Authors demonstrated that three 
different enrichment assessed in a unique final muscle biopsy allowed FBR evaluation. 
Presently, a new single sample method was directly validated in human subjects involving 
only two separate isotopic infusions to reliably assess a peptide FSR: this approach simplifies 
calculations and reduces technical workloads as well as economical expenses. 
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Impact of nutrition on inflammation, oxidative stress and muscle atrophy. 
Results shown in this work confirmed physical inactivity coherently upregulate oxidative 
stress at whole body level as well as in muscle: in particular, oxidative stress, together with 
inflammation, was strongly suggested to play a causative role on atrophy induction. 
Upregulated concentrations of homocysteine were, in fact, considered as marker of enhanced 
whole body oxidative stress. Moreover, enhanced muscle protein carbonylation and 
glutahione synthesis were strictly associated to muscle atrophy induction following 
experimental inactivity. Physical inactivity was also shown to upregulate whole body 
inflammation as displayed by changes in n-3 and n-6 fatty acid composition of red blood cell 
membrane: a link between whole body inflammation and muscle atrophy can be reliably 
hypothesized. 
Sedentary lifestyle and immobility are associated to lowered energy requirements (Ritz et al., 
1998). Excessive energy intake during long term period of inactivity can lead to obesity and to 
related drawbacks (Chaput and Tremblay, 2009). This suggest that dietary energy intake 
control during muscle unloading can be crucially important to compensate physical inactivity 
related consequences. Published evidences showed, in fact, that calorie restriction during 
experimental bed rest can worsen muscle atrophy progression (Biolo et al., 2007b): on the 
contrary, the impact of fat gain on  inactivity mediated alterations was poorly investigated.  
Dietary macronutrient composition can also play a role during inactivity. The role of protein 
supplementation on muscle atrophy during bed rest in healthy volunteers was previously 
investigated. Results displayed that supplementation with branched chain amino acids can 
attenuate protein loss during bed rest (Stein et al., 1999c), even though this intervention is not 
sufficient to ameliorate muscle atrophy (Brooks et al., 2008). Nevertheless, evidences showed 
amino acid supplementation can protect muscle function when catabolism is enhanced by 
stressful conditions (Fitts et al., 2007). Interestingly, protein and amino acid supplementation 
were, previously shown to ameliorate myocardial remodeling mediated by experimental bed 
rest (Dorfman et al., 2007). 
Impact of protein supplementation on homocysteine metabolism. 
The impact of bed rest and dietary protein supplementation on homocysteine kinetics was 
presently investigated. As shown in results obtained within the WISE study, a diet enriched in 
protein and amino acids during inactivity can blunt and reverse detrimental effects of muscle 
unloading on plasma concentrations and kinetics of homocysteine. While, in fact, bed rest in 
association with an adequate protein intake diet, increased homocysteine concentrations, the 
administration of a diet enriched in protein and amino acid content during bed rest, 
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significantly reduced homocysteine concentration at the end of the experimenatal period. This 
strongly suggest that amino acid supplementation during bed rest can effectively reduce 
cardiometabolic risk connected to inactivity, preventing whole body oxidative stress mediated 
by high levels of plasma homocysteine. Noteworthy, transsulfuration rate was shown to be 
significantly enhanced by bed rest both in subjects fed by a standard diet and by an high 
protein and amino acid intake diet: nevertheless, dietary supplementation significantly 
interacted with inactivity to induce a major increase in transsulfuration rate when matched to 
standard diet. In parallel to observed changes in transsulfuration kinetics, rates of 
remethylation and transmethylation were respectively decreased and increased by bed rest but 
no interaction with diet could be demonstrated: such evidences provide a convincing 
metabolic explanation of observed changes in plasma homocysteine concentrations secondary 
to dietary intervention. Analysis of relative changes in homocysteine clearance mediated by 
bed rest in association to the different dietary regimens further confirms such observations: 
high dietary protein and amino acid intake, in fact, significantly enhanced clearance by 
transulfuration while failed to affect clearance by remethylation. 
Previously published evidences suggest that in ambulatory conditions, artificially induced 
increase of animal proteins or methionine, even though determining a transient increase in 
homocysteine concentration, can stimulate transsulfuration pathway (Ueland and Refsum, 
1989). A recently published work showed in caged rats that nutritional supplementation with 
casein and amino acids determined a significant decrease of plasma homocysteine 
concentrations and that such effect was mediated by a stimulation of transsulfuration pathway, 
as evidenced by enhanced CBS activity (Ohuchi et al., 2009). Amino acid intake is, in fact, 
known to differentially affect homocysteine metabolism, principally modulating a key 
regulator as S-adenosylmethionine. S-adenosylmethionine is a crucial factor in 
transmethylation reaction as methyl donor (Loenen, 2006) and when this pathway is activated 
S-adenosylmethionine can inhibit remethylation rate reducing the activity of MTHFR. To 
prevent accumulation of homocysteine S-adenosylmethionine can stimulate transsulfuration 
enhancing the activity of cystationine β-synthetase and γ-cystationase (Finkelstein, 1998; 
Finkelstein and Martin, 1984). On the contrary, in conditions of normal or reduced protein 
availability, homocysteine is preferentially catabolized by MTHFR dependent remethylation 
(Ueland and Refsum, 1989). Such published data could provide a mechanistic explanation for 
present results showing enhanced homocysteine clearance by transsulfuration after prolonged 
administration of high protein and amino acid diet. Present results, moreover, strongly suggest 
that high protein and amino acid feeding can interact with bed rest condition to blunt 
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hyperhomocysteinemia determined by physical inactivity itself. Thus, this dietary treatment 
can be considered as a countermeasure to a condition linked to hyperhomocysteinemia as 
physical inactivity: such intervention, moreover, could potentially reduce whole body 
oxidative stress and cardiovascular risk. As abovementioned, in this study the impact of folate 
levels on homocysteine metabolism can be excluded as folate intake was strictly controlled 
and maintained constant (see “Methods”): this strongly suggest that observed effects are 
actually mediated by bed rest and dietary protein control. A recently published work 
demonstrated that supplementation of sulphur amino acids in healthy subjects can reduce 
protein carbonylation and can ameliorate antioxidant response both at muscle and plasma 
level (Zembron-Lacny et al., 2009): this further confirm that protein supplementation can 
interfere with oxidative stress induction at whole body and muscle level. 
Other results (unpublished data) deriving from WISE study show that amino acid and protein 
enriched diet ameliorated another alteration induced by physical inactivity as insulin 
resistance. Strikingly, in fact, protein and amino acid supplemented volunteers showed, after 
bed rest, almost unaltered insulin sensitivity values when compared to pre-bed rest 
assessments. This strongly suggest that high protein and amino acid content in diet can fully 
prevent insulin resistance induction mediated by physical inactivity, confirming the beneficial 
role of such dietary treatment on cardiovascular risk control. Finally, as previously evidenced 
within the WISE study, the protective effect of high protein and amino acid diet on cardiac 
atrophy mediated by bed rest, provides and additional evidence of cardioprotection linked to 
this nutritional regimen (Dorfman et al., 2007). 
Effect of energy balance 
The effect of energy balance control on selected alterations mediated by physical inactivity, 
was presently investigated: whole body composition and thickness of the vastus lateralis 
muscle were monitored in healthy volunteers during Valdoltra Bed Rest 2006 (Study A) and 
2007 (Study B) at different energy intake levels. To assess changes of skeletal muscle and fat-
free mass two independent methods were used. Bioimpedance analysis is a validated method 
for the assessment of fat and fat-free mass in healthy persons; the latter measure is a close 
marker of whole-body muscle mass (Kyle et al., 2004). In parallel, muscle atrophy assessment 
was directly performed by ultrasonography measurement of muscle thickness. This is a 
validated technique for assessing muscle size (Reeves et al., 2004; Miyatani et al., 2002). The 
average thickness of representative postural (vastus lateralis, gastrocnemius medialis, and 
tibialis anterior) and nonpostural (biceps brachii) muscles correlated directly with whole body 
fat-free mass, as determined by bioimpedance analysis, both before and at the end of the bed-
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rest period. Bioimpedance analysis, moreover, showed that most of the subjects accumulated 
body fat to various degrees. Results displayed that those who gained more fat suffered the 
greatest loss of skeletal muscle and fat-free mass. The decrease in thickness of the vastus 
lateralis, a key postural and locomotor muscle, and in total-body fat-free mass after bed rest, 
in subjects with greater increases in body fat, was greater than the decrease measured in 
volunteers with smaller changes in body fat. Additionally, positive energy balance and muscle 
atrophy were associated with activation of the systemic inflammatory response and 
antioxidant defenses. To investigate effects of bed rest and energy balance on antioxidant 
defenses, changes in glutathione metabolism were assessed within the study A. Glutathione is 
highly concentrated in erythrocytes where provides both local and systemic antioxidant 
protection (Richards et al., 1998).  Its synthetic capacity, as marker of activation of 
antioxidant response, was assessed by Western blot determination of expression levels of 
catalytic and modulatory subunits of the glutamate-cysteine ligase enzyme, which catalyzes 
the rate-limiting step in glutathione biosynthesis (Thompson et al., 2000). The actual rate of 
glutathione turnover was determined by a standard approach involving primed continuous 
infusion of deuterated cysteine and by monitoring, by GC-MS analysis in separate sequential 
blood samples, the incorporation of labeled precursor into glutathione (standard approach) 
(Lyons et al., 2001). Glutathione function was evaluated through measurement of glutathione 
peroxidase activity (Paglia and Valentine, 1967). As described in results, subjects were 
stratified a posteriori and divided into two groups accordingly to the median value of 
individual changes in fat mass: subjects showing a fat mass gain greater than the median value 
were assigned to a group defined as higher energy balance (HEBA). Conversely, subjects with 
fat mass changes lower than the median value were assigned to a group defined as lower 
energy balance (LEBA) 
Significant group × bed rest interactions were found for the catalytic subunit of the glutamate-
cysteine ligase enzyme and the rate of glutathione turnover leading to greater bed rest–
mediated increases in glutathione synthesis in the HEBA than in the LEBA group. Glutathione 
peroxidase activity did not change in the 2 groups. Present results indicate that the erythrocyte 
glutathione system is greatly activated during bed rest at positive energy balance, whereas bed 
rest at near-neutral balance is not associated with significant changes in glutathione synthesis. 
Evidence indicates that glutathione synthesis is up-regulated by proinflammatory mediators 
and oxidative stress (Lu, 1999). Significant group × bed rest interactions were found for 
plasma CRP and myeloperoxidase concentrations, which led to greater bed rest–mediated 
increases of these mediators in the HEBA group than in the LEBA group. Plasma CRP and 
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myeloperoxidase are suitable markers of activation of systemic inflammation (Podrez et al., 
2000). These results strongly suggest that an activation of the erythrocyte glutathione system 
is part of the systemic inflammatory and oxidative stress reaction to bed rest at positive energy 
balance. Such inflammatory and oxidative stress response can potentially upregulate 
molecular pathways leading to protein degradation (Kandarian and Jackman, 2006; Powers et 
al., 2007) during inactivity. Moreover, as discussed above, data derived from muscle biopsies 
performed in Valdoltra 2007 study (study B) showed that inactivity mediated inflammation 
and oxidative stress in muscle can induce muscle wasting. This further confirm that changes 
on systemic inflammation and oxidative stress mediated by fat gain during inactivity can 
effectively worsen the reduction of muscle mass and fat-free mass. Interestingly, published 
data showed in an animal model that overfeeding can depress muscle protein synthesis (Glick 
et al., 1982). Thus, enhanced inflammation and oxidative stress induced, during unloading, by 
excessive energy intake could provide reliable explanations for worsened muscle atrophy 
observed in HEB group. Furthermore, an increased ghrelin response after a period of 
overfeeding (Robertson et al., 2004) could contribute to an enhancement of muscle catabolism 
(Nagaya et al., 2005). 
One limitation of the present study is that, typically, only a small number of persons can be 
enrolled in bed-rest studies. The effect of positive energy balance on inactivity-induced 
muscle atrophy was assessed by combining the results of 2 bed rest studies, performed under 
the same experimental conditions and with similar primary outcomes. In contrast, energy level 
× bed rest interactions for inflammatory markers and glutathione kinetics were assessed in 2 
groups of only 5 subjects. Although extending these observations in a larger population would 
reinforce the present findings, it was possible to detect significant differences in key markers 
of inflammatory response and glutathione kinetics.  
Positive energy balance (ie, energy intake in excess of requirements) leads to fat deposition, 
and changes in body fat mass closely reflect energy balance over the long term, even in the 
presence of atrophying muscles. In fact, energy density of fat tissue is 9 times that of muscle 
and fat-free mass (FAO/WHO/UNU, 1985). Study A subjects were allowed to spontaneously 
adapt to decreased energy requirement during bed rest, whereas study B subjects were 
provided an activity-adjusted diet (1.2 times their calculated resting energy expenditure). At 
the end of the bed-rest periods, 9 of 10 study A subjects and 5 of 9 study B participants had 
gained >0.5 kg fat mass. Thus, study A subjects failed to spontaneously adapt to a lower 
energy requirement, whereas, in study B, an activity adjusted diet based on traditional 
predictive equations, overestimated the true requirement for most subjects. Achievement of 
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energy balance during experimental bed rest is a difficult task that involves constant 
monitoring of individual energy requirements and intakes and that goal has rarely been 
attained in previous investigations. Results obtained in the present and in 9 previous bed-rest 
studies reporting positive mean changes in fat mass (Blanc et al., 2000b; Krebs et al., 1990b; 
Gretebeck et al., 1995; Ferrando et al., 1996; Barbe et al., 1999; Lovejoy et al., 1999; Stein et 
al., 1999b; Scheld et al., 2001; Shackelford et al., 2004; Olsen et al., 2008) are shown in 
Figure 21. 
 
Figure 21 
 
Figure 21 shows the relation between average values of absolute changes in fat 
mass and lean mass or fat-free mass measured in previous studies and in the 
present work. Letters inside (or just outside of) circles represent values from these 
studies: a, (Barbe et al., 1999); b, (Scheld et al., 2001); c, (Stein et al., 1999a); d, 
present work, lower energy balance group; e, (Blanc et al., 2000b); f, (Krebs et 
al., 1990b); g, (Lovejoy et al., 1999); h, (Gretebeck et al., 1995); i, present study, 
higher energy balance group; j, (Ferrando et al., 1996); and k, (Olsen et al., 2008). 
R=-0.85, p=0.001; n=11 
 
Changes in fat mass are related to changes in LBM (by dual-energy X-ray absorptiometry) or 
fat-free mass (by bioimpedance analysis). Gain of body fat or loss of lean (fat free) mass is 
expressed as weekly percentage changes from baseline. Linear regression analysis indicates an 
indirect relation between fat gain and lean (fat free) mass loss, regardless of the duration of 
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inactivity. Similar results are obtained by excluding the present study from the analysis (r=-
0.97). Thus, there is excellent agreement between the retrospective analysis and the results 
from the present study, which suggest that, when energy intake is not strictly controlled during 
inactivity, fat mass tends to increase in parallel with LBM catabolism. The present study 
shows that excess fat deposition during physical inactivity is associated with greater muscle 
loss and greater activation of systemic inflammation and antioxidant defenses. Moreover, 
whole body or muscle inflammation and oxidative stress induction can potentially contribute 
to long-term changes in body composition and to the cardiometabolic risk observed in obese 
sarcopenic persons (Honda et al., 2007; Klein et al., 2007). In accordance with presently 
discussed stimulatory effect of positive energy balance on inflammation and oxidative stress 
during inactivity, previously published results obtained within STBR-IP study showed that 
calorie restriction could effectively reduce the concentration of proinflammatory markers 
(Bosutti et al., 2008). In particular, physical inactivity effectively interacted with calorie 
restriction to blunt and reverse inactivity mediated increases in CRP, IL-6 and IL-6 to IL-10 
ratio. Coherently, inactivity and calorie restriction interacted to increase levels of the anti-
inflammatory IL-10 (Bosutti et al., 2008). Thus mild reduction of calorie intake seems to play 
a positive and protective role on systemic inflammation. This could lead to hypothesize a 
beneficial effect also on muscle mass maintenance, but evidences collected in the same study 
design showed that hypocaloric diet during bed rest determines a significantly increased 
muscle atrophy associated to a greater rate of leucine oxidation, as a marker of net protein 
catabolism, and to slightly lowered protein synthesis, in the postabsorptive state (Biolo et al., 
2007b). This effect is strictly dependent on calorie intake as protein administration was 
maintained constant during all study phases.  
 
Effects of calorie restriction on glutamine and BCAA metabolism. 
In the present study, bed rest suppressed glutamine synthesis despite slightly increased 
baseline plasma BCAA concentrations: this suggests an active role of muscle unloading in 
control of amino acid metabolism. In parallel, calorie restriction failed to affect bed rest 
mediated decreases in glutamine availability and kinetics. A significant effect of moderate 
energy restriction was shown only on plasma BCAA concentrations. This may be due to the 
fact that a 20% energy restriction obtained by reduction of fat and carbohydrate intake is not 
strong enough to have detectable results on glutamine kinetics. A potential effect of calorie 
restriction on splanchnic glutamine synthesis (Arola et al., 1981) was not evidenced in this 
study. At present, no comparable previous studies assessed the effect of moderate calorie 
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restriction on glutamine turnover. Nevertheless, previous publications demonstrated that the 
fasting condition can accelerate BCAA release from muscle (Fryburg et al., 1990) and reduce 
their metabolic clearance (Sherwin, 1978). Intravenous infusion of a glutamine-free amino 
acid solution, providing about 32 g of amino acids, increased glutamine de novo synthesis by 
about 14–19% in both ambulatory and bed rest conditions at eucaloric or hypocaloric energy 
intake. This effect can be explained by anaplerotic processes involving carbon skeletons of 
selected amino acids (e.g. alanine, arginine, asparagine, etc.) and by increased nitrogen 
availability from the BCAA. Animal studies showed that hyperaminoacidaemia can, in fact, 
directly increase glutamine turnover (Garber et al., 1976). In addition, a previouslt published 
work showed that muscle glutamine synthesis can be greatly stimulated in postsurgical cancer 
patients by infusion of a BCAA-enriched amino acid mixture (Biolo et al., 2006).  
 
Effects of  nutrition: conclusions 
In this work, results collected from different studies show effects of modulation of energy 
balance and protein intake level on separate parameters affected by bed rest. A protein and 
amino acid enriched diet was shown to blunt physical inactivity mediated increases of plasma 
homocysteine concentrations, as marker of whole body oxidative stress, preferentially 
stimulating transulfuration as catabolic pathway. This confirms that elevation of dietary 
protein intake during inactivity can reduce the impact on whole body oxidative damage and on 
cardiovascular risk, potentially lowering endothelial damage. Such evidence could be 
explained by animal studies showing increased amino acid and protein intake can stimulate 
the activity of enzymes involved in transsulfuration pathway (Ohuchi et al., 2009).  
In parallel, energy balance was shown to actively affect muscle mass maintenance during 
inactivity. While previous publications showed that caloric restriction can enhance inactivity 
induced protein wasting and muscle atrophy in virtue of a reduction of energy intake (Biolo et 
al., 2007b), present data show a novel and unexpected achievement: positive energy balance 
itself can determine a significant reduction of muscle mass during bed rest. Worsened 
inflammatory and oxidative stress condition associated to positive energy balance during 
inactivity could explain the detrimental effect of fat gain on muscle mass maintenance. 
Interestingly, caloric restriction during bed rest was previously shown to attenuate 
inflammatory processes affecting the pattern of selected cytokine concentrations (Bosutti et 
al., 2008): as this dietary regimen worsened sarcopenia progression of volunteers (Biolo et al., 
2007b), involvement of additional factors in muscle mass control during inactivity can be 
hypothesized. Merging together such observations, dietary control of immobilized subjects 
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aimed to maintain neutral energy balance seems to be an eligible choice. This approach could, 
in fact, contemporarily minimize inactivity mediated muscle wasting and the pro-
inflammatory effect of muscle unloading, leaving other parameters unaltered. The lack of 
effect, in fact, of calorie restriction on glutamine availability and kinetics during bed rest, 
suggest that energy balance should not affect the metabolism of such important amino acid.  
Additionally, evidences reported in this work strongly suggest that a safe supplementation of 
dietary proteins or amino acids can successfully blunt inactivity mediated alterations of the 
oxidative stress and inflammation conditions in humans, potentially contributing to counteract 
muscle atrophy and cardiovascular risk induction. Protein intake level could potentially 
interact with changes of energy balance during inactivity: at present, studies investigating the 
effect of a parallel control of these two nutritional parameters during experimental bed rest are 
lacking. 
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